The role of desmoplakin and plakoglobin in desmosome associated disease by Cabral, Rita Meira e Cruz de Vasconcelos
 
 
The role of desmoplakin and 




Rita Meira e Cruz de Vasconcelos Cabral 
 
Supervisors: Prof. David Kelsell 
                   Dr. Andrew South 
 
 




Centre for Cutaneous Research, Blizard Institute of Cell and Molecular Science, 
Barts and The London School of Medicine and Dentistry, Queen Mary, 










The work presented in this thesis is my own unless otherwise stated, and is in 





































Desmosomes are intercellular junctions that connect intermediate filaments (IFs) of 
adjacent cells within tissues, generating a large and mechanically resilient network. 
Desmosomes are prominent in epithelia and the myocardium. Their importance for 
maintenance of the strength and flexibility of these tissues is underlined by mutations in 
desmosomal genes which compromise skin or heart and in some instances both. This 
thesis is focused on two obligate plaque proteins of the desmosome, desmoplakin (DP) 
and plakoglobin (PG), and their role in disease of skin and heart.  
A novel homozygous nonsense mutation, p.S24X, in the gene encoding PG, JUP, was 
identified in three non-consanguineous Argentinean patients, resulting in skin fragility, 
palmoplantar keratoderma (PPK) and woolly hair with no symptoms of 
cardiomyopathy. p.S24X mRNA was readily detected and an alternative AUG codon 
translates an N-terminally truncated PG, which is expressed in patient and parental skin 
samples at barely detectable levels. At the same time another novel homozygous 
mutation, c.468G>A, was identified in JUP causing a very similar phenotype in two 
Kuwaiti siblings and resulting also in very low levels of PG in the skin. These results 
suggest that PG is essential for maintenance of skin integrity, but not for normal heart 
development in children. 
The gene encoding DP, DSP, produces two alternative splice variants, DPI and DPII. A 
novel DP alternative splice isoform, DPIb, is described. As shown by RT-PCR, DSPIb 
is expressed in several epithelial and cardiovascular tissues and is the only DSP isoform 
detected in the aorta. Western blotting proteins from HaCaT and K1 cells identified this 
novel isoform, which has been previously missed due to its similarity in size to DPII. 
DPIb may help compensate defects in patients with DSPI-specific mutations. 
The molecular mechanisms of three different DSP mutations leading to skin disease or 
skin disease associated with cardiomyopathy were investigated. Mutations causing 
DPI/DPII haploinsufficiency and DPI knock-out lead to decreased expression levels of 
the desmosomal proteins DSC2, DSC3 and PKP1 in an experimental system using 
HaCaT keratinocytes. Expression of a mutant DSPI construct harbouring a dominant 30 
bp insertion results in the formation of large DPI aggregates at the cell membrane of 
HaCaT cells. The spectrum of DSP and JUP mutations which cause different clinical 
phenotypes is discussed. 
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ERK   Extracellular signal-Regulated Kinase 
ESE   Exon Splicing Enhancer 
ESS   Exon Splicing Silencer 
EST   Expressed Sequence Tag 
FBS   Foetal Bovine Serum 
g  Standard gravity 
G3PDH  Glyceraldehyde-3-Phosphate Dehydrogenase 
GFP   Green Fluorescent Protein 
GSK   Glycogen Synthase Kinase  
GTP   Guanosine Triphosphate  
h   hour 
HCl   Hydrochloric acid  
HD1   Hemidesmosome associated protein 1 
HEK   Human Embryonic Kidney 
hnRNP   heterogenous nuclear Ribonucleoprotein 
HPRT   Hypoxanthine Phosphoribosyl-Transferase gene 
HpV   Human papilloma Virus 
IA   Intracellular Anchor 
ICS   Intracellular Cadherin-typical Sequence 
IDP  Inner Dense Plaque 
IF   Intermediate Filaments 
IFAP   Intermediate Filament Associated Protein 
IgG   Immunoglobulin G 
IPL   Intracellular Proline-rich Linker 
ISE   Intron Splicing Enhancer 
ISS   Intron Splicing Silencer 
Kb   Kilobase 
KDa   Kilodalton 
LB broth  Luria Bertani broth 
LSM   Laser Scanning confocal Microscope 
LTRs    Long Terminal Repeats 
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LVDC   Left Ventricular Dilated Cardiomyopathy 
M   Methionine 
MACF   Microtubule-Actin Crosslinking Factor 
Mb   Megabase 
MCS   Multiple Cloning Site 
MDCK   Madin-Darby Canine Kidney 
MgCl2   Magnesium Chloride 
min   minute 
miRNA   micro RNA 
M-MLV RT  Moloney Murine Leukemia Virus Reverse Transcriptase 
n  Number of repetitions of a single experiment 
NaCl   Sodium Chloride 
N-cadherin  Neuronal cadherin 
NCBI   National Center for Biotechnology Information 
NEPPK   Non-Epidermolytic Palmoplantar Keratoderma 
NHK   Normal Human Keratinocytes 
NMD   Nonsense Mediated Decay 
nt   Nucleotide 
OD   Optical Density 
ODP  Outer Dense Plaque 
O-GlcNAc  O-N-acetylglucosamine 
p.   protein 
PAGE  Polyacrylamide Gel Electrophoresis  
PBS   Phosphate Buffered Saline 
PBST   PBS-Triton X-100 
PCR   Polymerase Chain Reaction 
PEG   Polyethylene Glycol 
PFA   Paraformaldeyde 
PG  Plakoglobin 
PKC    Protein Kinase C  
PKP   Plakophilin 
PPK   Palmoplantar Keratoderma 
PRD   Plakin Repeat Domain 
PTC  Premature Termination Codon  
qRT-PCR   Quantitative RT-PCR 
RISC   RNA-Induced Silencing Complex 
RNA   Ribonucleic Acid 
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RNAi   RNA interference 
RNase   Ribonuclease 
rpm   revolutions per minute 
RT   Room Temperature 
RT-PCR  Reverse Transcription PCR 
RUD   Repeated-Unit Domain 
RyR   Ryanodine Receptor 
SCF   Skp1-Cullin-F box protein 
SDS   Sodium Dodecyl Sulfate 
SEM   Standard Error of the Mean 
siRNA   short interfering RNA 
SNP   Single Nucleotide Polymorphism 
SPPK   Striate Palmoplantar Keratoderma 
SR   Serine/arginine-Rich 
STE   Sodium-chloride Tris EDTA 
TBE   Tris-Borate EDTA  
TBS   Tris-Buffered Saline 
TCF/LEF  T-Cell Factor/Lymphoid-Enhancer Factor 
TFIIIB   Transcription Factor IIIB 
TGF   Transforming Growth Factor 
TM   Transmembrane 
TTBS   Tween-20 TBS 
U   Unit 
ULF   Unit Length Filaments 
UTR   Untranslated Region 
UV   Ultraviolet  
VE-cadherin  Vascular Endothelial cadherin 
ZO   Zona Occludens 
β-TrCP   β-Transducin repeat Containing Protein 
 
 20
Publications, oral presentations and awards arising 




Peer reviewed publications: 
RM Cabral, L Liu, C Hogan, PJC Dopping-Hepenstal, BC Winik, RA Asial, R 
Dobson, C Mein, P Baselaga, JE Mellerio, A Nanda, M del C Boente, DP Kelsell, JA 
McGrath, AP South (2010). Homozygous mutations in the 5’ region of the JUP gene 
result in cutaneous disease but normal heart development in children. Journal of 
Investigative Dermatology (see Appendix F). 
 
Invited publications:  
Cabral RM and South AP. (2008). Inherited disease of the desmosome. In 
“Pathophysiology of the Desmosome” (Cirillo, N., Lanza, A., and Gombos, F., Eds), 
pp121-156, Research Signpost. Kerala. 
 
Abstracts: 
RM Cabral, L Liu, C Hogan, PJC Dopping-Hepenstal, BC Winik, RA Asial, R 
Dobson, C Mein, P Baselaga, JE Mellerio, A Nanda, M del C Boente, DP Kelsell, JA 
McGrath, AP South. Homozygous mutations in the 5’ region of the JUP gene result in 
cutaneous disease but normal heart development. (abstract/program #453W). Presented 
at the 59th Annual Meeting of The American Society of Human Genetics, October 21, 
2009, Honolulu, Hawaii. Available at http://www.ashg.org/2009meeting/abstracts/
fulltext/. 
 
RM Cabral, BC Winik, RA Asial, C Mein, P Baselga, PJ Dopping-Hepenstal, MC 
Boente, DP Kelsell, JA McGrath and AP South. A novel plakoglobin mutation reveals 
distinct roles for plakoglobin in heart and skin. Journal of Investigative Dermatology 
128, Supplement 1 (April 2008). Presented at the International Investigative 
Dermatology (IID) meeting, May 17, 2008, Kyoto, Japan.  
 
RM Cabral, BC Winik, RA Asial, C Mein, P Baselga, M del C Boente, DP Kelsell, JA 
McGrath, AP South. A novel plakoglobin mutation reveals distinct functional properties 
for plakoglobin in heart and skin. Presented at the Annual William Harvey Research 




Talk at the Institute of Cell and Molecular Science (ICMS) Graduate School Day, 
“Desmosomal defects in skin disease and ARVC”, April 24, 2009, QMUL, London, UK.  
 
Talk at the University of Dundee, “Characterising the roles of desmoplakin isoforms in 
keratinocyte biology”, March 19, 2009, Dundee, UK.  
 
Talk at the Annual Meeting of the British Society for Investigative Dermatology 
(BSID), “Analysing isoform- and tissue-specific functions of desmoplakin” April 8, 





1st prize for Best Oral Presentation at the Institute of Cell and Molecular Science 
(ICMS) Graduate School Day, “Desmosomal defects in skin disease and ARVC”, April 
24, 2009, QMUL, London, UK.  
 
International Investigative Dermatology (IID) 2008 Travel Award supported by the 
European Society for Investigative Dermatology (ESDR), to attend the IID meeting in 
May 2008, Kyoto, Japan.  
 
Travel award, Annual Meeting of the British Society for Investigative Dermatology 






There are many people I would like to thank for the last three years, which on 
the whole have been immensely rewarding and enjoyable. 
Firstly, a special thank you to both my supervisors Andy South and David 
Kelsell for their endless support, guidance and enthusiasm throughout the last three 
years. I was lucky to have two supervisors with such an active interest in my work at all 
times. Andy’s experienced advice and training at the bench were particularly crucial 
during my first year in the lab. 
Lab members during this time, particularly Maxine Holder and Celine 
Pourreyron, were invaluable in my training and integration in the lab. A special thanks 
to Dan Tattersall, who had an enourmous input in my work thereafter, for his infinite 
encouragement, friendship and invaluable theoretical and technical advice as well as for 
thorough and critical reading of this thesis. 
I would like to thank Graham Neill for his extensive help with retroviral 
transductions, Charles Mein and Richard Dobson for SNP array data analysis, 
Dominique Abrams for providing atrium tissue samples and Clare Cole for assistance 
with qPCR experiments. I would also like to thank other lab members, past and present, 
and everyone in the Centre for Cutaneous Research, in particular Georgie Cox, Trond 
Aasen, Claire Scott, Diana Blaydon, Tiago Matos, Anna Thomas, Claire Sinclair, 
Shefali Rajpopat, Kathrin Smuda, Manos Papadakis, Rudolf van Koningsveld, Manu 
Singh and Monika Cichon for their friendly advice, help and support in one way or 
another, and for making the lab a fun place to be. 
 Finally a very special thank you to the following people who have contributed to 
the successful completion of this work: Joana Martins, Vera Martins, Neil Cummins, 
Ana Marta Diniz and Lynne Archibald for their exceptional friendship; my granny 
Matilde M Cruz for her day to day support and caring; and my dad Luis Cabral who has 













Chapter 1 - Introduction 
 24
1.1. The skin 
The skin and its appendages, which in humans consist of hair, nails, sebaceous 
glands and sweat glands, form a physical barrier that covers the whole surface of the 
organism and protects it from the external environment. The specialised functions of the 
skin include protection and defence of the body from external microorganisms, water 
loss and UV radiation; exchange of gases and solutes, excretion of wastes, temperature 
regulation as well as synthesis and storage of nutrients. The skin is also a sensory organ 
capable of detecting pain, sensation, pressure, temperature, and assaults by external 
microorganisms or other chemical and physical stresses (Proksch & Jensen, 2007). 
The skin is the largest organ of the human body and is comprised of two major 
regions, the epidermis and the dermis, which are described below (sections 1.1.1 and 
1.1.2). Underneath the dermis there is another layer called the hypodermis or 
subcutaneous adipose layer, which is formed of connective tissue, elastin, large blood 
vessels, sweat glands and nerves. This layer contains about 50% of fat tissue and its 
main functions are to connect the skin to the underlying muscle and bone, to conserve 
the body’s heat and to serve as insulation or shock absorber for the body (Haake et al., 
2001). 
 
1.1.1. The epidermis 
The epidermis is the outermost region of the skin and originates primarily from 
the embryonic ectoderm (Blanpain & Fuchs, 2009). The thickness of the epidermis 
ranges from 0.05 mm (on the eyelids) to 1.5 mm (on palms and soles), which is usually 
only a small fraction of the full thickness-skin which varies between 1.5 mm and 4 mm. 
The skin epidermis and its appendages play the major role in providing the protective 
barrier to the body. Because they are constantly assaulted by physical, chemical and 
mechanical traumas, these tissues continuously regenerate and are capable of 
responding to injury by repairing wounds and damaged areas (Fuchs, 2007).  
The epidermis is a multilayered or stratified squamous epithelium composed of 
different types of cells, namely melanocytes, Largerhans cells, Merkel cells and 
keratinocytes (Chu, 2008). Melanocytes are dendritic cells found in the basal layer of 
the epidermis and are responsible for the production of the photoprotective pigment 
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melanine. This pigment is accumulated in specialised organelles called melanosomes, 
which are then transferred into other epidermal cells. In recipient cells, melanosomes 
localise over the nucleus to protect the DNA from the harmful effects of ionising UV-
radiation (Boulais & Misery, 2008). Largerhans cells are another type of dendritic cells 
found in the spinous layer of the epidermis. They are antigen-presenting cells which 
respond to a skin infection by internalising and processing the antigen, which is then 
recognised by immune cells in local lymph nodes (Boulais & Misery, 2008). Merkel 
cells are present in the basal layer of the epidermis and are usually closely associated, in 
a synapse-like like fashion, with the ends of nerve fibres. These complexes are 
designated as Merkel nerve endings and constitute one of the skin mechanoreceptors. 
They are sensitive to touch, pressure, texture and low frequency vibrations. In response 
to these stimuli, Merkel cells release neurotransmitters or neuromodulators which are 
sensed by the nerve terminals and transmitted to the brain (Halata et al., 2003). 
Keratinocytes constitute 95% of the epidermis and populate, from the bottom to 
the top, basal, spinous, granular and cornified layers, according to their differentiation 
stage (Figure 1.1). The innermost basal layer is a single cell layer of keratinocytes 
which have the unique property of being able to undergo mitosis. These cells 
continually exit the cell cycle and commit to the program of terminal differentiation. 
During this process, keratinocytes move upwards until they reach the uppermost layer, 
or cornified layer, at the skin surface. At this stage, these cells are dead, enucleated and 
flattened squames ready to be shed from the skin surface (Figure 1.1). The whole 
process of terminal differentiation (also called keratinisation or cornification), since the 
keratinocyte leaves the basal layer until it is slough from the surface, takes 
approximately four weeks (Fuchs, 2009). The correct balance between proliferation and 
differentiation must occur in order to maintain a constant number of cells within the 
epidermis, a process called homeostasis (Fuchs, 2007). 
The keratinocyte transcriptional profile, morphology and biochemistry change as 
it moves from the bottom to the top of the epidermis. Basal keratinocytes express 
keratin 5 and keratin 14 which form the cytoskeletal network of keratin IFs (IF proteins 
are described in section 1.4). As they move to the spinous layer, keratin 5 and keratin 14 
expression switches to keratin 1 and keratin 10, and this switch marks the beginning of 
the differentiation process. Keratinocytes in spinous and granular layers are post-mitotic 
but still metabolically active. When in the granular layer, these cells express the 
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cornified envelope glutamine- and lysine-rich proteins, such as involucrin, which 
accumulate beneath the plasma membrane. These cells also synthesize keratohyaline 
granules which are mainly formed by pro-filaggrin. Pro-filaggrin is the precursor of 
filaggrin, a histidine-rich protein that participates in the formation of large keratin-IF 
aggregates when cells transit to the cornified layer. Loricrin is another protein produced 
in the granular layer and is the main constituent of the cornified envelope, together with 
involucrin. Finally, an increase of intracellular calcium activates transglutaminase 1 
which biochemically cross-links the envelope proteins (such as involucrin, envoplakin, 
and periplakin) forming a macromolecular complex that lies underneath the plasma 
membrane and is reinforced by lipids. This macromolecular protein- and lipid-complex 
surrounds the keratin macrofibrillar aggregates of the dead corneocytes, which are now 
impermeable and insoluble protective structures, devoid of organelles and plasma 
membrane, at the skin surface (Fuchs, 1990; Fuchs, 2007; Houben et al., 2007; Proksch 




Figure 1.1. Schematic structure of the human epidermis. The different epidermal layers 
indicative of distinct keratinocyte differentiation stages are shown, including the basal, spinous, 
granular and cornified layers. 
 
1.1.2. The dermis 
The dermis is the region of the skin below the epidermis and its primary 
functions are to provide a physical support (including flexibility and tensile strength) 
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and also a supply of nutrients to the epidermis. The dermis is also involved in thermal 
regulation and contains receptors of sensory stimuli. It is mainly composed of 
connective tissue and in contrast with the epidermis, it is primarily derived from the 
embryonic mesoderm (Haake et al., 2001). 
The dermis is divided into two regions, the more superficial papillary dermis and 
the deeper reticular dermis. The papillary dermis contains blood vessels, which are 
essential to deliver nutrients to and receive wastes from the avascular epidermis. These 
exchanges are made via the dermal-epidermal junction (section 1.1.3), which is the 
region between the epidermis and the dermis. The papillary dermis also contains elastic 
and fibrous tissue and sensory nerve endings. Fibroblasts, which represent the major 
cell type in the dermis, are predominant in the papillary dermis, essentially in the 
dermal papillae which is the region just adjacent to the epidermis. Fibroblasts have 
mesenchymal origin and are responsible for the synthesis and maintenance of precursors 
of the extracellular matrix (ECM) components, including collagen and elastin fibres. 
Collagens are the most abundant components of the dermis (approximately 75% of its 
weight) and provide strength and resistance to the skin. Elastic fibres (such as elastin) 
constitute a very small fraction of the dermis (approximately 4% of the dermal matrix-
protein dry weight) and are responsible for the flexibility and resilience of the skin. The 
deeper reticular dermis is the thickest region of the dermis and is composed of larger 
blood and lymph vessels, thicker elastic and collagen bundles as well as nerve endings 
and epidermal appendages (Chu, 2008; Haake et al., 2001). 
The ECM, which is mainly produced by fibroblasts in the dermis, is a complex 
and heterogeneous interconnected network of macromolecules, including proteins and 
polysaccharides. These macromolecules form a gel-like structure that surrounds cells 
and can also be present in basement membranes. This molecular arrangement provides a 
scaffold through which cells can move (Lodish et al., 2003). Besides collagens and 
elastic fibres, this matrix also contains non-collagenous glycoproteins such as 
fibronectin (which cross-links cell surface proteins and other ECM components), 
laminins (which are adhesion molecules) and proteoglycans (which support cells) as 
well as hyaluronic acid (which resists compressive forces). The dermal ECM serves not 
only as a static structural support for the epidermis, but is also highly dynamic due to 
the constant turnover and remodelling of its components which influences cell 
behaviour. Growth factors and signalling molecules (such as cytokines) can be 
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produced either by keratinocytes in the epidermis or fibroblasts in the dermis under 
regulated conditions, which signal through membrane-bound receptors (Werner & 
Grose, 2003) (see sections 1.2 and 1.2.1.3) to control processes such as cell growth and 
differentiation. 
 
1.1.3. The dermal-epidermal junction 
The dermal-epidermal junction (DEJ) is the region that separates the epidermis 
from the dermis. The cutaneous basement membrane zone (BMZ) is included in this 
region and represents the interface between cells (in the epidermis) and their 
surrounding connective tissue (in the dermis) (Figure 1.2). The DEJ is composed of four 
distinct regions that can be distinguished by electron microscopy: (1) the plasma 
membrane of the basal keratinocyte; (2) the lamina lucida; (3) the lamina densa; (4) the 
sub-basal lamina densa (Burgeson & Christiano, 1997). The lamina lucida and 
lamina/sub-basal lamina densa compose the BMZ (Woodley & Chen, 2001). The 
plasma membrane of basal keratinocytes contains hemidesmosomes (see section 
1.2.1.3) which are anchoring points for keratin IFs (Figure 1.2). The lamina lucida is 
transversed by anchoring filaments which are thin threadlike structures consisting of 
laminin 5 that connect hemidesmosomes to the lamina densa. The lamina densa is 
connected to the underlying dermis through anchoring fibrils which are fibrillar 
structures composed mainly of collagen VII. Therefore, basal keratinocytes are 
connected to the dermis through a very complex series of protein-protein interactions 
which provide the DEJ with a high level of mechanical stability. These protein-protein 
interactions occur within the anchoring complex which is formed by hemidesmosomes 
together with anchoring filaments and anchoring fibrils. The DEJ serves as a support for 
the epidermis while it is selectively permeable to certain molecules and cells between 
the epidermis and the dermis. It also influences keratinocyte behaviour in terms of cell 
polarity, proliferation, differentiation and migration as well as playing roles in wound 
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1.2. Keratinocyte adhesion and communication within the skin 
In the development of multicellular organisms, differentiated cells of a certain 
type are organised into tissues, which in turn are organised into organs that perform 
specific functions. For a group of cells to become part of a specific tissue, molecular 
interactions have to occur at the cellular level, which allow cells to communicate with 
each other. Another very important characteristic of cells is their ability to adhere to one 
another and perform given functions in a spatial and temporal manner. Adhesion and 
communication among cells and between cells and their extracellular environment are 
therefore crucial for morphogenesis and to maintain tissue integrity (Green & Gaudry, 
2000). These molecular interactions depend on the expression of a wide range of 
specific adhesion molecules, which is tightly regulated in space and time (Lodish et al., 
2003). 
There are two basic types of cell junctions, namely cell-cell and cell-matrix 
junctions. Cell-cell (or intercellular) junctions connect one cell to another. Cell-matrix 
junctions occur where one cell adheres to components of the surrounding ECM (Figure 
1.2). Cell junctions can also be organised into three functional groups, namely 
occluding junctions, anchoring junctions and communicating junctions (Figure 1.3). In 
vertebrates, occluding junctions are represented by tight junctions, which are specialised 
to seal cells together and to create a diffusion barrier (see below). Anchoring junctions 
are important to strongly hold cells (and their cytoskeletons) together or cells to the 
ECM. Communicating junctions, represented by gap junctions in vertebrates, are 
responsible for the interchange of small molecules and solutes between the cytoplasm of 
adjacent cells (Alberts et al., 2002; Lodish et al., 2003). Figure 1.3 shows a basic 
schematic of these three types of cell junctions and their representatives in animal 
(vertebrate) tissues and Figure 1.2 shows their localisation in basal epidermal cells. 
A common feature of tight junctions and anchoring junctions is their structural 
composition and organisation. Firstly, the adhesive interface between adjacent cells is 
mediated by a complex of transmembrane proteins designated as cell adhesion 
molecules (CAMs). In a similar way, the adhesive interface between cells and the ECM 
is accomplished by transmembrane adhesion receptors. These adhesion molecules 
interact extracellularly to seal two cells together or one cell to the ECM. Secondly, 
CAMs or adhesion receptors are connected to the cytoskeleton or to signalling 
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Figure 1.2. Schematic diagram of epithelial cell-cell and cell-matrix junctions. Cell-cell 
junctions include tight junctions (in green), adherens junctions (in grey), desmosomes (in 
purple) and gap junctions (in orange), connecting two basal keratinocytes. Cell-matrix junctions 
include hemidesmosomes (in blue) and focal adhesions (in pink), connecting the basal 
keratinocytes to the basement membrane zone (BMZ). Adherens junctions and focal adhesions 
are shown to be connected to actin microfilaments (in light blue). Desmosomes and 
hemidesmosomes are connected to keratin IFs (in red). Adhesion in hemidesmosomes and focal 
adhesions is mediated by integrins (in green), which are involved in connecting the plasma 
membrane of basal keratinocytes to the BMZ. Adhesion in desmosomes and adherens junctions 
is mediated by cadherins (in black), which are involved in bonds between two keratinocytes. 
Adapted from Green and Gaudry (2000). 
 
 There are four kinds of anchoring junctions, namely adherens junctions, 
desmosomes, hemidesmosomes and focal adhesions (see Figures 1.2 and 1.3). Adherens 
junctions and desmosomes (in blue, Figure 1.3) participate in cell-cell adhesion and 
their transmembrane adhesion proteins belong to the cadherin family. In contrast, 
hemidesmosomes and focal adhesions (in green, Figure 1.3) participate in cell-matrix 
adhesion and their transmembrane adhesion proteins belong to the integrin family (see 
below and Figure 1.2) (Alberts et al., 2002). Both desmosomes and hemidesmosomes 
are connected to the resilient IF cytoskeleton. In contrast, adherens junctions and focal 
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adhesions are linked to the actin microfilament cytoskeleton at cell-cell or cell-matrix 
interfaces (Fuchs & Raghavan, 2002; Getsios et al., 2004b). Tight junctions are also 
linked to actin microfilaments (dashed line, Figure 1.3 and Figure 1.2) (Getsios et al., 
2004b). Although governed by similar architectural principles, each of these junctions 




Figure 1.3. Functional classification of the vertebrate cell junctions. Schematic diagram of 
the three major types of cell junctions - occluding, anchoring and communication junctions - 
and their representatives in vertebrate animals. Occluding junctions are represented by tight 
junctions and communicating junctions are represented by gap junctions in vertebrates. 
Anchoring junctions are represented by adherens junctions and focal adhesions, which are 
connected to the actin microfilament cytoskeleton and by desmosomes and hemidesmosomes, 
which are connected to the IF cytoskeleton. Tight junctions, adherens junctions, desmosomes 
and gap junctions (in blue) are cell-cell junctions, while focal adhesions and hemidesmosomes 
(in green) are cell-matrix junctions. 
 
Cell junctions are abundant in epithelial tissues, which all share the common 
functions of selective barrier and protection. Tight junctions contribute to this 
permeability barrier function by creating the diffusion barrier between the apical and 
basolateral membrane domains of these polarised epithelial cells (Green & Gaudry, 
2000). Besides being physically attached to one another and to the underlying basement 
membrane by anchoring junctions, epithelial cells are also chemically linked by 
intercellular channels or communicating junctions known as gap junctions (Getsios et 
al., 2004b). All together, these junctions are crucial to maintain the strength and 
flexibility of epithelial tissues which contribute to their protective function. The two 
basic types of interactions, named cell-cell and cell-matrix adhesion, therefore permit 
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the integration of cells into tissues and the transfer of information among cells and with 
their environment (Lodish et al., 2003). 
 
1.2.1. An overview of cell-cell and cell-matrix adhesion junctions 
 
1.2.1.1. Tight junctions 
Tight junctions contribute to the selective barrier function of epithelial tissues by 
separating the extracellular fluids that surround the apical and basolateral membranes of 
each polarised cell. This is accomplished by the formation of thin sealing bands of 
transmembrane proteins that totally surround each cell, and that interact with a similar 
array of transmembrane proteins in the neighbouring cell. Tight junctions can also 
control the paracellular transport of ions and solutes in between cells. The efficiency 
with which tight junctions restrict the transfer of ions between the membranes of two 
adjacent cells depends on the number of sealing bands composing the tight junction. 
The higher the number of sealing bands between two cells, the less permeable the tight 
junction is. Each sealing strand is formed by a long row of the transmembrane adhesion 
proteins, claudins and occludins, which interact in the intercellular space via their 
extracellular domains. The claudin gene family encodes multiple isoforms which have 
tissue-specific expression profiles. Claudins and occludins interact inside each of two 
apposing cells with intracellular peripheral membrane proteins named ZO-1, ZO-2 and 
ZO-3, which are cytoplasmic adaptor proteins. ZO proteins are in turn connected to the 
actin microfilament cytoskeleton. Many other proteins can be found associated with 
tight junctions, which are involved in the recruitment of binding partners and in the 
regulation of epithelial cell polarity (Alberts et al., 2002; Hartsock & Nelson, 2008; 
Lodish et al., 2003). 
 
1.2.1.2. Anchoring junctions involved in cell-cell adhesion 
 The transmembrane glycoprotein components of both adherens junctions and 
desmosomes belong to the large cadherin family of calcium-dependent adhesion 
molecules. Desmosomes are the major cell-cell anchoring junction in the epidermis and 
will be described in detail in the following sections. 
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Adherens junctions are formed by homophilic associations of members of the 
classical cadherin sub-family. Approximately 20 members of this sub-family have been 
described, which were originally named according to the tissue where they are 
predominantly expressed, i.e., E- (epithelial), VE- (vascular endothelial) and N- 
(neuronal) cadherins (Rudini & Dejana, 2008). It is currently known that each cadherin 
can be expressed in a variety of different tissues. The extracellular domains of classical 
cadherins associate via cis- (between molecules of the same cell) and trans- (between 
molecules of apposing cells) interactions in the intercellular space, and the cytoplasmic 
tails bind to the adaptor proteins of the catenin family. Members of the catenin family 
perform various functions, such as stabilisation of cadherins, organisation of the actin 
cytoskeleton and involvement in intracellular signalling pathways that control gene 
transcription. Four major catenins are involved in adherens junction formation, namely 
PG, β-catenin, p120-catenin and α-catenin. PG, β-catenin and p120-catenin belong to 
the armadillo family of junctional and signalling proteins, whereas α-catenin has 20-
30% sequence homology with vinculin (Herrenknecht et al., 1991), which is another 
actin-binding protein present in adherens junctions as well as focal adhesions (see 
section 1.2.1.3). Both p120-catenin and β-catenin interact with the cytoplasmic tail of E-
cadherin. Binding of p120-catenin is thought to be required to stabilise E-cadherin at the 
plasma membrane. β-catenin links E-cadherin to α-catenin which in turn interacts with 
actin microfilaments (Green & Gaudry, 2000). Although α-catenin interacts directly 
with both β-catenin and F-actin, this interaction might be mutually exclusive (Hartsock 
& Nelson, 2008; Yamada et al., 2005). P120-catenin, PG and β-catenin can translocate 
to the nucleus and interact with transcription factors (Rudini & Dejana, 2008). The 
amount of β-catenin that is not junction-bound is either degraded by the ubiquitin-
proteasome pathway or translocates to the nucleus, where it interacts with transcription 
factors of the T-cell factor/lymphoid-enhancer factor (TCF/LEF) family. Wnt signals 
lead to protection of β-catenin from degradation, which is then free to translocate to the 
nucleus. In the absence of Wnt signalling, the fraction of free β-catenin in the cytoplasm 
is very low. P120-catenin can interact with kaiso, a zinc finger transcription factor that 
represses target gene expression, and relieve its repression effect. P120-catenin is also 
regulated by the Wnt signalling pathway (Hartsock & Nelson, 2008; Jamora & Fuchs, 
2002; Rudini & Dejana, 2008). 
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1.2.1.3. Anchoring junctions involved in cell-matrix adhesion 
Hemidesmosomes are multiprotein complexes involved in linking epithelial cells 
to the underlying basement membrane. In the skin, they anchor basal epidermal 
keratinocytes and their keratin IF cytoskeleton to the lamina lucida and are connected to 
the lamina densa by anchoring filaments (see section 1.1.3). Hemidesmosomes are 
composed of: (1) cytoplasmic plaque proteins which link the IF cytoskeleton to the 
cytoplasmic surface of the cell membrane; (2) transmembrane proteins, which connect 
the cytoplasmic side of the cell to the ECM; and (3) basement membrane-associated 
proteins of ECM (Green & Jones, 1996). The cytoplasmic components include bullous 
pemphingoid antigen 230 (BP230 or BPAG1) and plectin, HD1, IFAP 300 and P200. 
BP230 and plectin belong to the plakin family of proteins which are cytoskeleton 
binding proteins. These molecules interact with keratin IFs. The transmembrane 
components include bullous pemphingoid antigen 2 (BPAG2, BP180 or collagen XVII) 
and α6β4 integrin (Borradori & Sonnenberg, 1996). These molecules are essential for 
hemidesmosome formation and for adhesion of keratinocytes to the ECM. BPAG2 
interacts with the other transmembrane protein, α6β4 integrin. BPAG2 also binds 
BP230 and plectin which are involved in IF attachment. Finally, α6β4 integrin interacts 
with laminin 5, which is the ECM ligand. Laminin 5 in turn associates with the collagen 
VII-containing anchoring fibrils (Borradori & Sonnenberg, 1996; Green & Jones, 1996). 
Focal adhesions and related structures (focal contacts, fibrillar adhesions and 
podosomes) are large and very dynamic multiprotein assemblies that (like 
hemidesmosomes) mediate adhesion of the cell cytoskeleton to the ECM. Cells use this 
type of contact, which comprises over 100 different proteins that are constantly being 
remodelled in response to signals and mechanical forces, for processes including 
motility, migration and morphogenesis. Focal adhesions are also signalling centres that 
convey information across the cell membrane and therefore play roles in the regulation 
of cell proliferation, differentiation and survival. Cell anchorage to the ECM by focal 
adhesions is also mediated by integrins, which are connected to actin microfilaments 
through the plaque proteins vinculin, talin, paxillin and tyrosine-phosphorylated 
proteins and to the ECM by fibronectin, laminin and collagen among other proteins. The 
Rho-family of GTPases, which are important molecular switches involved in the control 
of cytoskeletal assembly and contraction, stimulate the formation of focal adhesions. 
Enzymes including kinases, phosphatases, proteases, and lipases also contribute to the 
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formation and regulation of these adhesion complexes (Geiger et al., 2001; Wozniak et 
al., 2004). 
 
1.3. The desmosome: a specialised cell-cell anchoring junction 
Desmosomes were observed for the first time by the Italian pathologist Giulio 
Bizzozero in 1864, during his examination of the spinous layer of the epidermis under a 
light microscope. Notably, he described them as small dense nodules, subsequently 
named “nodes of Bizzozero”, at sites of adhesion between adjacent cells (Bizzozero, 
1864; Bizzozero, 1870). In 1920, Josef Shaffer named these nodules desmosomes, a 
name that originates from the Greek words “desmo”, which means bond and “some”, 
which means body (Schaffer, 1920). With the introduction of electron microscopy 
around 1944, a series of morphological studies emerged which revealed a high level of 
organisation within the desmosome (Calkins & Setzer, 2007). These studies led to a 
general view of the desmosome as structural “spot welds”, based on their ultrastructural 
appearance, while their biological importance in intercellular communication and 
signalling was not yet considered. In 1974, Skerrow and Matoltsy isolated desmosomes 
from bovine epidermis and separated the desmosomal components by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). They identified eight large 
protein bands and characterized the chemical nature of these proteins. They correctly 
deduced that interactions between the glycoproteins (cadherins) were responsible for 
intercellular adhesion (Skerrow CJ. & Matoltsy AG., 1974a; Skerrow CJ. & Matoltsy 
AG., 1974b). This work marked a shift from the morphological era to the biochemical 
characterization and functional analysis of desmosomal components (Bass-Zubek & 
Green, 2007). 
Desmosomes are classically known for their importance in intercellular adhesion 
and maintenance of tissue integrity. These junctions are specialised to form strong 
bonds between cells. Moreover, since each desmosome is connected to the IF 
cytoskeleton of two different cells, this resilient desmosome-IF network functions to 
distribute the physical impacts throughout tissues. Desmosomes therefore confer 
mechanical stability to a wide range of tissues, particularly epithelia (including 
epithelial cells of the skin, intestine, stomach, bladder, uterus, oviduct, liver, pancreas, 
salivary glands, thyroid gland and nephron) and the myocardium (Garrod & Chidgey, 
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2008; Holthofer et al., 2007). Desmosomes are also present in meningeal cells and the 
follicular dendritic cells of lymph nodes (Green & Gaudry, 2000). 
 
1.3.1. Ultrastructural organisation  
When observed under a transmission electron microscope, the desmosome can 
be divided into three highly organised regions: (1) an extracellular light space bisected 
by an electron-dense midline (Odland, 1958), designated as the extracellular core 
domain (ECD); (2) two symmetrical cytoplasmic electron-dense plaques lying parallel 
to the plasma membranes of two apposing cells, called the outer dense plaques (ODP); 
and (3) two slightly less dense plaques located next to the ODP, named inner dense 
plaques (IDP). The cytoskeletal IF network is attached to the plasma membrane at the 
desmosomal IDP (North et al., 1999). Figure 1.4 shows an electron micrograph of the 
desmosome where these three regions are highlighted. The ECD (or ‘desmoglea’) is 
approximately 34 nm wide (Al-Amoudi et al., 2004) and only shows the electron dense 
midline in mature desmosomes. This midline is lost from desmosomes in wounded 
epidermis or cultured keratinocytes in a “wounded” monolayer (Garrod et al., 2005 and 
see section 1.5; Wallis et al., 2000). The thickness of both the ODP and the IDP is 
approximately 15-20 nm and the electron-lucent space separating both plaques is about 
8 nm wide (North et al., 1999). The diameter of the desmosome is less then 1 µm 
(Garrod & Chidgey, 2008). 
The size and morphology of the desmosome differ between tissues (Cowin et al., 
1985) and in different regions of the same tissue. For instance, desmosomes are larger 
in palm epidermis compared to breast epidermis (Wan et al., 2003) and are also larger 
and more electron dense in the suprabasal layers of the differentiating epidermis 
compared to smaller and less organised desmosomes in the basal proliferating layer 
(Green & Simpson, 2007). 
 
1.3.2. Molecular composition 
The major components of desmosomes consist of two desmosomal-specific 
cadherin family members, desmogleins (DSGs 1-4) and desmocollins (DSCs 1-3), and 
several cytoplasmic plaque proteins. The plaque proteins comprise members of the 
armadillo family of nuclear and junctional proteins, such as PG and plakophilins 1-3 
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(PKPs 1-3), and members of the plakin family, such as DP (Figure 1.4). Although a 
minimal group of these core proteins is sufficient to form a desmosome, additional 
proteins adapt the desmosome to cell type-specific functions. These additional proteins 
include the plakin members of the cornified envelope envoplakin and periplakin and the 
corneodesmosome protein corneodesmosin, among others (Desai et al., 2009; Yin & 
Green, 2004). 
The N-terminal domains of the desmosomal cadherins interact in the 
intercellular space to couple the two halves of the desmosome and constitute the 
adhesive ECD. Interactions between these proteins in the extracellular space form the 
electron dense midline observed by electron microscopy (Figure 1.4 and section 1.3.1). 
The C-terminal tails of these proteins span the plasma membrane into the ODP region 
and interact directly with PG and PKPs (Cowin, 1994; Garrod & Chidgey, 2008; 
Getsios et al., 2004b; Hatzfeld, 1999; Kowalczyk et al., 1994; Schmidt & Jager, 2005). 
DP, which extends into the IDP, is responsible for the incorporation of IFs into the 
desmosomal plaque (Green & Hobbs, 2006; Hatsell & Cowin, 2001). The N-terminus of 
DP is important to organise the desmosomal complex, by recruiting the desmosomal 
cadherins to the plasma membrane through interactions with PG (Kowalczyk et al., 
1997) and PKPs (Kowalczyk et al., 1999). The C-terminal tail binds to IFs 
(Stappenbeck et al., 1993) (see section 1.3.2.2.2). The stability of the desmosome is 
increased through lateral interactions among these and other proteins within the 
desmosomal plaques (Green & Hobbs, 2006). Figure 1.4 shows a basic schematic of the 
desmosome composition and relative positions of its main proteins. 
Both desmosomes and adherens junctions are composed of different proteins, 
most of which belong to the same gene families (North et al., 1999; Yin & Green, 
2004). In both cases the protein chain starts with a cadherin family member, which 
binds an armadillo protein (β-catenin or PG in adherens junctions and PG in 
desmosomes). These armadillo proteins in turn bind to adaptor proteins (α-catenin in 
adherens junctions and DP in desmosomes) which belong to different gene families. 
This final link diverges to hold the different types of cytoskeletal fibres (actin 
microfilaments in adherens junctions and IFs in desmosomes) (Yin & Green, 2004). In 
the desmosome, PKPs interact with the desmosomal cadherins and DP, but also with PG 
(PKP2) and IF proteins (PKP2 and PKP3) (Bonne et al., 2003; Chen et al., 2002). 
Moreover, certain desmosomal cadherins can interact directly with DP in the absence of 
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PG (Bornslaeger et al., 2001; Smith & Fuchs, 1998; Troyanovsky et al., 1994). The 
existence of additional protein-protein interactions in these junctions suggests a higher 
level of specialisation, with each protein in the desmosomal plaque participating in 
multiple interactions with other partners. This observation, coupled to the fact that 
desmosomes arose later in metazoan evolution then their relatives, adherens junctions 
suggests that this more complex protein arrangement could provide greater tensile 




Figure 1.4. Structural organisation of the Desmosome. Schematic diagram of the desmosome 
(left hand side) showing the relative localisation of the desmosomal cadherins (desmocollins 
and desmogleins), plaque proteins (plakoglobin, plakophilins and desmoplakin) and keratin 
intermediate filaments, and electron micrograph of a human epidermal desmosome (right hand 
side) showing ultrastructural domains: IDP, inner dense plaque; ODP, outer dense plaque; ECD, 
extracellular core domain. Adapted from South (2004). Electron micrograph courtesy of Dr. 
Beatrice Winik (Servicio de Microscopía Electrónica, INSIBIO, Universidad Nacional de 
Tucumán—CONICET, Tucumán, Argentina). 
 
1.3.2.1. The desmosomal cadherins form the adhesive core 
The desmosomal cadherins are single-pass transmembrane glycoproteins 
encoded by seven individual genes (DSC1-3 and DSG1-4) localised in chromosome 18. 
Each of the three DSC genes generates two splice variants through alternative splicing, a 
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longer ‘a’ isoform and a shorter ‘b’ isoform that differ in the length of the C-terminal 
tails (Green & Simpson, 2007) (see Figure 1.5A). 
All cadherins have three functional domains. The first is an extracellular N-
terminal domain which is calcium-dependent and important for intercellular 
associations. This region includes four highly conserved repeat subdomains (EC1 to 
EC4) and the more variable extracellular anchor subdomain (EA). The EC domains are 
separated by flexible linkers, which can accommodate up to three calcium ions each 
(Garrod et al., 2005). The second is a single transmembrane domain (TM). The third is 
a cytoplasmic domain which interacts with plaque proteins. This domain includes the 
intracellular anchor (IA) and the intracellular cadherin-typical sequence (ICS). Both 
DSC ‘a’ and ‘b’ splice variants have an IA domain, but only the ‘a’ proteins have the 
complete ICS domain, whereas ‘b’ isoforms have a truncated version of this domain. 
The ICS domain is responsible for PG binding and therefore the ‘b’ splice variants are 
not able to interact with PG (Troyanovsky et al., 1993), but can instead associate with 
the plaque protein PKP3 (Bonne et al., 2003). The DSGs contain an extra cytoplasmic 
region downstream of the ICS which is absent from DSCs. This region is formed by an 
intracellular proline-rich linker (IPL) domain, a variable number of repeated-unit 
domains (RUD) and a glycine-rich DSG terminal domain (DTD) (Delva et al., 2009; 
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Figure 1.5. Structure of desmosomal proteins. (A) Domain structure of the desmosomal 
cadherins, DSG1-4 and DSC1-3. All desmosomal cadherins contain an extracellular domain 
formed by four conserved repeat subdomains (EC1 to EC4) and a variable extracellular anchor 
subdomain (EA), which is followed by a transmembrane subdomain (TM). Intracellularly, they 
possess an intracellular anchor domain (IA) followed by an intracellular cadherin-typical 
sequence (ICS). Additionally, DSGs 1-4 have an intracellular proline-rich linker (IPL) domain, 
a variable number of repeated-unit domains (RUD) and a glycine-rich DSG terminal domain 
(DTD). Alternatively, the intracellular domain of the ‘a’ splice variants of DSCs 1-3 have only 
the IA and ICS domains and the intracellular domain of the ‘b’ splice variants have a truncated 
version of the ICS domain followed by a number of unique amino acids (purple segment). (B) 
Armadillo proteins PG and PKPs 1-3. PG has 13 arm-repeat domains (armadillo repeats) and 
PKPs have nine arm-repeat domains with an insert between repeats five and six (red insert) 
which creates a bend in these proteins. PKP1 and PKP2 exist as two splice variants, ‘a’ and ‘b’. 
PKP1b has 21 extra amino acids between arm-repeats three and four compared to PKP1a and 
PKP2a and 2b differ by the insertion of 44 amino acids between arm-repeats two and three. (C) 
DPI and DPII splice variants. The N-terminal plakin domain is formed by six α-helical 
fragments (NN, Z, Y, X, W and V) which form an antiparallel α-helical bundle. This domain is 
followed by a central coiled-coil rod domain and a C-terminal tail containing subdomains A, B 
and C which are the plakin repeat domains (PRD). Adapted from Desai et al. (2009). 
 
Both homophilic and heterophilic interactions have been shown to occur in vitro 
between DSCs and DSGs. These interactions are thought to occur both in cis (between 
molecules in the same cell) and trans (between molecules of adjacent cells) 
conformations (Garrod & Chidgey, 2008; Getsios et al., 2004b). Heterophilic, calcium-
dependent interactions contributing to intercellular adhesion were observed between 
endogenous DSG2 and recombinant DSC1a in the human fibrosarcoma cell line 
HT1080 (Chitaev & Troyanovsky, 1997). Recombinant proteins containing the first two 
EC domains of DSC2 and DSG2 were also demonstrated to interact in solution, 
involving both homophilic and heterophilic associations. Homophilic interactions 
between DSG proteins were weaker and possibly calcium-independent whereas 
heterophilic associations were demonstrated to be calcium-dependent (Syed et al., 
2002). Other studies suggested that both DSCs and DSGs are necessary for strong cell-
cell adhesion (Chitaev & Troyanovsky, 1997; Marcozzi et al., 1998; Tselepis et al., 
1998). Moreover, the DSG1:DSC1 ratio was demostrated to be important for 
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desmosomal adhesion in fibroblasts (Getsios et al., 2004a). Further studies will be 
necessary to define the mechanisms of cis and trans interactions between desmosomal 
cadherins, and whether homophilic, heterophilic or both types of interactions occur in 
vivo (Delva et al., 2009; Holthofer et al., 2007). 
 
1.3.2.2. The desmosomal plaques contain armadillo and plakin proteins 
Desmosomal plaque proteins refer to those found in the ODP and IDP (Figures 
1.4 and 1.5) and facilitate binding of the IF network to the transmembrane desmosomal 
cadherins. Two families of proteins are found here, the armadillo and the plakin 
families. 
 
1.3.2.2.1. Armadillo proteins 
Armadillo proteins are characterized by their highly conserved central arm-
repeat domains (Figure 1.5B). Each repeated motif has 42 amino acids and the number 
of repetitions varies among different members (Garrod & Chidgey, 2008). Armadillo 
members include β-catenin, PG, p120-catenin, p0071, ARVC, δ-catenin and PKPs 
(Delva et al., 2009). The structure of the central arm-repeat domain has been resolved 
for β-catenin (Huber et al., 1997) and PKP1 (Choi & Weis, 2005) by X-ray 
crystallography. Each repeat was found to consist of three α-helices. The repeats are 
organised together forming the arm-repeat domain which has the shape of a right-
handed superhelix. In the case of these two proteins, the superhelix has a positively 
charged groove which interacts with binding partners. 
PG is encoded by the JUP gene in chromosome 17 (Aberle et al., 1995) and was 
the first member of this family to be discovered (Cowin et al., 1986). PG is closely 
related in structure to β-catenin, which is the best characterised armadillo protein and is 
present in adherens junctions (Huber, 2003). Both of these proteins are composed of N- 
and C-terminal domains separated by a series of 12 arm-repeat domains in the case of β-
catenin (Huber et al., 1997) and 13 arm-repeat domains in the case of PG (Sacco et al., 
1995) (Figure 1.5B). PG can be found in desmosomes, adherens junctions and in the 
nucleus. In adherens junctions, PG interchanges with β-catenin. However, it appears to 
be localised predominantly in desmosomes, probably because its affinity for the 
desmosomal cadherins is higher than for E-cadherin (Chitaev et al., 1996). In contrast, 
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β-catenin is usually only found in adherens junctions, possibly because its N- and C-
terminal domains inhibit its interaction with DSG1 (Troyanovsky et al., 1996a; Wahl et 
al., 2000). Interactions between PG and its binding partners occur mainly through its 
central arm-repeat and C-terminal domains. Arm-repeats 1-3 are required for 
interactions with the ICS domain of DSG1 and DSC2a (Chitaev et al., 1998). Also 
within this region of PG is the binding site for α-catenin. Binding of DSG to PG was 
shown to disrupt the interaction between PG and α-catenin, possibly explaining the 
absence of α-catenin in the desmosome (Aberle et al., 1996; Chitaev et al., 1998; 
Miravet et al., 2003; Sacco et al., 1995). The E-cadherin binding site in both PG and β-
catenin is localised in the centre of the arm-repeat domain and lies in a different region 
from the desmosomal cadherin binding site (Chitaev et al., 1998). PG also interacts with 
DP (Kowalczyk et al., 1997), PKP2 and PKP3 (Bonne et al., 2003; Chen et al., 2002), 
p0071 (Hatzfeld et al., 2003) and keratins (Smith & Fuchs, 1998), but the precise PG 
binding sites for these proteins have not been determined (Holthofer et al., 2007). 
Deletion of the PG C-terminus led to the formation of large desmosomes by lateral 
association in cultured cells (Palka & Green, 1997a). It was therefore suggested that PG 
may participate in the control of desmosomal size by regulating lateral interactions 
between other desmosomal components (Palka & Green, 1997a). 
Additionally to having a structural role in cell-cell junctions, PG also 
participates in intracellular signal transduction. PG is functionally related to β-catenin 
which is a modulator of the canonical Wnt/β-catenin signalling pathway (Moon et al., 
2002). Both PG and β-catenin interact with and compete for proteins involved in this 
signalling pathway. These common binding partners include adenomatosis polyposis 
coli (APC) (Rubinfeld et al., 1993; Shibata et al., 1994) and LEF-1/TCF (Huber et al., 
1996; Zhurinsky et al., 2000). Similarly to β-catenin, PG interacts with axin leading to 
phosphorylation in the N-terminus (serine 28) by glycogen synthase kinase-3β (GSK-
3β) (Kodama et al., 1999) and interacts with the F-destruction box protein β-TrCP of 
the Skp-, Cullin-, F-box- (SCF) containing E3 ubiquitin ligase complex (Sadot et al., 
2000), which are all mediators of the Wnt/β-catenin signalling pathway. Although it is 
now accepted that PG has a role in the Wnt/β-catenin pathway, it is not clear whether it 
activates or represses Wnt/β-catenin target genes or whether it acts on a different set of 
genes (Garrod & Chidgey, 2008). Some studies indicate that PG’s function in the 
Wnt/β-catenin pathway is independent from that of β-catenin (Maeda et al., 2004; 
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Teuliere et al., 2004; Williamson et al., 2006) and that PG cannot compensate for the 
lack of β-catenin in β-catenin knock-out mice (Bierkamp et al., 1996; Haegel et al., 
1995; Ruiz et al., 1996). Other authors suggest PG interferes with β-catenin’s turnover 
and/or transcriptional activity (Miravet et al., 2002; Teuliere et al., 2004). The idea that 
changes in desmosome composition or function could also alter Wnt/β-catenin 
signalling is supported by a study where suppression of DP expression in cardiac 
myocytes (using short interfering RNA [siRNA]) led to PG translocation to the nucleus 
and suppression of this signalling pathway (Garcia-Gras et al., 2006). 
PKPs are members of the p120-catenin subfamily of armadillo domain proteins 
and have a large N-terminal head domain followed by nine arm-repeat domains and a 
short C-terminal tail (Choi & Weis, 2005). PKPs contain a large and flexible insert 
between arm-repeats five and six which introduces a major bend in the overall structure 
(Choi & Weis, 2005) (see Figure 1.5B). PKP1 and PKP2 exist in two alternatively 
spliced variants, a shorter ‘a’ variant and a longer ‘b’ isoform (Figure 1.5B). PKP1b has 
an extra 21 amino acids between arm-repeats three and four compared to PKP1a 
(Schmidt et al., 1997) and PKP2b has an extra 44 amino acids between arm-repeats two 
and three compared to PKP2a (Mertens et al., 1996). The gene encoding PKP3 is only 
known to originate one transcript (Garrod & Chidgey, 2008; Schmidt et al., 1999) (see 
Figure 1.5B). 
All three PKPs localise to desmosomes and the nucleus, but the non-junctional 
function of PKPs is not yet clear. PKP1b splice variant was only found in the nucleus 
(Schmidt et al., 1997). PKP2 has been reported to associate with β-catenin (Chen et al., 
2002), with RNA polymerase III and with the transcription factor TFIIIB (Mertens et 
al., 2001). PKP3 was also found constitutively associated with RNA binding proteins 
(Hofmann et al., 2006), however the significance of these observations is not clear. 
PKPs interact with several partners including cadherins, other armadillo proteins 
(including β-catenin and PG), the N-terminus of DP, and IFs directly, thus likely 
participating in lateral stabilising interactions in the plaque (Hatzfeld, 2007). All the 
interactions identified so far occur through the PKP head domain (Choi & Weis, 2005; 
Hatzfeld, 2007). 
The p120-catenin subfamily member p0071 is also known as PKP4. In contrast 
with PG and the PKPs, which are essential for desmosomal adhesion, p0071 is 
considered to be an accessory protein (Garrod & Chidgey, 2008). However, it localises 
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to desmosomes and adherens junctions of epithelial cells and interacts with many 
junctional proteins including DSC3a, PG, DP, PKP2 and E-cadherin (Hatzfeld et al., 
2003). p0071 is also found in endothelial cell junctions, where it interacts with VE-
cadherin and DP (Calkins et al., 2003). Several splice variants of p0071 have been 
detected (Hatzfeld & Nachtsheim, 1996) and a cytoplasmic pool has been described 
which may be involved in cell signalling (Wolf et al., 2006). 
 
1.3.2.2.2. Desmoplakin is the most abundant plakin of the desmosome 
Plakins are large molecules with multiple binding domains which provide 
linkage between cytoskeletal proteins and junctional complexes. Seven members of this 
family have been identified so far, namely DP, plectin, BPA-1, microtubule-actin 
crosslinking factor (MACF), envoplakin, periplakin and epiplakin. Four of the known 
mammalian plakins (DP, envoplakin, periplakin and plectin) have been reported to 
localise to the desmosome, of which DP is the most abundant and well characterised 
(Leung et al., 2002). 
Members of the plakin family are characterised by their N-terminal plakin 
domain and C-terminal plakin repeat domain (PRD). The plakin domain is formed by 
six α-helical fragments (NN, Z, Y, X, W and V) which form an antiparallel α-helical 
bundle (Virata et al., 1992). This domain targets plakins to cell junctions and is 
possessed by all members of this family, except for epiplakin. The PRD is a repeated 
region that comprises three globular motifs designated as A, B and C. Each of these 
motifs contains 4.5 repetitions of a 38-amino acid strand. This domain interacts with IFs 
(Leung et al., 2002) (see Figure 1.5C). 
DP is an obligate component of the desmosomal plaque. It is a cytoplasmic 
protein composed of a typical N-terminal plakin domain, a central α-helical coiled-coil 
rod domain, and a C-terminal IF-binding PRD (Figure 1.5C). The globular head or 
plakin domain directs DP to the desmosome through interactions with the armadillo 
proteins PG and the PKPs (Bornslaeger et al., 2001; Green & Hobbs, 2006; Hatzfeld, 
1999; Hatzfeld, 2007; Kowalczyk et al., 1997; Schmidt & Jager, 2005; Smith & Fuchs, 
1998) and recent evidence suggests that it consists of two pairs of spectrin repeats 
separated by a Src-homology-3 domain (Jefferson et al., 2007). The rod domain of 
plakins is mostly formed of heptad repeats that mediate homodimerisation and, in some 
Chapter 1 - Introduction 
 46
plakins, possibly heterodimerisation (Leung et al., 2002). The subdomains A, B and C 
of the PRD of DP (Figure 1.5C) are separated by flexible linking regions and followed 
by a terminal 68-residue regulatory tail, which is glycine-serine-arginine rich. This C-
terminal tail is a versatile domain that can interact with different types of IFs (see 
below). 
DP is encoded by the DSP gene, located on chromosome 6p24, which contains 
24 exons and produces two isoforms through alternative splicing: DPI (~332KDa) and 
DPII (~260KDa). An alternative donor splice site in exon 23 of the DSP gene generates 
the latter isoform. DPII retains both the N- and C-terminal domains, but lacks 
approximately two thirds (599 residues) of the rod domain (Green & Hobbs, 2006). 
Both DPI and DPII are abundantly expressed in the skin. DPI is also present in 
specialised vascular and lymphatic endothelial cell junctions named complexus 
adhaerentes, together with VE-cadherin and PG (Borrmann et al., 2006; Franke et al., 
2006; Hammerling et al., 2006). In the intercalated disc of the heart muscle, DP and 
other desmosomal molecules were shown by immunoelectron microscopy to interact 
with classical cadherin components in both desmosomes and adherens junctions. This 
observation led Franke et al. (2006) to re-name this region of the cardiomyocyte plasma 
membrane as the “area composita” of adhering junctions (Green & Hobbs, 2006). DPII 
expression is abundant in the skin and in most epithelial tissues but barely detectable in 
the heart (Uzumcu et al., 2006). 
Although the crucial role of the DPI splice variant in the anchorage of IFs to the 
desmosome is widely known, the function of the DPII isoform has not been determined. 
During the construction of a molecular map of the desmosomal plaque, antibodies 
against the N- and C-terminal domains of DP were used to map its functional regions 
within the desmosome (North et al., 1999). This study demonstrated that the N-terminus 
is orientated toward the membrane and the C-terminus toward the nucleus, which is in 
agreement with experiments demonstrating that the N-terminus targets the molecule to 
the cell membrane and the C-terminus interacts with the IF network. In this study, the 
calculated length for both DPI and DPII was approximately 42 nm, measured 
perpendicular to the plasma membrane. However, this value corresponds to the 
predicted size of DPII based on sequencing analysis (Green et al., 1990) and on rotary 
shadowing (O'Keefe et al., 1989), whereas DPI was predicted to be about 130 nm in 
length. These results led North et al. (1999) to suggest that DPI is folded or coiled or 
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orientated at an angle to the membrane, and that DPII may determine the extent of the 
desmosomal IDP (Figure 1.4). 
DP is the protein primarily responsible for mediating the various IF-
desmosomal-protein interactions and is critical for normal desmosomal adhesion. The 
C-terminal domain of DP interacts with keratin IFs in epithelia, desmin IFs in the 
myocardial and Purkinje fibre cells of the heart and vimentin IFs in the meningeal cells 
and the follicular dendritic cells of lymph nodes (Fontao et al., 2003; Franke & Moll, 
1987; Kouklis et al., 1994; Meng et al., 1997; Stappenbeck et al., 1993; Stappenbeck & 
Green, 1992). The relative contributions of the A, B and C subunits of PRD, of the 
flexible linker regions and of the terminal regulatory tail for interactions with IFs are 
not yet clear. However, several studies suggest that these contributions may differ 
according to the type of IF that is attached to the desmosome (Green & Hobbs, 2006). 
Phosphorylation of the serine residue at position 2849 within the terminal regulatory tail 
weakens the interaction between DP and keratin IFs (Stappenbeck et al., 1994), which 
was supported by the observation that a point mutation at this site (S2849G) disrupts DP 
assembly into desmosomes (Godsel et al., 2005) (1.7.2.4.3). Additional serine sites 
located in the key linking regions surrounding the PRD and tail were recently identified 
which could also influence the IF-binding properties of this domain (Beausoleil et al., 
2004; Green & Hobbs, 2006; Green & Simpson, 2007). 
Besides DP’s vital importance for the maintenance of tissue integrity, its 
involvement in the regulation of the ERK-Akt signalling pathway (Wan et al., 2007) 
and in the organisation of microtubules during epidermal differentiation have been 
reported (Desai et al., 2009). 
 
1.4. The intermediate filament cytoskeleton 
IFs are a type of protein fibres which, together with actin microfilaments and 
microtubules compose the cytoskeleton. IFs are pliant rod-shaped fibres with a diameter 
which is intermediate between those of microfilaments (7-8 nm) and microtubules (25 
nm), and hence their designation as IFs. The IF super-family comprises five types (or 
families) of IF fibres, and each type contains a range of different proteins that are 
altogether encoded by approximately 70 different human genes. IFs are grouped into 
these five different types according to cell-, tissue-, differentiation- and development-
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specific expression patterns. Most types of IFs are cytoplasmic (types I-IV) and extend 
from the nucleus to the cell membrane where they are anchored to cell-cell and cell-
matrix junctions (Figure 1.6). Only type V-IFs (including lamins) are present within the 
nucleus. Type I IFs comprise the acidic keratins (keratins 9-20) and type II the basic 
keratins (keratins 1-8). Type III IFs include desmin, which is the IF fibre present in the 
heart muscle, and vimentin which is present in mesenchymal cells. Type IV IFs include 




Figure 1.6. Double immunocytochemistry of HaCaT cells showing the keratin IF network 
and IF-desmosome attachments. Cytokeratin filaments extending from the nucleus to the cell 
periphery are shown (in green) connecting the cell sheet via desmosomes which are represented 
here by DP (in red). 
 
All IF proteins are composed of a α-helical coiled-coil central rod domain, 
which is highly conserved, and more variable globular N- and C- terminal domains. The 
formation of IFs involves five sequential steps. First, similarly to DP, the rod domain is 
involved in dimerisation of IF proteins forming parallel coiled-coil apolar heterodimers 
(in the case of type I and type II keratins) or homodimers (in the case of type III IFs, 
such as desmin and vimentin). Second, these dimers associate laterally, in an anti-
parallel fashion, to form tetramers with a staggered conformation. Third, these tetramers 
associate into higher order oligomers to form unit length filaments (ULF). Fourth, 
longitudinal annealing of ULF occurs to form filaments that are thicker than the mature 
IFs. Fifth, radial compression of these immature filaments results in the formation of the 
approximately 10 nm-wide mature filaments (reviewed in Godsel et al., (2008). 
Keratin IFs are major components of epithelial cells and are interconnected 
among cells or with the substratum via desmosomes and hemidesmosomes, 
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respectively. Together with these cell junctions, keratin IFs provide epithelial tissues 
with mechanical strength and resilience. Keratins always form heterodimers composed 
of one acidic and one basic keratin, which are tissue- and differentiation-specific (see 
section 1.6) (Kimyai-Asadi et al., 2002). 
 
1.5. Modulation of desmosomal adhesion 
Desmosomes are not just static structures that glue cells together; instead, they 
are very dynamic and adaptable complexes as shown by their ability to adopt different 
conformations with different adhesive affinities (Garrod et al., 2005; Kimura et al., 
2007; Wallis et al., 2000). The “hyper-adhesive” state is the calcium-independent 
conformation, and therefore “hyper-adhesive” desmosomes do not disassemble in 
response to chelating agents (Garrod & Chidgey, 2008). Mature desmosomes in normal 
epidermis have this “hyper-adhesive” conformation which allows them to resist the 
forces of physical stress. However, this strongly adhesive state seems incompatible with 
cell motility which is necessary, for instance, during wound healing. For keratinocytes 
to migrate under the clot and close the wound, desmosomal adhesion needs to be down-
regulated, and this coincides with a reversion to a calcium-dependent state. These more 
weakly adhesive desmosomes can separate into half desmosomes and be internalised 
following depletion of extracellular calcium. These different adhesive states correlate 
with ultrastructural changes within the desmosome. “Hyper-adhesive” desmosomes 
present with an electron-dense midline with cross-bridges extending to the plasma 
membrane, which is believed to represent a highly ordered and resistant structure. This 
midline is lost from desmosomes of wounded epidermis which have become calcium-
dependent and less adhesive. Adherens junctions do not show this electron dense 
midline and are not able to become “hyper-adhesive”, which is therefore a property 
thought to be unique to desmosomes (Garrod & Chidgey, 2008). 
Protein kinase Cα (PKCα) activation was shown to occur at wound edges and to 
cause the switch to a calcium-dependent state (Wallis et al., 2000). Additionally, in 
wound edge epidermis, PKCα becomes associated with the desmosomal plaque, where 
it co-localises with DP (Garrod et al., 2005). These results indicate that the change in 
the adhesive state is produced by an “inside-out” signal by PKC which has been 
proposed to facilitate epithelial remodelling (Wallis et al., 2000). Therefore, altered 
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phosphorylation of desmosome and/or associated cytoskeletal components, DP and PG 
being likely candidates, may shift the desmosome to a less adhesive state (Garrod & 
Chidgey, 2008). 
Low calcium concentrations in culture inhibit the formation of cell-cell junctions 
and cause these junctions to be disassembled. Immature desmosomes, which refers to 
desmosomes that have not yet reached a calcium-independent conformation, are also 
disassembled by calcium chelating agents. However, mature or calcium-independent 
desmosomes in a confluent cell sheet will remain unaffected. Interestingly, South et al. 
(2003) demonstrated that PKP1-null immortalised keratinocytes were unable to become 
mature or calcium-independent in culture, suggesting a role for PKP1 in desmosome 
maturation. Further studies will be necessary to understand the detailed mechanisms 
leading to desmosome stability and the contributions of each desmosomal protein other 
than their adhesive functions. 
 
1.6. The desmosome and intermediate filament network composition 
changes in a tissue- and differentiation-specific manner 
As mentioned in section 1.3.1, desmosomes vary in appearance, size and 
composition in different cell types and during epidermal differentiation. IFs associated 
with desmosomes also exhibit tissue- and differentiation-specificity. DP and PG are 
expressed in all tissues that contain desmosomes and in all layers of the stratifying 
epidermis (Figure 1.7) despite these variations.  
In the skin, desmosomes and adherens junctions appear to be distinct structures, 
the only component in common between the two junctions being PG. In contrast, the 
intercalated disc of the myocardium has mix-typed junctions (the “area composita”, see 
section 1.3.2.2.2) that resemble both desmosomes and adherens junctions. These mixed 
junctions contain the desmosomal proteins DP, PKP2, DSG2 and DSC2, together with 
the adherens junction proteins N-cadherin, cadherin-11, β-catenin, α-catenin, ARVCF, 
afadin and p120-catenin, the tight junction protein ZO-1, as well as proteins that can be 
present in more than one type of junction such as PG, p0071 and vinculin (Borrmann et 
al., 2006). In these junctions PKP2 was also shown to associate with αT-catenin 
forming another link between the cadherin-catenin complex and the IF-network via a 
desmosomal protein (Goossens et al., 2007). 
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DSG1, DSG3 and DSG4 as well as DSC1 and DSC3 are restricted to stratified 
epithelial tissues. In contrast, DSG2 and DSC2 are expressed in all desmosome-
possessing tissues, including the myocardium and simple epithelia (Garrod et al., 2002; 
Ishii & Green, 2001). Hence, desmosomes of tissues such as the colon and cardiac 
muscle only contain DSG2 and DSC2. In the epidermis, DSG2 is restricted to the basal 
layer. DSC2, DSC3 and DSG3 are expressed in a gradient with the highest levels in the 
basal layer and minimal levels in the spinous or granular layers (Figure 1.7). In contrast, 
the expression pattern of DSG1 and DSC1 follows a gradient pointing in the opposite 
direction, with the highest expression levels in the upper layers, particularly in the 
granular layer. DSG4 is highly represented in the hair follicle and is also expressed in 
the granular layer, predominantly in the upper cell layer (Figure 1.7). The same cell 
expresses several different desmosomal cadherin isoforms and single desmosomes 
contain more than one DSG and more than one DSC isoform (North et al., 1996; Nuber 
et al., 1996; Shimizu et al., 1995). 
PKPs 1-3 also show complex tissue-specific patterns of expression. PKP1 is a 
major component of desmosomes in stratifying and complex epithelia but is also widely 
expressed in the nuclei of cells that lack desmosomes (Schmidt et al., 1997). PKP2 is 
expressed in all tissues that have desmosomes and also in some cell types lacking 
desmosomes, and is the only PKP isoform expressed in the myocardium (Chen et al., 
2002; Mertens et al., 1996). PKP3 is present in desmosomes of most simple and almost 
all stratified epithelia, with the exception of hepatocytes, and is also absent from 
cardiomyocytes. All three isoforms are expressed in the epidermis. While PKP3 is 
expressed at similar levels throughout all layers of the epidermis, PKP2 is prominent in 
the basal and spinous layers and PKP1 is most abundant in the upper spinous and 
granular layers (South, 2004) (see Figure 1.7).  
 




Figure 1.7. The desmosomal composition varies in a differentiation-specific manner. 
Schematic of the epidermis showing differential expression of desmosomal proteins according 
to differentiation stage. The basal epidermal layer is rich in DSG2/3, DSC2/3 and PKP2. 
Expression of these proteins ceases (in the case of DSG2) or decreases with increased 
differentiation, and is minimal in the granular layer. In contrast, expression of DSG4, DSG1, 
PKP1 and DSC1 is patterned in a gradient that points in the opposite direction. Expression of 
PKP3, PG and DP is approximately constant throughout all layers of the epidermis. Adapted 
from Desai et al. (2009). 
 
The expression patterns of the desmosome-associated keratin IFs also vary 
according to the type of tissue and during epidermal differentiation. Keratins 8/18 are 
typical of simple epithelial cells. In interfollicular epidermis, keratins 5/14 are 
predominant in the basal keratinocytes, while keratins 1/10 are only expressed in 
suprabasal keratinocytes. The pair of keratins 2e/10 is also expressed in the upper 
spinous and granular layers. Keratins 6a/16 and 6b/17 are expressed in suprabasal 
keratinocytes of interfollicular epidermis during processes such as wound healing or 
hyperproliferation. In palmoplantar epidermis, keratins 1/9 are the major representatives 
of suprabasal cells, but keratins 6a/16 are also expressed. Palmoplantar epidermis (acral 
epidermis) is much thicker and expresses higher levels of keratin IFs than non-acral 
epidermis. These keratin IFs also form denser aggregates in the upper spinous and 
granular layers, which provide extra resistance and structural support to the mechanical 
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1.7. Desmosome hereditary disease and mouse models 
Skin and heart are tissues that experience mechanical stress on a daily basis. In 
order to resist these physical forces, the epidermis and the intercalated disc of the 
myocardium have evolved strong and resilient desmosomes that are tailored to serve 
these different tissues. When desmosomal components are disrupted, either by naturally 
occurring or engineered genetic mutations or in autoimmune disease, adhesion between 
keratinocytes and cardiomyocytes fails leading to diseases of skin, hair and heart 
(Cheng et al., 2005; McGrath, 2005). These diseases are designated as cardio-cutaneous 
syndromes (Bolling & Jonkman, 2009). 
 
1.7.1. Palmoplantar keratoderma and arrhythmogenic right ventricular 
cardiomyopathy 
Hereditary PPKs are a large and highly heterogeneous group of skin disorders 
that can be inherited as both autosomal dominant and recessive traits. These disorders 
are generally characterised by thickening and hyperkeratosis of the epidermis from 
palms and soles. The PPKs can be divided into three groups – simple, complex and 
syndromic – according to the observed phenotypes. Simple (or non-syndromic) 
keratodermas affect only the palmoplantar epidermis whereas complex keratodermas 
also manifest as lesions of non-volar skin, hair, teeth, nails or sweat glands. Syndromic 
keratodermas involve abnormalities in other organs such as cardiomyopathy, cancer, or 
deafness (Braun-Falco, 2009; Hatsell & Kelsell, 2000). PPKs can also be divided into 
three sub-groups based on clinical appearance, namely focal, diffuse and punctate PPK. 
In focal PPK, the lesions are restricted to pressure points and sites of recurrent friction, 
whereas in diffuse PPK the thickening of the epidermis is uniformly observed across the 
palmoplantar surface. Striate PPK (SPPK) is a sub-type of focal PPKs characterised by 
linear hyperkeratosis on the digits. Punctate PPKs are characterised by the development 
of numerous and small hyperkeratotic nodules (Hatsell & Kelsell, 2000). 
PPKs can additionally be classified as epidermolytic (EPPK) or non-
epidermolytic (NEPPK) based on histological as well as clinical observations. 
Histologically, EPPK shows clear spaces of different sizes around keratinocyte nuclei 
(perinuclear vacuolisation) in the upper spinous and granular layers. Cytolysis, 
blistering, clumping of keratin IFs and keratohyalin granules of various shapes in 
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suprabasal layers are also observed in EPPK (Ross et al., 2008). These characteristics 
are not observed in NEPPK. 
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a 
genetic heart disorder that results in fibro-fatty replacement of right ventricular 
myocytes and consequent ventricular arrhythmias (Fontaine et al., 1999). Involvement 
of the left ventricle may also occur. Although ARVC is an infrequent cardiomyopathy, 
it is one of the most common causes of unexpected sudden death in the young, 
particularly athletes (Basso et al., 1996; Thiene et al., 1988). The prevalence of 
ARVC/D is estimated to range between 1/2000 and 1/5000 in the general population 
and a genetic cause has been demonstrated in at least 50% of the cases (Corrado & 
Thiene, 2006). To date, seven genes have been implicated in the pathogenesis of 
ARVC, of which five encode proteins of the cardiac desmosome (Table 1.1). Two non-
desmosomal genes have been associated with specific types of ARVC, namely the gene 
encoding the cardiac ryanodine receptor 2 (RyR2) reported in ARVC type 2 (ARVC2) 
(Danieli & Rampazzo, 2002; Tiso et al., 2001) and the gene encoding transforming 
growth factor-β3 (TGFβ3) in ARVC type 1 (ARVC1) (Beffagna et al., 2005). 
ARVC can be inherited as an autosomal dominant trait with variable penetrance 
or as a recessive trait, usually associated with skin disease. The latter phenotype is 
called syndromic form of ARVC, of which Naxos disease and Carvajal syndrome are 
examples. Naxos disease manifests as diffuse PPK, woolly hair and right ventricular 
cardiomyopathy, whereas Carvajal syndrome consists of SPPK, woolly hair and dilated 
left ventricular cardiomyopathy (Braun-Falco, 2009). The Carvajal syndrome is 
clinically similar but more severe than Naxos disease in which ARVC usually appears 
later. Additionally, the cardiomyopathy in Carvajal syndrome affects usually the left 
ventricle which shows no adipose depositions, in contrast with Naxos cardiomyopathy 
which affects the right ventricle and which hallmark is the fibrofatty replacement 
(Bolling & Jonkman, 2009). McKenna et al. (1994) first described a number of clinical 
criteria, known as the “Task Force criteria” to diagnose patients with ARVC/D. These 
criteria include electrical and histopathological features of the myocardium as well as 
clinical characteristics (Vatta et al., 2007). 
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1.7.2. Genetic mutations affecting desmosome components and associated proteins 
lead to cardio-cutaneous disease 
Human inherited disease of the desmosome can be caused by mutations in genes 
encoding desmosomal cadherins, armadillo or plakin proteins, which are the three major 
desmosomal protein families. The target genes include DSP, JUP, PKP1 and PKP2, 
DSG1, DSG2 and DSG4, DSC2 and DSC3. Table 1.1 summarises the range of human 
phenotypes resulting from dominant or recessive mutations in desmosomal genes. 
Defects in different desmosomal components, such as DP and DSG1 or DP and PG, can 
lead to similar clinical phenotypes, such as SPPK and Carvajal/Naxos syndrome, 
respectively. Additionally, similar phenotypes can arise from mutations affecting 
different regions of the same protein, for instance ARVC caused by DSP mutations 
(Figure1.8). In contrast, mutations affecting the same functional domain of one protein 
can cause distinct clinical features in much the same way as mutations in different 
desmosomal components. This lack of correlation between the genotypes and 
phenotypic characteristics may suggest that apart from having a common adhesive 
function, some desmosomal proteins may participate in other overlapping processes, 
such as cytoskeletal organization, cell signalling, and tissue patterning (Kottke et al., 
2006).  
Desmosomal proteins involved in disease restricted to the skin and/or its
appendages are DSG1, DSG4, DSC3, PKP1 and DP. Heterozygous mutations in the 
genes encoding DSG1 (Rickman et al., 1999), DP (Armstrong et al., 1999; Whittock et 
al., 1999) and additionally the gene encoding the IF protein keratin 1 (Whittock et al., 
2002a) can cause non-syndromic SPPK. Mutations in the gene encoding PKP1 cause a 
distinct phenotype involving skin and hair abnormalities called ectodermal dysplasia-
skin fragility syndrome which was first described by McGrath et al. (1997). Mutations 
in the genes encoding DSG4 and recently DSC3, have been reported to lead to 
hypotrichosis, which is a hair disorder characterised by thin and sparse scalp hair as 
well as sparse or absent eyebrows and eyelashes and atrophic hair follicles (Ayub et al., 
2009; Kljuic et al., 2003). The DSC3 mutation also resulted in recurrent skin vesicles 
filled with fluid (Ayub et al., 2009).  
Desmosomal proteins involved in non-syndromic cardiomyopathy are DSG2, 
DSC2, PKP2, DP and PG. Proteins that can cause both heart and skin disease are DP, 
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PG and DSC2 (Bolling & Jonkman, 2009). Dominant mutations are usually associated 
with the non-syndromic forms of either skin or heart disease whereas recessive 
mutations usually cause the syndromic forms (see Table 1.1). 
Mutations in genes encoding the basal (epidermal) keratin pair 5/14 (Kang et al., 
2010) as well as plectin (Bolling et al., 2009) (which is considered an accessory protein 
in the desmosome) can result in epidermolysis bullosa (EB) simplex. EB is a skin 
disease mainly characterized by severe skin fragility, including erosions and blistering 
in response to minor trauma. These plectin mutations were associated with early onset 
dilated cardiomyopathy additionally to EB simplex (Bolling et al., 2009). Mutations in 
keratin 14 can also lead to keratoderma disorders in the same way as mutations in the 
suprabasal keratins 1, 2, 9, 10 and 16 (Uitto et al., 2007). In particular, mutations in the 
genes encoding keratin 1 and keratin 9 cause EPPK (Godsel et al., 2008; Uitto et al., 
2007), which is a phenotype that can also be caused by mutations in DSP. As expected, 
while mutations in basal keratins affect predominantly the basal layer of the epidermis, 
mutations in suprabasal keratins lead to problems in the upper epidermal layers. 
Mutations in desmin (which forms the heart muscle IF network, see section 1.4), in 
contrast, result in cardiomyopathies. Coupled with other mutations in desmosomal 
components, these observations suggest that an adhesion impairment, which is 
aggravated by mechanical stress, results from defects in any region of the desmosome- 
IF complex, leading to fragility of the skin and heart. This implies that the
desmosome-IF complex provides mechanical integrity to these tissues. 
This thesis will be focused on the desmosomal components DP and PG; 
therefore an overview of the consequences of natural or engineered mutations in the 
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Table 1.1. Distinct phenotypes resulting from dominant and recessive mutations in desmosomal 
genes 
 





















Bullous dermatosis, PPK, total alopecia and ARVC
DSC2





Focal and diffuse PPK and woolly hair            
Ectodermal-dysplasia skin fragility syndrome and ARVC 
Lethal acantholytic epidermolysis bullosa
Dominant




1.7.2.1. Plakoglobin mouse models 
Mouse knock-out studies have highlighted the importance of PG in both the 
epidermis and the heart during development. PG-null mutant mouse embryos generated 
through gene targeting die between embryonic days E10.5-E16 due to severe heart 
problems (Bierkamp et al., 1996; Ruiz et al., 1996). Although some mutant embryos 
developed further (12 out of 121 embryos), they died around birth with additional 
severe skin fragility, reminiscent of the human blistering disease, epidermolytic 
hyperkeratosis (EPPK) (Bierkamp et al., 1996). Ultrastructural analysis revealed that 
desmosomes had altered structure and were reduced in number in both the skin and 
heart of PG-null mice (Bierkamp et al., 1996). Additionally, PG’s closest homologue, β-
catenin, was shown to become localized to desmosomes in the heart of JUP-/- embryos 
(Ruiz et al., 1996) and to associate with DSGs in JUP-/- embryonic skin (Bierkamp et 
al., 1996). 
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1.7.2.2. Plakoglobin and Naxos disease or ARVC 
Following these studies with PG knock-out mouse models, it was found that the 
autosomal recessive Naxos disease mapped to 17q21.2, a locus that was known to 
include the JUP gene (Coonar et al., 1998). Sequence analysis of Naxos patient DNA 
revealed a homozygous deletion of 2 bp (JUP2157delTG) close to the 3’ end of JUP 
(McKoy et al., 2000). This deletion caused a frameshift and resulted in the truncation 
the C-terminal domain of PG (McKoy et al., 2000). Although PG-null mice exhibited a 
more severe phenotype with skin blistering from acantholysis, Naxos patients present 
with diffuse PPK which does not show blistering. Heterozygous carriers of this 
mutation show minor abnormalities on electrocardiography but no skin phenotype 
(Protonotarios et al., 2001). Genetic linkage has demonstrated that loci other than JUP 
can cause Naxos disease, but to date no other candidate genes have been described 
(Stuhrmann et al., 2004).  
Recently, a second human JUP mutation has been identified. This is an 
autosomal dominant 3 bp-insertion mutation, S39K40insS, found in a family with 
ARVC but no cutaneous abnormalities (Asimaki et al., 2007). 
 
1.7.2.3. Desmoplakin mouse models 
Ablation of DP in the germline of mice through the use of gene targeting results 
in embryonic lethality at E6.5 (Gallicano et al., 1998), which is earlier than in PG-null 
mice (Bierkamp et al., 1996; Ruiz et al., 1996) (see section 1.7.2.1). These developing 
embryos had a reduced number of desmosomes (approximately 10 times) and the few 
remaining desmosomes showed a disrupted IF network and lack of keratin IF 
attachment. These results suggested a role for DP in the formation and stabilisation of 
the desmosome, besides its previously known role in desmosome-IF attachment 
(Gallicano et al., 1998). To study the function of DP specifically in later embryonic 
development, a tetraploid aggregation approach was carried out by the same researchers 
to rescue the lethal phenotype and the functions of extraembryonic tissues in DSP-/- 
embryos. The resulting mice were partially rescued up to E10 of embryonic 
development but still exhibited heart, skin and neuroepithelium abnormalities, which 
were more severe than the ones observed in PG-null embryos. Defects in 
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microvasculature, which have complexus adherens instead of desmosomes, were also 
observed (Gallicano et al., 1998).  
Recently, another report described the conditional ablation of DP in the heart of 
mice generated by crossing α–myosin heavy chain–Cre recombinase transgenic mice 
and floxed DSP mice. The resulting animals also died from E11 onwards due to severe 
cardiac abnormalities (Garcia-Gras et al., 2006). A conditional DP mouse knock-out 
was also generated to investigate the role of DP in the skin (Vasioukhin et al., 2001). 
The DSP gene was inactivated specifically in the epidermis by breading DSP floxed 
mice with mice transgenic for the Cre recombinase under the control of the keratin 14 
promoter, which is active in basal cells of the epidermis. Newborn mice lacking DP in 
the epidermis showed severe skin defects including stress-induced intercellular 
separations, terminal differentiation problems and loss of barrier function. Although the 
number of desmosomes in DP-null epidermis was comparable to wild type epidermis, 
they lacked an IDP and IF attachment was impaired. DP-null cultured keratinocytes 
derived from these mice showed reduced number of desmosomes as well as lack of 
actin reorganisation and reduced adherens junctions. This result highlighted the 
interdependence between desmosomes and the microfilament-associated adherens 
junctions, as adherens junctions failed to properly mature in DP-null cells in vivo and in 
vitro (Vasioukhin et al., 2001). DP has also recently been implicated in the 
rearrangement of the microtubule cytoskeleton during epidermal differentiation (Lechler 
& Fuchs, 2007). 
Taken together, these studies revealed the importance of DP for morphogenesis, 
integrity and function of epithelial and cardio-vascular tissues both during early 
development and later for the correct architecture and function of tissues such as the 
epidermis and the heart (Green & Hobbs, 2006). 
 
1.7.2.4. Human mutations in desmoplakin lead to defects of skin, hair and heart 
Human DSP mutations can be inherited with both autosomal dominant and 
recessive modes of transmission. In contrast with only two JUP mutations identified so 
far, 36 mutations have been described in the DSP gene. These mutations can result in 
different cardio-cutaneous disorders that range from relatively mild skin conditions 
caused by DP haploinsufficiency, to severe skin fragility and morphogenetic defects or 
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death due to ARVC (Green & Hobbs, 2006). Figure 1.8 and the following sections 
summarise the DSP mutations identified so far and their associated phenotypes. 
 
1.7.2.4.1. Desmoplakin and skin disease 
The first reported DSP mutations were autosomal dominant nonsense (p.Q331X) 
and splice site (939+1G>A) mutations leading to haploinsufficiency (Armstrong et al., 
1999; Whittock et al., 1999). Affected individuals presented with SPPK, aggravated by 
mechanical trauma. Histological and ultrastructural analysis of lesional skin revealed 
widening of intercellular spaces between suprabasal keratinocytes, fewer desmosomes 
and clumping of keratin IFs. Heterozygous DP-null newborn mice, in contrast, did not 
show any histological defects (Gallicano et al., 1998). 
Whittock et al. (2002b) described two unrelated individuals with autosomal 
recessive mutations in DSP. These patients had focal or diffuse PPK and woolly hair 
with varying degrees of alopecia. Both of these cases were compound heterozygotes for 
nonsense/missense combinations of mutations (p.C809X/p.N287K and 
p.Q664X/p.R2366C). While heterozygous carriers of any of these mutations displayed 
no phenotypic abnormalities, the combination of DP haploinsufficiency with a missense 
mutation led to a disease phenotype (Figure 1.8). 
 
1.7.2.4.2. Desmoplakin and cardio-cutaneous disease 
The first human autosomal recessive mutation in DSP leading to a cardio-
cutaneous phenotype was described by Norgett et al. (2000). Following an earlier 
clinical description of the same family (Carvajal-Huerta, 1998), this phenotype is now 
referred to as Carvajal syndrome (see section 1.7.1). Affected family members were 
homozygous for 7901delG (p.S2542fsX2560), a deletion that results in the truncation of 
DP just downstream of the B plakin repeat domain (PRD), and presented with heart 
failure early in life due to cardiomyopathy. Histological analysis of these patients’ skin 
revealed widened intercellular spaces and collapsed IFs. Cells derived from these 
patients exhibited weakened adhesion when subject to stress in vitro (Huen et al., 2002). 
Another C-terminal homozygous missense mutation (p.G2375R) was shown to cause 
defects in skin, hair and heart in a Naxos-like fashion (Alcalai et al., 2003). As 
mentioned above, a mutation in the same domain of DP (p.R2366C, motif B of the 
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PRD, Figure 1.8) led to skin abnormalities only, when in a haploinsufficiency 
background (Whittock et al., 2002b). Compound heterozygous mutations (p.R1934X/ 
p.L2031fsX2058) within the last exon of DSP leading to truncations of the IF-binding 
domain of DP were shown to cause a lethal condition named “lethal acantholytic 
epidermolysis bullosa” (Jonkman et al., 2005). This patient presented with extremely 
severe fragility of the skin and mucous membranes, complete alopecia, neonatal teeth 
and nail loss and died 10 days after birth from heart failure, probably in combination 
with massive trans-cutaneous fluid loss. This is the most severe human phenotype 
caused by DSP mutations and resembles the phenotype of conditional epidermal DP-
null mice which die early after birth. Histological analysis revealed acantholysis 
throughout the spinous layer of the epidermis, with an intracellular split between the 
desmosomal IDP and the IF network. Electron microscopy revealed relatively normal 
desmosomes, but which were often torn out of adjacent cells due to the lack of 
cytoskeletal attachment to the plaque. These observations underscored the importance 
of DP and IF attachment for epidermal integrity (Bolling & Jonkman, 2009). 
Norgett et al. (2006) went on to describe a dominant case of left sided ARVC, 
SPPK and woolly hair in a patient harbouring a 30 bp insertion in exon 14 of DSP 
(c.1823_1824 ins30 bp, p.I608ins10), predicted to result in the insertion of 10 extra 
amino acids to the N-terminus of DP (Norgett et al., 2006) (see Chapter 5). 
The rod domain of DP is thought to be involved in the dimerisation of this 
protein (see section 1.3.2.2.2). A homozygous nonsense mutation within the DPI-
specific region (p.R1267X) was found to result in complete loss of DPI, without 
affecting DPII (Uzumcu et al., 2006). This patient had a severe form of a Naxos-like 
syndrome with skin, heart and hair involvement and died at the age of four of heart 
failure (see Chapter 5). Other mutations affecting the DPI-specific region of the rod 
domain were found recently, also associated with cardiomyopathy with or without skin 
disease. These cases are introduced here and in the following section (1.7.2.4.3). 
Compound heterozygous deletions affecting the N-terminus (p.H839fsX23) and the 
DPI-specific rod domain (p.N1324fsX23) were found in a patient with a phenotype 
involving PPK, skin fragility, woolly hair and severe biventricular dilated 
cardiomyopathy (Tanaka et al., 2009). Compound heterozygous nonsense mutations 
affecting the N-terminus (p.Q673X) and the DPI-specific region of the rod domain 
(p.Q1446X) were associated with complete alopecia, PPK, skin fragility and left sided 
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dilated cardiomyopathy leading to death at the age of nine. The phenotype of this child 
was designated as epidermolytic bullous dermatosis with associated lethal 
cardiomyopathy (Asimaki et al., 2009a) (Figure 1.8). 
 
1.7.2.4.3. Desmoplakin and arrhythmogenic right/left ventricular cardiomyopathy 
The majority of DSP mutations leading to arrhythmogenic right/left ventricular 
cardiomyopathy (AR/LVC) without skin or hair involvement are inherited in a 
dominant fashion. Three heterozygous missense mutations (p.R1255K, p.R1755I and 
p.K1583R) affecting the DPI-specific part of the rod domain were found to cause 
ARVC (Basso et al., 2006; Bauce et al., 2005). One of these mutations (p.R1755I) was 
predicted by structural analysis to cause impairment on dimerisation (Bauce et al., 
2005). A heterozygous nonsense mutation (p.R1113X) affecting the region of the rod 
domain that is common to both DPI and DPII caused AR/LVC resulting in sudden 
cardiac death at the age of 36 (Asimaki et al., 2009a). Immunohistochemistry of this 
patient’s heart revealed markedly reduced expression of DP and PG at the intercalated 
disc but normal PKP2 and N-cadherin staining. 
A heterozygous missense mutation (p.R2834H) in the region encoding the C-
terminus was also found to be the cause of ARVC (Yang et al., 2006). Transgenic mice 
conditionally over-expressing this mutant in the heart showed enlargement of both 
ventricles and cardiac dysfunction accompanied by an increased cardiomyocyte 
apoptosis, cardiac fibrosis and lipid accumulation, which are symptoms that recapitulate 
the human disease. In these mice, desmin IFs failed to co-localise with DP in the 
intercalated disc indicating disruption of DP-desmin interactions. Interestingly, this 
mutation occurs close to serine 2849, which is a phosphorylation site known to be 
important for regulation of DP-IF interactions (Godsel et al., 2005). Two additional 
heterozygous C-terminal missense mutations caused ARVC leading to sudden death in 
one of the cases (p.R2541K) (Beffagna et al., 2008). This patient also carried another 
missense mutation (p.V30M). In the other case (p.R2639Q), a rare SNP could not be 
excluded (Yu et al., 2008). 
Missense mutations in the N-terminus of DP were also found to cause AR/LVC. 
One of these mutations (p.S299R) modifies a potential phosphorylation site in this 
region (Rampazzo et al., 2002). Two other DP mutants (p.V30M and p.Q90R) were 
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unable to localise to the plasma membrane and to interact with PG in vitro (Yang et al., 
2006). Two additional missense mutations (p.S507F and p.S442F) were found to cause 
cardiomyopathy with biventricular involvement and led to sudden death at the ages of 
32 and 44 (Sen-Chowdhry et al., 2008). Another two dominant missense mutations in 
the N-terminus of DP (p.K470E, p.A566T), as well as compound heterozygosity for 
these two mutations, were also found to lead to ARVC (Basso et al., 2006). 
Three heterozygous splice site mutations, possibly leading to haploinsufficiency, 
also in the N-terminus of DP caused AR/LVC, in one case leading to sudden death at 
the age of 25 (423-1G>A) (Asimaki et al., 2009a; Basso et al., 2006; Bauce et al., 
2005). A dominant nonsense mutant led to ARVC due to haploinsufficiency (p.W233X) 
(Yang et al., 2006). A single bp insertion (c.2034insA) caused a frameshift which led to 
the production of a truncated protein, which contained the first 586 amino acids of the 
N-terminal domain and eight additional non-DP residues (p.T586fsX594) (Norman et 
al., 2005). This mutation was associated with ALVC. A deletion of one bp also leading 
to a frameshift (p.S1015fsX1017) was associated with AR/LVC (with involvement of 
both ventricles) and sudden death at the age of 26 (Sen-Chowdhry et al., 2008). 
All together, these observations highlight the importance of DP for maintenance 
of heart integrity and normal function. Additionally, they indicate that cardiomyopathies 
involving the right or left ventricles as well as both can be caused by dominant or 
recessive mutations, including missense, splice site, insertion, deletion and nonsense 
mutations, which can lead to DP haploinsufficiency, absence of DP isoforms or C-
terminal truncations as well as amino acid substitutions (Figure 1.8). 
 




Figure 1.8. Schematic of DP showing the locations of reported mutations causing cardio-
cutaneous disease. DP consists of three functionally distinct domains (N-terminus, Rod and C-
terminus depicted in blue, yellow and orange, respectively). Mutations are colour coded 
according to the different resulting phenotypes. Mutations causing haploinsufficiency are 
depicted in bold print; # refers to mutations that are predicted to result in haploinsufficiency 
although confirmation is lacking; mutations resulting in a truncated protein are marked by 
vertical discontinuous bars; mutations connected by a horizontal line are compound 
heterozygous mutations; mutations located within the two discontinuous vertical black lines are 
DPI-isoform-specific. D = dominant; R = recessive; * 939+1G>A splice site mutation has also 
been reported to cause non-syndromic ARVC; ** L1654P mutation was present in conjunction 
with a heterozygous PKP2 nonsense mutation in a patient with ARVC. Adapted from Bolling 
and Jonkman (2009). 
 
1.8. RNA interference as an experimental tool to study the effect of 
mutations causing protein loss 
The RNA interference (RNAi) pathway is a conserved biological mechanism of 
post-transcriptional regulation of gene expression and of protection of the genome from 
internal and external threats in animals and plants (Hannon, 2002). It is triggered by 
either long, usually exogenous, double-stranded RNAs which are cleaved into double-
stranded short interference RNAs (siRNAs) or by endogenous precursor transcripts 
named primary microRNAs (pri-miRNAs) which are subsequently processed into 
miRNAs. The RNase III enzyme Dicer is responsible for the excision of siRNAs and 
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miRNAs from their precursor RNA duplexes in the cytoplasm, producing 20-24 
nucleotide duplexes paired in a way that leaves two-nucleotide 3’ overhangs (Carthew 
& Sontheimer, 2009). One of the strands, the antisense or guide strand, is uploaded into 
the RNA-induced silencing complex (RISC), which is then guided to the 
complementary sequence of the target mRNA to be silenced. The other strand, the sense 
or passenger strand, is ultimately degraded (Ghildiyal & Zamore, 2009). Perfect 
complementarity between the guide strand and the target mRNA induces the catalytic 
component of RISC, named argonaute, to cleave the target mRNA at a very precise site 
(Tomari & Zamore, 2005) leading to its subsequent degradation by cellular 
exonucleases (Orban & Izaurralde, 2005). 
As an experimental tool, chemically synthesized siRNAs which mimic Dicer 
products can be introduced into the cytoplasm of cultured cells. These synthetic siRNAs 
will transiently trigger the biological response of the RNAi pathway and lead to target 
mRNA degradation (Elbashir et al., 2001). 
One of the differences between siRNAs and miRNAs is that while siRNAs are 
perfectly complementary to sequences within the target mRNAs, most miRNAs bind 
with mismatches and bulges to the 3’UTRs of target mRNAs. Only nucleotides 2-8 
within the 5’ end of miRNAs, representing the seed region, need to be perfectly 
complementary to their targets in order to cause silencing. Given the small size of the 
seed region, a single miRNA can regulate many different genes. siRNAs can also bind 
imperfectly to unintended mRNA targets in a miRNA-like fashion. This is of 
considerable practical importance when performing siRNA mediated gene silencing, as 
it appears to account for most off-target effects of siRNAs (Carthew & Sontheimer, 
2009). 
 
1.9. Hypothesis of this study 
Two major hypotheses, which are described below, prompted the work 
described in this thesis. The first hypothesis emerged from the finding that three non-
consanguineous patients originating from Argentina presented with a cutaneous 
phenotype consisting of skin fragility, PPK and woolly hair, but no symptoms of 
cardiomyopathy. These patients were suspected of having a recessive desmosomal 
disease caused by a genetic mutation in one of the desmosomal genes. 
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The second hypothesis of this thesis is based on three different types of 
mutations in the DSP gene that were previously identified and affect different domains 
of DP. One of the mutations is a DSPI isoform-specific nonsense mutation leading to 
absence of DPI, two other mutations cause DPI/DPII haploinsufficiency and the third 
type is a dominant DSPI/DSPII 30 bp-insertion in the 5’ end of the gene. All three 
mutations are associated with PPK, which is syndromic (affecting also the heart) both in 
the case of the DSPI-specific mutation and the DSPI/DSPII insertion mutation and non-
syndromic for the DPI/DPII haploinsufficiency mutations. The clinical features of the 
affected patients vary in terms of the severity of skin and heart disease (see Chapter 5). 
The DSPI-specific nonsense mutation was shown to cause complete absence of DPI in 
patient skin by immunohistochemistry, but no further studies were carried out to 
investigate the effect and molecular mechanisms of this mutation (Uzumcu et al., 2006). 
The DP haploinsufficiency mutations were shown by immunohistochemistry and 
electron microscopy to cause thickening of the epidermis and impaired cell-cell 
adhesion with widening of intercellular spaces and DP-IF detachment (Armstrong et al., 
1999; Wan et al., 2004; Whittock et al., 1999). The 30 bp-insertion mutation was shown 
to result in discontinuous distribution of DP and PG around the cell membrane with 
some cytoplasmic localisation, particularly in the lower layers of the epidermis (Norgett 
et al., 2006). These results suggest that these different DSP mutations have different 
effects on intercellular adhesion and on the distribution and cellular localisation of DP 
and DP-associated proteins. Additionally, the different mutations seem to disrupt 
different differentiation-specific binding partners, as the 30 bp-insertion mutation 
appears to affect predominantly the lower regions of the epidermis while the 
haploinsufficiency mutations cause abnormalities mainly in the upper layers. Equally, 
different DP isoforms may have different functions within the desmosome, as shown by 
the fact that DPII alone cannot fully compensate for the absence of DPI in a patient 
harbouring the DSPI-specific nonsense mutation (see Chapter 5). 
The hypothesis of this thesis are: (1) the three Argentinean unrelated patients, 
who present with similar clinical features, harbour a common disease-causing mutation 
in a desmosomal gene, inherited as a recessive trait; (2) different mutations in the same 
desmosomal gene, DSP, will affect different aspects of keratinocyte and cardiomyocyte 
adhesion, differentiation and/or signalling; and (3) the different DP isoforms and 
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different binding sites within this protein have separate roles in desmosome biology as 
determined by pathogenic variation in the human DSP gene. 
 
1.9.1. Aims of this study 
In order to test the first hypothesis, genetic and molecular analysis were 
undertaken in the three Argentinean patients, including the following approaches: 
1) Identification of candidate gene by whole genome homozygosity SNP array; 
2) Candidate gene approach: mutation screening in candidate gene using PCR 
and sequencing analysis; 
3) Investigation of mutant mRNA and protein expression levels by RT-PCR 
and western blot, respectively. 
 
In order to test the second and third hypotheses the following approaches were 
carried out: 
4) RNAi technology was used to mimic the haploinsufficiency and DSPI-
nonsense mutations 
5) DSPI cDNA constructs were generated, including wild type DSPI and a 
mutant construct containing the 30 bp insertion mutation; 
6) The effects of DP haploinsufficiency and DSPI-nonsense mutations on the 
expression levels of junctional proteins were examined in an experimental 
system using HaCaT cells by western blot. 
7) The effects of the three different types of DSP mutations on the adhesive 
properties of the desmosome were examined by subjecting genetically 
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2.1. Chemicals and tissue culture consumables 
All chemicals were purchased form Sigma-Aldrich (St. Louis, MO) and all 
laboratory consumables were purchased from Fisher (Leicestershire, UK), unless 
otherwise stated. 
 
2.2. Molecular Biology I – DNA and RNA methods 
 
2.2.1. RNA isolation from cells 
Total RNA was isolated from cultured cells at 70-90% confluency, using the 
RNA-Bee reagent (AMS Biotechnology, Madrid, Spain) according to the 
manufacturer’s specifications. Briefly, cells were washed in phosphate buffered saline 
(PBS), and subsequently lysed directly by the addition of approximately 20 µl/cm2 of 
RNA-Bee reagent. The lysates was separated into aqueous and organic phases by the 
addition of 4 µl/cm2 of chloroform followed by centrifugation, which removes DNA 
and proteins from the RNA-containing aqueous phase. The RNA was isolated from the 
aqueous phase by isopropanol precipitation, followed by ethanol wash and 
solubilisation in RNase free double-distilled water (ddH2O). RNA was stored at -80ºC. 
 
2.2.2. RNA isolation from tissue 
Five µm-thick cryosections from patient skin biopsies samples were obtained 
from the National Diagnostic Epidermolysis Bullosa Laboratory, St Thomas’ Hospital. 
Total RNA was isolated from 10 frozen skin sections using the RNAeasy mini kit 
(Qiagen, Duesseldorf, Germany), according to the manufacturer’s specifications. 
Briefly, samples were lysed and ethanol was added to the lysates to provide ideal 
column binding conditions. The lysates were then loaded onto the RNeasy membrane 
which retains RNA, and the contaminants were washed away. Pure, concentrated RNA 
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2.2.3. Reverse Transcription (RT) 
cDNA was generated from total RNA using M-MLV reverse transcriptase 
(Promega, Madison, WI). Briefly, 7 µl of 5x M-MLV RT-PCR buffer (Promega), 1 µl 
of RNasin (Promega), 4 µl of 10 mM dNTPs (Invitrogen, Paisley, UK) and 1 µl of first-
strand random primers (OD 90, Invitrogen) were added to 20 µl of RNase free ddH2O 
containing: 150-300 ng of total RNA, when isolated from frozen tissue sections (see 
section 2.1.2); 10-60 µg of total RNA, when isolated from cells (section 2.1.1). RNA 
was denatured at 65oC for 10 min. Samples were then placed directly onto ice, and 2 µl 
of M-MLV reverse transcriptase (400 U) were added; when performing a negative 
control, 2 µl of RNase free water were added to a duplicate sample. Samples were 
incubated in a thermal cycler at 42oC for 90 min. cDNA was stored at -20ºC. 
 
2.2.4. Nucleic acid quantification 
Nucleic acid concentration was measured using a NanoDrop ND-1000 
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA), according to the 
manufacturer’s specifications. An assessment of nucleic acid purity was achieved by 
determining the ratios of spectrophotometric absorbance of the sample at 260/230nm 
and 260/280nm. Pure preparations of DNA and RNA have an A260/A280 ratio of 
approximately 1.8 and 2.0, respectively, and an A260/A230 ratio of approximately 2.2. 
 
2.2.5. Polymerase Chain Reaction (PCR) 
 
2.2.5.1. Primer design 
All primers were purchased from Sigma-Aldrich. Specific primer pairs were 
designed either to PCR amplify or sequence the regions of interest. The oligonucleotide 
length varied from 18 to 24 bp depending on the GC content, which ranged from 45-
65%. The GC content of each primer in a pair was designed to be as close a match as 
possible. Primers were designed to contain a G or C nucleotide at the beginning and end 
of each primer sequence. Calculation of each primer annealing temperature (AT) was 
determined using the following equation: 
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AT = 69.3 + (0.41× GC%) – (650/oligo length) 
 
For each primer pair, the lowest AT was initially used in the PCR cycle and where 
necessary this parameter was optimised. 
 
2.2.5.2. Genomic PCR for mutation screening 
PCR for mutation screening was performed using the Fast Start High Fidelity 
PCR system (Roche, Basel, Switzerland). A typical 50 µl PCR reaction comprised: 5 µl 
of 10x reaction buffer containing 1.8 mM MgCl2; 0.05 U/µl of Fast Start High Fidelity 
PCR enzyme blend; 200 µM of each nucleotide (Promega); 0.4 µM of each primer and 
25-100 ng of template DNA. Cycling conditions consisted of 95ºC for 2 min, followed 
by 35-40 cycles of 95ºC for 10 sec, primer annealing for 10 sec and 72ºC for 30-40 sec, 
with a final extension step at 72ºC for 5 min. 
Coding exons 2-7 of the JUP gene from three patients and three family members 
were screened for mutations. These exons were amplified using primers described 
previously (Whittock et al., 2000) with some modifications, which are included in Table 
2.1. The resulting DNA fragments were sequenced as described in section 2.2.18. In 
addition to patients and family members, control DNA from 54 unrelated individuals 
was used to amplify exon 2 of the JUP gene and the resulting DNA fragments were 
either digested with HinfI restriction enzyme (see section 2.2.13) and resolved by 
agarose gel electrophoresis (section 2.2.7), or sequenced directly.  
 










size ( bp) 
2 gtgcccccagtagccacg† ctacaatctgcctcctttcac 58† 312 
3 gagaggtagaatggccagtc gtcagactcatcacacacgg 55 540 
4 ccgtgtgtgatgagtctgac ggcacatagtaggtgctcac 55 446 
5 ccatgccaggctcacatgt cagtcgcatgatgaagcatg 55 410 
6 gctgaagctcagtaatgacag gagcatggctgactgagcct 55 316 
7 tgagtatgatggccttgagg ccacagtacctcaggtcagat 55 295 
†modifications to Whittock et al. (2000); AT = annealing temperature. 
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2.2.5.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
PCR amplification of cDNA was performed as described in section 2.2.5.2, 
except that 3-5 µl of cDNA (generated as described in section 2.2.3) were used as 
template. When the region to be amplified was over 800 bp, denaturing and annealing 
times were raised to 30 sec. Extension times were calculated according to the size of the 
fragment to be amplified, based on the assumption that 1 min is required to amplify 1 
Kb of sequence. 
 
2.2.5.3.1. RT-PCR for expression profiling of desmoplakin isoforms in multiple tissues  
Expression profiling of DSP isoforms in various tissues was carried out by RT-
PCR on Clontech Human Multiple Tissue cDNA Panel 1 and Human Cardiovascular 
Multiple Tissue cDNA Panel (BD Biosciences, Franklin Lakes, NJ). Primers and 
cycling conditions indicated in Table 2.2 were designed to amplify and distinguish 
between DSPI, DSPIb and DSPII isoforms. DSPIb is a novel DSP splice variant 
described in Chapter 4. The primer pair DSPIbF/DSPR was used with an extension time 
of 23 sec, which allowed for the amplification of DSPIb but not the 1712 bp-isoform 
DSPI. In the same way, the primer pair DSPIIF/DSPR was used with an extension time 
of 45 sec for selective amplification of the shorter DSPII isoform (Table 2.2).  
 














DSPIF cttggaactaaggagccag (5526-5544) 
DSPI 
DSPR ccacctgagtacactgattc (5685-5704) 
57 179 11 
DSPIbF gcttgatagactttcaaggg (3993-4012) 383 (DSPIb) 
DSPIb 




DSPIIF gatcgaagttttggaagagg (3378-3397) 530 (DSPII) 
998 (DSPIb) DSPII 




*Position of primers according to the NCBI reference sequence NM_004415.2 (DSPI) is given in 
parenthesis. DSPIb is a novel DSP isoform described in Chapter 4. AT = annealing temperature; Ext. time 
= extension time in seconds.  
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2.2.5.3.2. RT-PCR sequencing 
The primers and cycling conditions used to amplify cDNA corresponding to 
exons 1-3 of JUP are indicated in Table 2.3. Primers which amplified the hypoxanthine 
phosphoribosyl-transferase (HPRT) housekeeping gene were used as a control of cDNA 
abundance (Table 2.3). Forty cycles were used for each reaction. 
 





Primer sequence (5’-3’)* 
Product 





F1 gagctcagttcgctgtcc (37-54) 1 
JUP 
R1 caatggccgacttgagcag (483-501) 1 
465 59 28 
F2 ctatcaaggtgactgagtgg (148-167) 1 
JUP 
R2 cctggtagttgatgagatg (504-522) 1 
375 58 23 
HPRTF tgacactggcaaaacaatgca (578-598) 2 
HPRT 
HPRTR ggtccttttcaccagcaagct (651-671) 2 
94 58 10 
*Position of primers according to the NCBI reference sequence 1NM_002230 (JUP) and 2NP_386759 
(HPRT) are given in parenthesis. AT = annealing temperature; Ext. time = extension time in seconds.  
 
2.2.5.3.3. RT-PCR for mapping of the potential DSPIa splice variant 
Primers and cycling conditions used to map the putative DSPIa splice variant are 
depicted in Table 2.4. 
 











DSPIaF cagtttgagaccgagatcaac (4372-4392) Potential 
DSPIa DSPR ccacctgagtacactgattc (5685-5704) 
53-56 0-60 
*Position of primers according to the NCBI reference sequence NM_004415.2 (DSPI) is given in 
parenthesis. AT = annealing temperature; Ext. time = extension time in seconds.  
 
2.2.5.3.4. RT-PCR cloning 
The primer pairs and PCR conditions indicated in Table 2.5 were used to 
amplify overlapping fragments of DSP cDNA from primary normal human 
keratinocytes (NHK) in order to generate DSP constructs (see section 2.3). 
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Following TA cloning (section 2.2.8) and transformation of E. coli cells (section 
2.2.9), one individual colony was picked with a tip and cells were released in a tube 
containing 25 µl of sterile ddH2O. These cells were lysed at 95ºC for 5 min and then 
placed onto ice. The same tip was then placed in a tube containing 3 ml of LB broth 
(Invitrogen) with 50 µg/ml of the appropriate antibiotic (ampicilin or kanamycin), and 
cells were grown at 37ºC whilst shaking at 220 rpm overnight. The DNA contained in 
the boiled lysates was used as template for a diagnostic PCR to confirm the presence of 
the desired construct. PCR was performed as described, using 2 l of the boiled lysates 
and the conditions summarised in Table 2.5. This procedure was used to screen a 
minimum of 8 colonies for each cloned fragment. After the screening PCR, the 
overnight cultures of the clones that contained the desired constructs were used to 
isolate plasmid DNA as described in section 2.2.11. 
 





Primer sequence (5’-3’)* 
AT 
(ºC)
Size of PCR 






1F gtccgcctatccttggcccc (188-207) 
1 
1R cgcttggcctcctcctgaaac (4278-4298) 
57 4111 4.12 40 
2F ggctcaatgacagcatcttg (4043-4062) 
2a 
4R ctgttcctggagtaactgcc (5276-5295) 
57 1253 1.3 40 
4F cctgcaagaggaagaagctg (5042-5061)
2b 
2R cgatcagctgacactcatag (6219-6238) 
57 1197 1.2 40 
2F ggctcaatgacagcatcttg (4043-4062) 
2 
2R cgatcagctgacactcatag (6219-6238) 




55 3028 3.03 40 
1F gtccgcctatccttggcccc (188-207) 
4 
5R gtaccgagcatgaacatctg (3269-3288) 
57 3101 3.2 35 
5F gagcagaagaacttgcacag (3064-3083)
5 
2R cgatcagctgacactcatag (6219-6238) 
62 1378 1.4 35 
*Position of primers according to the NCBI reference sequence NM_004415.2 (DSPI) is given in 
parenthesis. See relative position of each fragment in Figure 2.1. AT, annealing temperature; Ext. time, 
extension time in minutes. 
 
2.2.5.3.5. Quantitative RT-PCR (qRT-PCR) 
Quantitative RT-PCR amplification of 400 ng of cDNA was performed using the 
MiniOpticon detection system (BioRad, Berkeley, CA) and the DyNAmo SYBR Green 
qPCR kit (Finnzymes, Espoo, Finland). Primers which amplified DSPI, DSPIb and 
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DSPII are indicated in Table 2.2. The cDNA was added to a mixture containing qPCR 
Mastermix Plus for SYBR Green 2x reaction buffer, forward and reverse primers 
(0.4µM each), and ddH2O to a final volume of 20 l. A fragment from the housekeeping 
gene β2 microglobulin (B2M) cDNA was also amplified as an internal control (reference 
gene). Cycling conditions consisted of 95ºC for 10 mins followed by 40 cycles of 94ºC 
for 10 sec, 60ºC for 20 sec and 72ºC for 20 sec, with a final extension step at 72ºC for 5 
min. Relative quantification was established by defining the difference between the 
reference and target cycle threshold (Ct) values for each sample. 
 
2.2.6. Illumina Beadchip mapping arrays and analysis 
DNA from each patient was column purified (section 2.2.15) and sent to the 
Genome Centre, Charterhouse Square, London, to be hybridised to Illumina 
HumanHap550v3_A Genotyping Beadchips according to the manufacturer’s 
specifications (Illumina Inc, San Diego, CA). These arrays allow for the interrogation of 
550,000 tag single nucleotide polymorphisms (SNP) per sample. SNPs were called 
using BeadStudio v3 with Illumina-defined SNP cluster positions (Illumina). SNP-
called data were analyzed by Dr. Charles Mein and Dr. Richard Dobson to identify 
blocks of 20 consecutive homozygous SNPs. The number of SNPs residing in 
consecutive blocks per chromosome was recorded. 
 
2.2.7. Agarose gel electrophoresis 
Agarose gels were used to identify and separate PCR products and restriction 
digest fragments. For separation of fragments shorter than 800 bp, 2% (w/v) agarose 
(Bioline, London, UK) gels were prepared. Briefly, the agarose was melted in the 
appropriate volume of TBE buffer (see Appendix E) and ethidium bromide was added 
at final concentration of 10 mg/ml. The clear solution was poured into a gel tray with a 
suitable comb to form the sample wells, and left to solidify. The gel was flooded with 
TBE in an electrophoresis tank. For detection of fragments longer than 800 bp, 1% 
(w/v) agarose gels were prepared in a similar way. DNA samples were mixed with 
DNA loading buffer (see Appendix E) in a 5:1 ratio and loaded on the gel alongside 
1Kb Plus DNA ladder (10% (v/v) 1 Kb Plus DNA ladder (Invitrogen), 16% (v/v) 
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loading buffer). Samples were electrophoresed at a constant voltage of 80-100 V. DNA 
was visualised under UV transillumination.  
 
2.2.8. TA Cloning 
PCR products were cloned into pCRII-TOPO cloning vector using the TOPO 
TA Cloning Kit (Invitrogen) according to the manufacturer’s specifications, with the 
following modifications. A reaction containing 2 l of PCR product and 0.5 l of 
pCRII-TOPO vector was gently mixed and incubated for 5 min at RT. The reaction was 
placed on ice and then used to transform competent cells (section 2.2.9). 
 
2.2.9. Transformation of chemically competent bacterial cells 
The generated constructs were used to transform chemically competent E. coli 
cells. The chemical transformation protocol was performed using One Shot TOP10 
Chemically Competent E. coli cells (Invitrogen), according to the manufacturer’s 
instructions. Briefly, 2 l of each construct generated by TA cloning (section 2.2.8) or 
following ligation (section 2.2.17) were mixed with TOP10 Chemically Competent E. 
coli cells. Following an incubation of 15 min on ice, cells were heat-shocked for 30 sec 
at 42ºC and then immediately transferred to ice. After addition of 250 l of RT SOC 
medium (Invitrogen), cells were incubated at 37ºC for 1h to allow expression of the 
antibiotic resistance genes. Cells were plated on a pre-warmed LB agar plate (LB broth 
with 1.5% (w/v) bacteriological agar) containing 50µg/ml ampicillin or kanamycin. 
When appropriate, 40 l of 40 mg/ml X-gal (Qiagen) were spread on each LB plate. 
Inoculated agar plates were incubated at 37°C overnight. 
 
2.2.10. Glycerol stocks of transformed bacterial cells 
Glycerol stocks of transformed E. coli cells were prepared by the addition of 200 
µl of 80% glycerol to 800 µl of freshly grown overnight bacterial cultures. Glycerol 
stocks were stored at -80°C. 
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2.2.11. Small scale plasmid preparation 
Small scale plasmid DNA preparations were obtained using the Wizard Plus 
Minipreps DNA Purification Systems (Promega), according to the manufacturer’s 
specifications, with some modifications. Briefly, a single colony was picked from a 
freshly streaked selective plate and grown in 3 ml LB broth (Invitrogen) containing 50 
g/ml of ampicilin or kanamycin for 16-18h at 37ºC. Cells were pelleted by 
centrifugation for 2 min at 7,063×g and the pellet was re-suspended in cell re-
suspension solution. Cells were lysed and then neutralised. The lysate was centrifuged 
at 13,226×g for 5 min and the DNA in the supernatant was mixed with 1 ml of resin and 
bound to a minicolumn. The column was washed twice with 1 ml of Column Wash 
Solution each time and then centrifuged for 2 min at 13,226×g to dry the resin. The 
plasmid DNA was eluted with 30 l of nuclease-free ddH2O by centrifugation at 
13,226×g and stored at 4ºC. 
 
2.2.12. Large scale plasmid preparation 
Large scale plasmid DNA preparations were obtained using the HiSpeed 
Plasmid Maxi kit (Qiagen) according to the manufacturer’s specifications regarding 
low-copy number plasmids, with the following modifications. A single colony was 
picked from a freshly streaked selective plate and a starter culture of 5 ml LB medium 
containing 50 g/ml of ampicilin or kanamycin was inoculated. The culture was 
incubated at 37ºC for 8h whilst shaking at 300 rpm. The starter culture was added into 
250 ml of selective LB medium (~1/50 dilution) and incubated at 37ºC for 12-16h.  
 
2.2.13. Restriction enzyme digests 
Restriction enzyme digests were used to specifically linearise plasmid vectors 
and excise DNA inserts in subcloning experiments, as well as to confirm the presence of 
the required DNA constructs in the desired orientation after cloning experiments. This 
method was also used to confirm the presence of mutations in patient and control 
genomic DNA samples (see section 2.2.5.2). Restriction enzyme digests were 
performed according to the manufacturer’s specifications. Generally, the required 
quantity of DNA (between 1-10 g of plasmid DNA or 4-10 l of PCR amplified DNA) 
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was incubated with 2 l of the suitable restriction endonuclease (New England Biolabs, 
Ipswich, MA) and 2 l of the appropriate 10x reaction buffer in a final volume of 20 l. 
Where necessary, the reaction was scaled up to a larger final volume and when more 
than one enzyme was used in the same reaction the total volume of enzyme did not 
exceed 1/10 of the final reaction volume. 
 
2.2.14. DNA purification from agarose gel 
After restriction enzyme digest, or after PCR if non-specific DNA fragments 
were present, agarose gel purification was used to recover the desired band. In order to 
eliminate the risk of introducing mutations caused by exposure to the UV light, care was 
taken not to expose the band to be recovered. A duplicate sample, resolved alongside, 
was used to indicate the position of the required fragment by exposing only this 
duplicate sample to the UV light. After excision of the required band, a QIAquick Gel 
Extraction Kit (Qiagen) was used to purify the DNA, according to the manufacturer’s 
specifications. 
 
2.2.15. Purification of PCR products 
The QIAquick PCR Purification Kit (Qiagen) was used for DNA purification 
prior to sequencing reactions as well as in sequential restriction digests for removal of 
the first enzyme’s optimal buffer. Where necessary, it was also used to purify patient 
genomic DNA prior to exon PCR-amplification and mutation screening (section 
2.2.5.2). This kit was used according to the manufacturer’s specifications.  
PCR products were cleaned up enzymatically using the ExoSAP-IT reagent 
(United States Biochemical, Cleveland, OH) according to the manufacturer’s 
instructions, prior to sequencing reactions. ExoSAP-IT utilizes two hydrolytic enzymes, 
exonuclease I and shrimp alkaline phosphatase, to remove unconsumed dNTPs and 
primers from PCR products.  
 
2.2.16. Ethanol/sodium acetate DNA precipitation 
DNA was purified and/or concentrated when necessary by ethanol/sodium 
acetate precipitation. To this end, 2 volumes of 100% ethanol and 1/10 of a volume of 
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3M sodium acetate, pH 5.5 were added to the DNA and mixed. This mixture was 
incubated on ice for 90 min (or -80°C overnight) and then centrifuged at 14,000xg at 
4°C for 30 min. The pelleted DNA was washed with ice cold 70% ethanol, air dried and 
re-suspended in the appropriate volume of ddH2O. 
 
2.2.17. Ligations 
Ligations of linear DNA into a cloning vector were performed using the DNA 
ligation kit (Sigma-Aldrich) according to the manufacturer’s specifications, with the 
following modifications. The molar ratio of insert DNA to plasmid DNA was 10:1. A 
20 l reaction mix was prepared by combining 5 ng of plasmid DNA, 50 ng of insert 
DNA, 1 l of 10x ligation buffer, 1 l of 10 mM ATP solution, 1 l of 24% (w/v) PEG 
solution and 1 l of T4 DNA Ligase with ddH2O to bring the volume up to 20 l. As 
negative controls, three additional reactions were prepared which are summarised in 
Table 2.6. These controls were used to check the efficiency of the restriction enzyme 
digests (section 2.2.13). All reactions were incubated at 16 ºC for 24-48h. 
 
Table 2.6. Negative control ligation reactions 
 
Control 1 Control 2 Control 3 
5 ng plasmid DNA 5 ng plasmid DNA 50 ng insert DNA 
1 µl 10x ligation buffer 1 µl 10x ligation buffer 1µl 10x ligation buffer 
1 µl 10 mM ATP 1 µl 10 mM ATP 1µl 10 mM ATP 
1 µl PEG 1 µl PEG 1µl PEG 
- 1 µl T4 DNA Ligase 1µl T4 DNA Ligase 
 
2.2.18. Sequencing 
Sequencing was performed using the BigDye Terminator version 3.1 Cycle 
Sequencing Kit (Applied Biosystems, Foster City, CA). Between 5-15 ng purified PCR 
product (3.2.15) or 300 ng of plasmid DNA were added to a reaction containing 1 l of 
Big Dye Terminator Master mix v3.1, 3 l of better buffer (Microzone, Ottawa, 
Canada) 0.5 l of 20 pmol/l specific primer and ddH2O up to a final volume of 10 l. 
Cycling conditions consisted of 25 cycles of 96 ºC for 30 sec, 55ºC for 15 sec and 60ºC 
for 4 min, followed by a final incubation at 4 ºC for 10 min.  
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The reaction products were precipitated with ethanol/EDTA/sodium acetate. 
Briefly, 2 l of 125 mM EDTA, 2 l of 3M sodium acetate and 50 l of ice cold 100% 
ethanol were added to the sequencing reaction and incubated on ice for 30 min. The 
mixture was centrifuged at 4100xg at 4ºC for 30 min; the pellet was washed with 70 % 
ethanol and air dried. Precipitated products were sent to the Genome Centre, 
Charterhouse Square, London, where sequences were read in an ABI sequencer. 
 
2.3. Molecular Biology II – DSP cloning strategies 
 
2.3.1. Generation of wild type DSPI and DSPIb constructs 
To generate DSPI and DSPIb constructs, cDNA was first generated by reverse 
transcription of primary NHK mRNA (see section 2.2.3). DSPIb is a novel, previously 
unknown DSP splice variant described in Chapter 4. Five cDNA fragments were PCR 
amplified (Table 2.5) with primers shown in Figure 2.1. Fragments 1 and 3 (amplified 
with primers 1F/1R and 3F/3R, respectively) are common to both DSPI and DSPIb 
isoforms whereas fragments 2a and 2b (amplified with primers 2F/4R and 4F/2R, 
respectively) are DSPI-specific and fragment 2 (amplified with primers 2F/2R) is 
DSPIb-specific (see Table 2.5 and Figure 2.1). Each fragment was gel purified (section 
2.2.14) where necessary and cloned into pCRII-TOPO cloning vector (Invitrogen) in the 
3’ to 5’ direction (see section 2.2.8 and Figure 2.2).  
To clone DSPI, and because of repetition of useful restriction enzyme sites (see 
Figure 2.1) fragments 2a and 2b were first joined. Fragment 2b in pCRII-TOPO was 
linearised with the vector MCS’s NotI and insert’s internal BmgBI, and fragment 2a, cut 
out of the cloning vector with the same enzymes, was inserted. Next, fragment 1, 
similarly cut out of the cloning vector with AfeI and NotI was inserted into the new 
2a/2b construct which had been linearised with the same enzymes. Finally, fragments 
1/2a/2b were inserted into the vector containing fragment 3 in a similar way, using NotI 
and NdeI. This strategy is summarized in Figure 2.2. 
 




Figure 2.1. DSPI and DSPIb cloning strategies. Schematic diagram of the three DSP splice 
variants showing locations of primer pairs and restriction enzymes used to clone DSPI and 
DSPIb. To clone DSPI, four overlapping cDNA fragments were PCR amplified with primers 
1F/1R (fragment 1), 2F/4R (fragment 2a), 4F/2R (fragment 2b) and 3F/3R (fragment 3). 
Fragments 2a and 2b were first ligated using BmgBI (position 5193). This larger fragment was 
then ligated with fragment 1 using AfeI (position 4184) and then fragment 3 was joined using 
NdeI (position 6118) (see also Figure 2.2). To clone DSPIb, fragment 2 was PCR amplified with 
primers 2F/2R and joined to fragment 1 using AfeI. The generated fragment was subsequently 
ligated to fragment 3 using NdeI. 
 
DSPIb and DSPII were cloned in a similar way. DSPII was constructed by first 
inserting fragment 4 into the cloning vector containing fragment 5 using the enzymes 
Bsu36I and NotI, followed by addition of fragment 4/5 to the fragment 3 construct using 
the enzymes NdeI and NotI. To generate DSPIb, fragments 1 and 2 were first ligated 
following digest of the respective pCRII-TOPO vectors with AfeI and NotI. 
Subsequently, these fragments were joined with fragment 3 using NdeI and NotI (Figure 
2.1). 
During the above cloning, where the restriction digest produced two fragments 
of similar size, an additional restriction enzyme (NcoI, shown in red, Figure 2.2) was 
used to aid separation by gel purification. When necessary (when two or more enzymes 
were not compatible in the same reaction buffer) sequential digests were performed 
(section 2.2.13). DNA purification columns (section 2.2.15) were used between the two 
enzymes to remove traces of the first buffer. 
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Figure 2.2. Graphical representation of DSPI cloning strategy. Fragments 1 (red), 2a 
(yellow), 2b (blue) and 3 (orange) were PCR amplified from NHK RNA and TA cloned into the 
pCRII-TOPO cloning vector. Vectors containing fragments 2a and 2b were digested with 
BmgBI and NotI and fragment 2a was ligated with the vector containing fragment 2b. Fragment 
1 was ligated to the vector containing fragment 2a/2b in the same way, following digests with 
AfeI and NdeI. Fragment 1/2a/2b was inserted in the vector containing fragment 3 using NdeI 
and NotI. 
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In order to subclone DSPIb into the pBabe puro retroviral vector (Morgenstern 
& Land, 1990), the pBabe vector was first digested with EcoRI (section 2.2.13) and 
then the 3' recessed ends were filled-in using Klenow DNA polymerase I (Invitrogen), 
according to the manufacturer’s specifications. The linearised vector with blunt ends 
was de-phosphorylated using shrimp alkaline phosphatase (Roche), according to the 
manufacturer’s specifications, and then gel purified (section 2.2.14). In the same way, 
DSPIb was excised from the pCRII-TOPO cloning vector using the unique MCS’ 
enzymes KpnI and NotI and its ends were made blunt using Klenow DNA polymerase I, 
prior to gel purification. To check the efficiency of the restriction enzyme digests and 
pBabe vector de-phosphorylation, the following ligation reactions were prepared as 
negative controls: vector alone, vector+ligase and vector+ligase+T4 polynucleotide 
kinase (Invitrogen). The DSPIb insert were then ligated to the linearised pBabe vector 
as described in section 2.2.17. 
 
2.3.2. Generation of wild type- and I608ins10-DSPI-flag expression constructs 
The 30 bp insertion mutation (I608ins10) was generated within the first fragment 
of DSPI (fragment 1; Figure 2.1) and a cDNA sequence encoding the flag tag was 
inserted into the third fragment (fragment 3; Figure 2.1) immediately upstream of the 
natural stop codon (TAG). These fragments were then ligated to fragment 2a/2b in the 
order described above (section 2.3.1), to generate the full length I608ins10-DSPI-flag 
construct which was then sub-cloned into one pBabe puro vector as described (section 
2.3.1). 
The strategy used to generate the 30 bp insertion mutation consisted of inserting 
a 155 bp oligonucleotide duplex containing the mutation into fragment 1. To generate 
the 155 bp duplex, the four compatible oligonucleotides with 5’ phosphate (5’P) groups 
shown in Figure 2.3A were re-suspended in ddH2O at a concentration of 1 μg/μl and 
diluted to 500 ng/μl in STE buffer (see Appendix E). Equal volumes (30 μl) of 
oligonucleotides I30 Sense A and I30 AsenseB were duplexed by incubation at 95°C for 
5 min followed by 5°C decrements of 1 min each from 95°C to 25°C. Oligonucleotides 
I30 Sense B and I30 Asense A were duplexed in the same way. The resulting duplexes 
are shown in Figure 2.3B. 
 








Figure 2.3. Generation of a 155 bp oligonucleotide duplex containing the 30 bp-insertion 
mutation (I608ins10). Four 5’P oligonucleotides (A) were used to generate the 155 bp insert 
containing the insertion mutation. Oligo I30 Sense A was annealed with oligo I30 AsenseB and 
oligo I30 Sense B was annealed with oligo I30 AsenseA to generate 2 compatible A/B duplexes 
(B). The duplexes (B) are depicted in bold print with the I30 mutation highlighted in lowercase 
print. Bases in blue bold print are compatible with the 5’ end of the vector and bases in red bold 
print are compatible with the 3’ end of the vector. Bases in green bold print are compatible 
between the 2 A/B duplexes and used to join them. 
 
A triple fragment ligation was performed to join the two duplexes (forming the 
155 bp insert) and the vector. This ligation was performed using the following equation: 
 
Mass of insert = ((i:v ratio) x length insert x mass of vector) / (length vector), 
 
where an i:v (insert to vector) ratio of 10:1 was used; the length of the insert was 155 bp 
(formed by the two A/B duplexes) and 11 ng of vector with 6164 bp was used. 
Therefore, the calculated mass of insert was 2.84 ng and 1.42 ng of each duplex were 
ligated to 11 ng of vector using conditions described in 2.2.17. 
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Figure 2.4. Generation of I608ins10-DSPI. Schematic of DSP fragment 1 cloned into pCRII-
TOPO vector (nucleotides 118 to 4298) showing the location of the 30 bp insertion mutation 
(I608ins10) (nucleotide 2102, in red) and restriction sites for BsrGI (in brown), BbsI (in blue) 
and PflMI (in green) enzymes, used to generate the I608ins10 mutation (top diagram). BbsI 
digest released nucleotides 2017 to 3937 and a fragment containing the insertion mutation and 
BbsI compatible ends was inserted. The fragment released by BsrGI and PflMI digest 
(containing I608ins10) was inserted into a vector containing wild type fragment 1, opened up 
with the same enzymes (bottom diagram). 
 
This strategy was achieved in three steps due to the lack of unique restriction 
sites that would enable the insertion of the 155 bp duplex directly into the fragment 1-
containing vector. First, fragment 1 was digested with the enzyme BbsI releasing 
nucleotides 2017 to 3937 (see Figure 2.4). Second, the 155 nucleotide duplex containing 
the 30 bp insertion mutation and ends compatible with BbsI- (2017 and 3937) digested 
fragments was ligated to the open vector. Third, the resulting vector was digested with 
the unique restriction enzymes BsrGI (1614) and PflMI (2142) and the released 
fragment containing the insertion mutation was inserted into the original vector 
containing fragment 1 which was previously opened up with the same enzymes (Figure 
2.4) 
The flag tag was generated in a similar way. A 32 bp duplex consisting of 
annealed oligonucleotides (Figure 2.5) containing the flag tag-encoding sequence 
followed by a STOP codon (TAG) was generated as described above. The vector 
containing fragment 3 was digested with SpeI, the natural TAG termination codon was 
removed from fragment 3 using Mung Bean Nuclease (New England Biolabs) and the 
resulting fragments were digested with KpnI. The 32 bp duplex, which had a blunt end 
Chapter 2 – Materials and Methods 
 86
(compatible with the blunt extremity of the vector generated with the Mung Bean 
Nuclease) and a KpnI compatible end, was then inserted.  








Figure 2.5. Generation of a 32 bp oligonucleotide duplex containing the flag tag-encoding 
sequence. Two 5’P oligonucleotides (A) were used to generate the 32 bp sequence encoding the 
flag tag followed by a STOP codon. Oligo Flag Sense was annealed with oligo Flag Asense to 
generate the 32 bp duplex (B). The duplex (B) is depicted in bold print with the 3’ overhang 
compatible with the vector depicted in purple bold print and the flag-encoding sequence 
highlighted in lowercase print.  
 
2.4. Molecular Biology III – Protein methods 
 
2.4.1. Antibodies 
Primary antibodies used for western blot and immunocytochemistry and 
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11-5F Mouse 1:250 1:100 
Kind gift from Prof. 
David Garrod 













AC-15 Mouse 1:1,000 ------------ Abcam 
Mab anti-
vinculin 
hVIN-1 Mouse 1:40,000 ------------ Sigma-Aldrich 
Pab anti-
DSC2 





Mouse 1:250 ------------ Progen 
Mab anti-β-
catenin 
14 Mouse 1:2,000 ------------ BD 
Mab anti-
PKP1 
PP1-5C2 Mouse 1:100 ------------ Progen 
Mab anti-
PKP2 
Pkp2-518   Mouse 1:500 ------------ Progen  
Mab anti-
PKP3 
23E3/4   Mouse 1:500 ------------ Abcam  
Mab anti-
keratin 14 













5G11   Mouse 1:250  ------------ Abcam  
Mab anti-
DSG1/2 
DG3.10 Mouse ------------ 1:250 Progen 
Mab anti-
DSG2 
10G11 Mouse 1/50 ------------ Progen 
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2.4.2. Western blotting 
 
2.4.2.1. Protein preparation from frozen skin biopsies 
Twenty cryosections from frozen skin biopsies samples (5 µm-thick) were 
scraped into 60 µl of 2x Laemmli buffer (Appendix E). Samples were heated to 100°C 
for 5 min and centrifuged at 15,700xg for 5 min before being subjected to SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) (see section 2.4.2.4) or stored at -
80ºC.  
 
2.4.2.2. Protein preparation from normal human atrium biopsies 
 Small fragments of redundant atrium tissue were obtained during cardiac 
surgery and transported to the lab in dry ice. These small fragments were solubilised 
into an appropriate volume of 2x Laemmli buffer (see Appendix E) and subsequently 
heated to 100°C for 5 min and centrifuged at 15,700xg for 5 min before being subjected 
to SDS-PAGE (section 2.4.2.4) or stored at -80ºC. 
 
2.4.2.3. Protein preparation from cell extracts 
Whole-cell protein extracts were prepared from HaCaT keratinocytes or from 
Phoenix amphotropic retroviral packaging cells (see section 2.5.2 for cell culture 
conditions). HaCaT keratinocytes were seeded at high density (7x105 cells/well of a 6-
well dish) and total protein was extracted 24-48h later. Phoenix cells were grown to 
approximately 70% confluence before protein isolation. The cells were washed in PBS 
before lysis in boiling SDS sample buffer (see Appendix E). Cells were scraped and the 
cell lysate was transferred to microcentrifuge tubes and heated to 100°C for 5 min 
before being subjected to SDS-PAGE (section 2.4.2.4) or stored at -80ºC.  
Protein lysates from the HpV immortalised human breast keratinocyte cell line 
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2.4.2.4. SDS-Polyacrylamide Gel Electrophoresis (PAGE) and transfer 
 
2.4.2.4.1. Pre-cast gradient SDS-polyacrylamide gels and transfer 
Whole cell lysates were resolved on NuPAGE Novex 4-12% Bis-Tris Mini Gels 
or NuPAGE Novex 3-8% Tris-acetate Mini Gels (Invitrogen), when western blotting for 
PG and DP respectively according to the manufacturer’s specifications. Between 5-10 
µl of protein sample and 12-15 µl of High Mark Pre-stained Molecular Weight Marker 
(Invitrogen) were loaded on the pre-cast SDS-polyacrylamide gels. The gel was run at 
80-120 V until the desired separation was obtained. Proteins were subsequently 
transferred onto a Hybond – C Extra nitrocellulose membrane (GE Healthcare, 
Buckinghamshire, UK) in a wet transfer electrophoretic cell (Invitrogen) according to 
the manufacturer’s specifications. 
 
2.4.2.4.2. Preparation of SDS-polyacrylamide gels and transfer 
A 10% separating polyacrylamide gel mixture was prepared and poured between 
two glass plates and 1.5 mm spacers in a gel electrophoresis apparatus (BioRad). The 
gel mixture was overlaid with 1 ml of isopropanol, and left to polymerise at RT for 
approximately 20 min. When the gel was polymerised, the isopropanol was washed 
away with ddH2O. A 5% stacking gel mixture was prepared and cast with sample combs 
over the resolving gel, and left to polymerise at RT for approximately 30 min. Between 
5-20 µl of protein sample as well as 10-12 µl of Full-range Rainbow Molecular Weight 
marker (GE Healthcare) were loaded on the SDS-polyacrylamide gel. The gel was run 
at 80-120 V in running buffer (Appendix E) until the desired separation was obtained. 
Proteins were transferred onto a Hybond – C Extra nitrocellulose membrane (GE 
Healthcare) in a wet transfer electrophoretic cell (BioRad) with transfer buffer 
(Appendix E), usually at 80 V for 1.5h (or 10 V overnight). Quality of loading/transfer 
was assessed by staining of the membrane with ponceau stain (Appendix E) solution for 
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2.4.2.5. Immunoblotting and visualisation 
Non-specific antibody binding to the membrane was prevented by incubating the 
membrane in 5% (w/v) non-fat milk TTBS (see Appendix E) for 30 min at RT. Blocked 
membranes were incubated at 4ºC overnight in 5% (w/v) non-fat milk TTBS containing 
the appropriate primary antibody at the suitable dilution. Following three 5 min washes 
in TTBS, membranes were incubated in 5% (w/v) non-fat milk TTBS containing the 
appropriate peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulins (Dako) at 
a 1:1000 dilution, for 1h at RT. Membranes were subsequently washed again as 
described above, incubated in ECL or ECL Plus solution (GE Healthcare) for 5 min, 
sealed in a plastic sheet, and exposed to chemiluminescence sensitive film (GE 
Healthcare). The membrane was then washed in TTBS for 5 min and re-probed with an 
anti-vinculin or anti-β-actin primary antibody (Table 2.7) for 1h at RT. Vinculin and β-
actin were used as controls for equal loading. Subsequent washes, incubation in anti-
mouse secondary antibody and exposure were performed as described above.  
 
2.5. Cell culture 
 
2.5.1. Primary human keratinocyte culture conditions 
First, 3T3 fibroblasts (primary mouse embryonic fibroblast cells) were grown in 
Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 5% (v/v) Foetal 
Bovine Serum (FBS; Biosera, East Sussex, UK) and 2 mM L-glutamine in a 5% CO2 
humidified incubator at 370C. When approximately 70-80% confluent, 3T3 cells were 
incubated for 3-4h in DMEM (supplemented with 5% (v/v) FBS (Biosera) and 2 mM L-
glutamine) containing 7 µg/ml Mitomycin C to stop them from dividing. These cells 
were then washed in PBS and detached from the flask using 1 part 10x trypsin/EDTA to 
3 parts versene. The trypsin was quenched with DMEM followed by centrifugation at 
250xg for 5 min and re-suspension in DMEM:Ham’s F12 (3:1) supplemented with 10% 
(v/v) FBS (Biosera), 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin 
and RM+ (see Appendix E for RM+ composition). Cells were then counted using a 
hematocytometer and 2 million cells were seeded in a 75cm2 culture flask. 
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Second, primary NHK (6 million cells for a T75 flask) were inoculated in the 
flask containing the Mitomycin C treated 3T3 fibroblasts and incubated at 37°C in a 
10% CO2 humidified incubator. The medium was changed every 2-3 days and when 
necessary, more 3T3 cells were added. The keratinocytes were split once around 70% 
confluent. To split the keratinocytes, the 3T3 cells were first removed using versene and 
the keratinocytes were then detached using 1 part 10x trypsin/EDTA to 3 parts versene. 
 
2.5.2. HaCaT and Phoenix culture conditions 
The HaCaT spontaneously immortalised human keratinocyte cell line was 
cultured in DMEM:Ham’s F12 (1:1) supplemented with 10% (v/v) FBS (Biosera), 2 
mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and RM+ (see Appendix 
E for RM+ composition) and maintained at 37°C in a 5% CO2 humidified incubator. 
When 80-90% confluent, cells were passaged (2.5.1) and re-seeded. Growth medium 
was changed every 2-3 days. 
Culture of Phoenix cells was performed as described above, except that DMEM 
growth medium supplemented with 10% (v/v) FBS (Biosera), 100 U/ml penicillin, 100 
µg/ml streptomycin and 2 mM L-glutamine was used. 
 
2.5.3. Cryopreservation of cells 
For cryopreservation, 80-90% confluent cells were detached from the culture 
dish with trypsin/EDTA as described (2.5.1), pelleted by centrifugation and resuspended 
in 90% FBS:10% DMSO. Vials were frozen slowly at -80°C for at least 24h and then 
transferred into liquid nitrogen for long term storage. 
 
2.6. Retroviral transduction of HaCaT cells 
 
2.6.1. Transient transfection of Phoenix cells 
The Phoenix amphotrophic retroviral packaging cell line was used to generate 
viral particles as described previously (Kinsella & Nolan, 1996). These cells were 
seeded at a density of 1 million cells per well of a 6-well plate and transfected 24h later 
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with the appropriate DNA construct and FuGene 6 transfection reagent (Roche), at a 
ratio of 1:2.5. To this end, 25 µl of FuGene 6 were added dropwise to 200 µl of DMEM 
serum-free medium in a polystyrene tube and incubated for 5 min at RT. Subsequently, 
this mixture was added to another polystyrene tube containing 10 µg of DNA and 
incubated for 15 min at RT. Besides the plasmid constructs of interest, a GFP-pBabe 
control plasmid was used to follow expression, as well as a negative control where no 
DNA was added (mock control). The final mixture was added dropwise to cells in a 6-
well plate containing 3 ml of DMEM complete medium and incubated at 37°C. When 
completely confluent, fresh DMEM medium was added to these cells, which were 
incubated at 32°C for 24h to allow virus production. The retrovirus-containing 
supernatant was then filtered using a 0.45 µm filter to remove cell debris and either 
directly used to infect target cells or snap frozen and kept at -80°C for long term 
storage. Fresh media was added again to Phoenix cells which were incubated at 32°C 
for another 24h to produce a second round of virus. 
 
2.6.2. Infection of HaCaT cells with recombinant retroviruses 
HaCaT cells were seeded at a density of 2x105 cells per well of a 6-well plate 
24h prior to retroviral infection. These cells were incubated in DMEM:Ham’s F12 (1:1) 
supplemented with 10% (v/v) FBS (Biosera), 2 mM L-glutamine, 100 U/ml penicillin, 
100 µg/ml streptomycin and RM+ (see Appendix E for RM+ composition) containing 5 
µg/ml of polybrene (hexadimethrine bromide) for 10 min at 37°C to increase virus 
attachment to the cells. The polybrene-containing medium was replaced by 2 ml of 
retroviral supernatant containing 5 g/ml of polybrene and centrifuged for 1h at 350xg. 
Cells were washed twice with PBS and incubated in DMEM:Ham’s F12 (1:1) 
supplemented with 10% (v/v) FBS (Biosera), 2 mM L-glutamine, 100 U/ml penicillin, 
100 µg/ml streptomycin and RM+ (see Appendix E for RM+ composition) at 37°C 
overnight. A second cycle of infection was performed and 24h later, cells were selected 
with 1 g/ml puromycin until the mock control cells were all killed. Cells were 
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2.7. Transient siRNA mediated DSP knock-down 
Transfection conditions were optimised using siGLO Cyclophilin B Control 
siRNA (Thermo Fisher Scientific). For transient down-regulation of DSP splice 
variants, siRNAs were designed using the custom siRNA design tool from Thermo 
Fisher Scientific, according to the manufacturer’s specifications (see Appendix B). 
Table 2.8 summarises the characteristics of these siRNAs. The criteria used for siRNA 
design, as well as optimisations of transfection conditions, testing of the four designed 
siRNAs, optimisation of siI pool concentration and time course analysis of DPI down-
regulation in HaCaT cells are described in Appendix B. The siRNA designated as siI/II 
(Table 2.8) was published previously (Wan et al., 2007). 
Transfections were performed according to the DharmaFECT general 
transfection protocol (Thermo Fisher Scientific) and optimised for a 6-well plate format. 
HaCaT cells were plated at a density of 2x105 cell per well of a 6-well dish and 
incubated in complete antibiotic-free medium at 37°C, 24h prior to siRNA transfection. 
In separate polystyrene tubes, 10-100 nM of siRNA (final concentration) and 6 µl of 
DharmaFECT 1 were mixed in serum- and antibiotic-free media and incubated at RT 
for 5 min. The siRNA-containing medium was added to the tube containing the 
DharmaFECT 1 and these contents were mixed and incubated for 20 min at RT. 
Complete antibiotic-free media was added to the mix (transfection media). The culture 
media was then removed from the cells in the 6-well plate and 2 ml of transfection 
media were added to each well. Cells were incubated in transfection media for 
approximately 20h at 37°C and then this media was replaced by complete antibiotic-free 
medium. Cells were maintained in this media for 2-10 days and subsequently harvested 
for experiments. Cells transfected with a pool of four non-targeting (NT) siRNAs (on-
target plus siControl non-targeting pool; Thermo Fisher Scientific) as well as cells 
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Table 2.8. Characteristics of the siRNAs used 
 
  siRNA  siRNA sequence Target mRNA 
Position in 
target mRNA* 
  si1 GCGAAGGCGAGCTGAAGAA DSPI/DSPIb 4077-4095 
si2 ATAAGGAGATCGAGAGACT DSPI/DSPIb 4250-4268 






si4 AGATAGAACTGAAGCAGGT DSPI/DSPIb 4154-4172 
  siI/II AACCCAGACTACAGAAGCAAT† DSPI/DSPIb/DSPII 1633-1653 








siDSPI 2 CGAACAGAGGAGAGCGTAA DSPI 4651-4669 
* Position of siRNAs according to the NCBI reference sequence NM_004415.2 (DSPI). 
† Previously described in Wan et al. (2007) 
 
2.8. Immunocytochemistry 
For immunocytochemistry, cells were plated on coverslips at approximately 
80% confluency in 12-well plates and grown overnight at 37°C. Cells were washed 
twice in PBS and fixed either in methanol:acetone (section 2.8.1) or in 
paraformaldehyde (PFA, section 2.8.2). Following fixation, cells were washed three 
times in PBS, then permeabilised in 0.1% Triton X-100 in PBS (PBST) for 5 min at RT, 
and finally blocked with 3%BSA in PBS (blocking buffer) for 30 min at RT. The cell-
containing coverslips were then inverted onto a 50 µl drop of primary antibody-
containing blocking buffer at the appropriate dilution and incubated for 1h at RT. Cells 
were washed three times in PBS and then incubated with the appropriate Alexa Fluor 
488- (green) and/or 568- (red) conjugated goat anti-rabbit, mouse or guinea pig IgG 
secondary antibody (Invitrogen), at a 1:250 dilution in PBS, for 40 min at RT. DAPI 
was used as a nuclear stain at 100 ng/ml. Cells were mounted with Immu-mount 
(Thermo Fisher Scientific). 
Immunfluorescence images were acquired with a Zeiss LSM 510 laser scanning 
confocal microscope (Carl Zeiss Ltd, Hertfordshire, UK). Images were processed using 
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2.8.1. Methanol:acetone fixation 
Cells were washed twice with PBS and fixed in ice cold 1:1 methanol:acetone 
for 10 min at -20°C. This fixation method was used for staining with all primary 
antibodies used in this study, except for the anti-PG (PG5.1) antibody. 
 
2.8.2. Paraformaldehyde (PFA) fixation 
A fresh solution of 4% PFA in PBS (containing 0.8mM NaOH) was prepared 
each time. To this end, 2 g of PFA were dissolved in approximately 40 ml of boiling 
ddH2O containing 20 µl of 2M NaOH. The solution was cooled to RT and 5ml of 10x 
PBS were added. Water was added to a final volume of 50 ml. Cells were washed twice 
with PBS and fixed in 4% PFA for 15 min. This fixation method was used for staining 
with the anti-PG primary antibody (PG5.1) (see Table 2.7). 
 
2.9. Flexcell adhesion assay 
The Flexcell FX-4000 Tension System (Flexcell, Hillsborough, NC) is a 
computer-regulated bioreactor that uses vacuum pressure to apply cyclic or static strain 
to cells cultured on flexible-bottomed culture plates. This system was used to subject a 
cell monolayer to mechanical stress. HaCaT cells were grown to approximately 80% 
confluency on BioFlex 6-well plates coated with pronectin (Flexcell) which contain a 
rubber membrane in each 35 mm well. Each plate was placed over the loading station 
containing 6 planar faced cylinders or posts. Each post (25 mm) is centred beneath the 
rubber membrane of each 35 mm well. Cells were subject to cyclic mechanical stretch 
with a frequency of 2Hz (i.e. two cycles of stretch and relaxation per second) and an 
elongation of amplitude ranging from 11 to 14% (i.e. increase in diameter across the 
silicone membrane from 11 to 14%). Cells were stretched for different periods of time, 
between 0h (unstretched) and 3h, and then prepared for immunocytochemistry as 
described (section 2.8). In order to stain the cells contained in each well of the 6-well 
dish with more than one antibody, the flexible rubber membrane was cut into 8 
triangular fragments with a scalpel. Each of these cell-containing fragments was stained 
with a different antibody. 
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2.10. Statistical analysis 
Statistical analyses were carried out using the two-tailed, paired t-test on 
Microsoft Excel. p<0.05 was significant; p<0.01 was highly significant; p<0.001was 
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Genetic Analysis of Patients with 






Three non-consanguineous patients originating from Argentina presented with a 
similar cutaneous phenotype. Their clinical and histopathological characteristics were 
suspected to be caused by a hereditary desmosomal defect. The focus of the work 
presented in this chapter was to investigate the genetic basis of disease in these patients 
to gain further insight into the mechanisms of this cutaneous disease. The following 
introductory sections describe clinical and histopathological findings which led to the 
hypothesis that this condition is a desmosomal disease. These findings were published 
elsewhere (Winik et al., 2009), describing data determined prior to the work described 
here. 
 
3.1.1. Clinical observations 
Three non-consanguineous children (Figure 3.1A) from the province of Santiago 
del Estero in Argentina were examined at the Department of Dermatology at Tucuman 
Children’s Hospital, over a period of four years. All three patients were born to healthy 
unrelated parents. Two of the patients originated from distant villages of the same 
county, whereas the third patient was from a separate county. The patients were aged 
between two and eleven years old. 
All three patients had comparable skin phenotypes, which consisted of skin 
fragility with diffuse PPK, and woolly scalp hair (Figure 3.1B and C). They presented 
with blisters and erosions at sites of trauma since the first month of life (Figure 3.1C), 
and later development of hyperkeratotic palmoplantar plaques (Figure 3.1B) also 
associated with blisters and erosions. These lesions were present on the limbs, around 
the mouth and ears, in perianal and intergluteal folds and at the surface of the joints 
(Figure 3.1B and 3.1C) (Winik et al., 2009). Each patient has been examined on up to 
nine occasions for cardiac abnormalities and all have presented with normal 
echocardiogram and normal resting electrocardiography. The eldest patient was 14 
years old at the time of the last cardiac examination. 
This clinical phenotype has features in common with the ectodermal dysplasia-
skin fragility syndrome, which is caused by mutations in the PKP1 gene. It also 
resembles some aspects of the Carvajal syndrome and Naxos disease, which are caused 
by mutations in DSP and JUP, respectively. However, the overall clinical picture of 
these patients is distinctive, and therefore the suggested clinical classification for this 
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novel genodermatosis is acantholytic ectodermal dysplasia due to similarities with 
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Figure 3.1. Pedigree structure of the three Argentinean families investigated in this study 
and clinical features showing distinct phenotype of skin fragility, PPK and woolly hair. (A) 
Filled symbols represent affected family members (P1, P2 and P3). Squares represent male and 
circles represent female individuals. I1, I2 and I3 code for investigated healthy family members. 
(B) Clinical phenotype of one affected patient. Diffuse PPK, erosions on the face and around the 
mouth and woolly scalp hair are shown. (C) Clinical features of another patient showing severe 
skin fragility and the extent of blistering in early months of life. 
 
3.1.2. Histological, ultrastructural and immunohistochemical findings 
Histological examination of affected skin from these patients showed thickening 
of the epidermis with hyperkeratosis and acanthosis (increased cell number). The 
intercellular spaces between keratinocytes of the spinous and granular layers in lesional 
skin were wider. Acantholysis within the upper spinous and granular layers, resulting in 
intra-epidermal clefts, was also observed (Figure 3.2A). Ultrastructurally, desmosomes 
were noted to be reduced in number and not fully developed. IFs were collapsed around 
the nuclei and their attachment to the desmosomal plaques was defective (Figure 3.2B). 











plaques (IDPs) of desmosomes. Desmosomes with discontinuous outer dense plaques 
(ODPs) were frequent (Figure 3.2C) (Winik et al., 2009). 
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Figure 3.2. Histology and electron microscopy of affected skin. (A) Histology of affected 
skin stained with haematoxylin and eosin shows thickening of the epidermis with 
hyperkeratosis. Intercellular widening and acantholysis are observed in the upper spinous and 
granular layers (arrows). An increase in the cell cytoplasmic basophilia is also observed 
(arrowheads). (B) Ultrastructural analysis reveals intercellular widening (arrowheads) and 
poorly developed desmosomes (arrows). Clumped keratin IFs are observed in a perinuclear 
region with no clear insertions into desmosomes. The split between keratinocytes is observed 
intracellularly at the level of the IDPs (C) Poorly developed desmosome showing discontinuous 
ODPs (arrows). Figure courtesy of Dr. Beatrice Winik (Servicio de Microscopía 
Electrónica, INSIBIO, Universidad Nacional de Tucumán—CONICET, Tucumán, 
Argentina). 
 
Immunohistochemistry of patients’ skin with antibodies raised against 
desmosomal proteins demonstrated disrupted expression of both DP and DSG1, 
characterised by increased cytoplasmic staining compared to bright membrane bound 
immunoreactivity in normal control skin. More striking was the virtually absent PG 
staining in patient skin, compared to control skin. Moreover, the little amount of PG 
observed was not membrane bound, but mainly cytoplasmic. PKP1 and DSC 1-3 
expression and localisation were normal. Immunostaining with antibodies raised against 
the adherens junction proteins E-cadherin and β-catenin also appeared normal (Cabral et 







The three patients described here presented with an identical, distinctive 
phenotype and all originated from Argentina. Therefore, it was hypothesised that all 
three patients inherited the same ancestral disease allele on both maternal and paternal 
chromosomes. Additionally, as the three affected children were born to healthy parents, 
de novo dominant mutations were not suspected. Histological and ultrastructural 
analysis of these patients’ skin suggested a desmosomal disorder and 
immunofluorescence staining suggested the presence of mutations in PG, DP or DSG1. 
PG was the most likely candidate due to the very low immunoreactive signal observed 
by immunofluorescence staining of patient skin with a PG antibody, and to the 
discontinuous ODPs seen by electron microscopy. To gain further insight into the 





3.2.1. SNP genomic mapping 
Given that a recessive mode of inheritance was expected, a genome wide search 
for regions of common ancestry (homozygosity) was carried out in collaboration with 
Dr. Charles Main and Dr Richard Dobson. Common regions of genomic homozygosity 
were searched using the Illumina HumanHap550v3_A Genotyping BeadChip SNP 
mapping arrays. Scoring blocks of more than 20 consecutive homozygous SNPs 
common to all patients identified a region of 815 homozygous SNPs on chromosome 17 
from positions 32 to 40 Mb (Figure 3.3). The next largest shared homozygous stretch on 
other autosomes was 94 SNPs on chromosome one (data not shown). 
The homozygous region on chromosome 17 contains over 200 coding genes, 
among which a gene cluster encoding different keratins and the JUP gene encoding PG 
stood out. Given that ultrastructural data revealed defective desmosomal complexes 
with discontinuous ODPs (Winik et al., 2009 and Figure 3.2C), PG was more likely to 





Figure 3.3. Allelic profile of chromosome 17 for the three affected individuals reveals a 
common 8 Mb region of homozygosity which includes the JUP gene. Scoring blocks of more 
than 20 consecutive SNPs which were homozygous in all three patients identified a major 
region of 815 homozygous SNPs from positions 32 to 40 Mb of chromosome 17. This 8 Mb 
region contains the gene encoding PG, JUP, which is the most likely candidate for the disease 
phenotype. Work done in collaboration with Dr. Charles Main and Dr Richard Dobson 
(Genome Centre, Barts and the London, Queen Mary's School of Medicine and Dentistry, 
University of London, London, UK). 
 
3.2.2. Mutation analysis in the PG gene, JUP 
The JUP gene was the most likely candidate within the 8 Mb region of 
homozygosity on chromosome 17. Exons eight to 14 of JUP had been screened for 
mutations in these patients prior to this study commencing (Dr. Andrew South). 
Therefore, genomic DNA from one patient was used to PCR amplify across the coding 
exons two to seven. Sequencing of these products identified a cytosine to adenine 
homozygous transversion at coding nucleotide 71, in the first coding exon of JUP (exon 
two). This substitution changes a serine amino acid codon, TCG, to a premature 
termination codon (PTC), TAG (c.71C>A, p.S24X). Further analysis revealed this 
homozygous change in the two remaining patients and heterozygous change in all three 
parental DNA samples studied (Figure 3.4A). The presence of this mutation destroys a 
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HinfI restriction enzyme site and therefore its absence from 108 control chromosomes 








Figure 3.4. Identification of a nonsense mutation (c.71 C>A, p.S24X) in the JUP gene of 
three affected individuals and family members. (A) Electropherograms of control, parental 
and patient genomic DNA sequences within the second exon of JUP. Sequencing of patient 
DNA reveals a homozygous transversion from cytosine to adenine at coding position 71, which 
changes a serine amino acid codon, TCG, to a stop codon, TAG (c.71C>A, p.S24X). Unaffected 
parents are heterozygous carriers of this mutation. The HinfI restriction site, which is destroyed 
by the mutation, is shown. (B) Verification of the mutation by PCR/HinfI restriction enzyme 
digest of wild type and c.71C>A mutant JUP. Control (C) DNA shows complete digest (two 
fragments of 75 bp and 227 bp); DNA from a heterozygous c.71C>A carrier (mother, M) shows 
incomplete digest (one undigested fragment of 302 bp from the mutant allele and two digested 
fragments from the wild type allele); patient (P) DNA shows one undigested mutant fragment, 
indicating that the HinfI site is ablated. MW = molecular weight marker. 
 
3.2.3. RT-PCR from skin RNA and sequencing analysis 
RT-PCR of total RNA from skin samples of one of the patients, his mother and a 
normal control was carried out to determine if mutant c.71C>A transcripts were readily 
detectable. Amplification across exons one to three of JUP with primers F1/R1 and 
F2/R2 (Figure 3.5A) showed the presence of JUP mRNA in the patient sample (Figure 
3.5B), indicating that nonsense mediated mRNA decay (NMD) of mutant transcripts 
was not taking place. The c.71C>A mutant transcripts were expressed at higher levels 
than wild type transcripts (Figure 3.5A). Sequencing analysis of the PCR products 
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confirmed the presence of mutant transcripts in the patient sample as well as in the 
heterozygous maternal sample (Figure 3.5C) and no alternative 5’ splicing was detected. 
Although this analysis is not quantitative it is clear from the sequencing data (Figure 
3.5C) that the mutant mRNA is expressed at roughly equivalent levels to wild type 










Figure 3.5. c.71C>A nonsense mutation results in detectable mutant transcript in patient 
skin. (A) Schematic diagram of exons one to three of the JUP gene, showing primer pairs used 
to amplify JUP cDNA (F1/R1 and F2/R2) and the relative location of c.71 C>A mutation 
(indicated with an arrow). Exon 1 (in grey) is non-coding. Primers F1/R1 and F2/R2 were 
designed to PCR amplify cDNA fragments of 465 bp and 375 bp, respectively. (B) RT-PCR of 
total RNA from normal control skin (NS), maternal skin (MS) and patient skin (PS) samples. 
Normal skin RNA in the absence of reverse transcriptase (NS-RT) and water (W) were used as 
internal negative controls. Primers to amplify the hypoxanthine-guanine 
phosphoribosyltransferase housekeeping gene (HPRT) were used as a control of cDNA 
abundance. (C) Sequencing analysis of RT-PCR products generated with primers F1/R1 and 
F2/R2 shows the presence of mutant transcript in both maternal and patient samples, indicating 





3.2.4. Immunoblotting of skin proteins 
PG expression was assessed by western blot of total skin proteins isolated from 
patient, mother and control samples, using an antibody mapped to the C-terminus of PG 
(PG 5.1, see Figure A1 in Appendix A). In the control sample, full length PG was 
observed at approximately 82 KDa, as expected. In the mother’s sample, in addition to 
full length PG, a truncated protein was detected at a much lower expression level. The 
patient’s sample only contained low levels of this truncated protein with no full length 
PG present. The truncated protein was not observed in the control sample (Figure 3.6A). 
Identical results were observed when using an N-terminal PG antibody (clone 15F11) 
which reacts with a C-terminally truncated PG protein containing only amino acids 1-
144 (Sacco et al., 1995) (see Figures A1 and A2 in Appendix A). 
 
3.2.5. Identification of alternative translation initiation sites in the JUP mRNA 
Three previous observations suggest that an N-terminally truncated PG protein is 
produced from the mutant transcript. Firstly, the c.71C>A nonsense mutation generates 
a PTC within the first coding exon of JUP. Secondly, the corresponding transcript is 
correctly 5’ spliced, and thirdly a shorter mutant protein was detected by western blot. A 
possible explanation as to how this truncated protein is produced is by initiation of 
translation through an alternative start codon downstream of the PTC. Therefore, 
analysis of in-frame downstream AUG codons was undertaken to confirm whether this 
explanation was likely in this case. 
Three potential alternative initiation sites for translation were found (Figure 
3.6B). The first AUG codon downstream of the native translation start site, encoding 
methionine 43 (M43), is part of the strongest Kozak consensus sequence (Figure 3.6B). 
The Kozak consensus sequence is known to strongly facilitate translation initiation 
when containing the highly conserved nucleotides adenine at position -3 and guanine at 
position +4 (Kozak, 1981) (Figure 3.6B). Translation starting from the AUG codon 
encoding M43 would produce a protein with 703 amino acids, which would lack the 
first 42 amino acids of the wild type PG. This protein is calculated to be 5 KDa smaller 
than wild type PG, according to the protein molecular weight prediction of The 
Sequence Manipulation Suite bioinformatics program 
(http://www.bioinformatics.org/sms/index.html). The calculated molecular weights for 
the predicted N-terminally truncated protein (77KDa) and wild type PG (82KDa) 
correspond to those observed by western blot, based on the migration of the marker 
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proteins of known molecular weight. Therefore, these results suggest that the truncated 
PG protein is generated through the use of an in frame alternative site for translation 
initiation encoding M43 and lacks the first 42 amino acids. The N-terminally truncated 








Figure 3.6. p.S24X mutation results in an N-terminally truncated protein, likely through 
alternative initiation of translation. (A) Western blotting of skin proteins from a normal 
control (C), maternal (M) and patient (P) samples with a C-terminal PG antibody (PG5.1) shows 
low levels of a truncated protein predicted to be 77 KDa (p.S24X PG) in both maternal and 
patient samples. Full length PG which is 82 KDa (wt PG) is observed in control and maternal 
skin samples. β-actin (42 KDa) was used as loading control. (B) Schematic diagram of JUP 
exons one to three showing primer pairs used to amplify JUP cDNA (F1/R1 and F2/R2), the site 
of the c.71C>A mutation (indicated with an arrow), the native Kozak consensus sequence of 
JUP and three possible alternative sites for translation initiation downstream of the mutation. 
The alternative AUG translation start codon encoding methionine 43 (M43) has the strongest 
Kozak sequence characterised by an adenine at conserved position -3 and a guanine at 
conserved position +4, as observed for the native Kozak sequence (M1). A truncated protein 
initiated from M43 is 703 amino acids, predicted to be 77 KDa which corresponds to the 






The goal of the work described in this chapter was to identify the disease 
causing genetic mutation in three non-consanguineous patients originating from the 
same region of South America. These patients were hypothesised to have a desmosomal 
disease caused by a common recessive mutation in a desmosomal gene. 
During the course of this study, two additional sibling patients originating from 
Kuwait were identified, who presented with a very similar clinical phenotype to that of 
the Argentinean patients described here. This phenotype constitutes a novel 
genodermatosis designated as acantholytic ectodermal dysplasia. The Kuwaiti patients 
were found to carry a homozygous guanine to adenine transition at coding nucleotide 
468, c.468G>A, in the 5’ region of JUP. This mutation occurs in the last nucleotide of 
the second coding exon and is predicted to ablate splicing in this region (Cabral et al., 
2010) (see below). A PTC is found 18 nucleotides downstream of the mutation site 
which could lead to activation of the NMD pathway. Ultrastructural and 
immunohistochemical analysis of these patients’ skin were performed (Cabral et al., 
2010) (discussed below), however, availability of biopsy material prevented detailed 
analysis of c.468G>A skin. 
 
3.3.1. Clinical, histopathological and ultrastructural characteristics in acantholytic 
ectodermal dysplasia 
 
3.3.1.1. Similarities between Argentinean and Kuwaiti patients 
Both the Argentinean and Kuwaiti children have severe and widespread skin 
fragility, which was observed since the first month of life, with blisters and erosions in 
different sites of the body together with diffuse PPK and woolly hair (Figures 3.1B and 
3.1C and 3.7A). The hair in Kuwaiti patients was predominantly sparse in contrast with 
the hair of Argentinean patients. No cardiac abnormalities were observed in any of the 
five children. All five patients were born to healthy parents. Histological analysis of 
these patients’ skin revealed thickening of the epidermis, widening of intercellular 
spaces between suprabasal keratinocytes and loss of cell-cell contacts (Figure 3.7B). 
Immunohistochemistry of these patients’ skin with antibodies raised against 
desmosomal proteins showed similar expression levels and localisation of these proteins 
in all patients. The distribution of DP and DSG1 was slightly disrupted but more 
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striking was the marked reduction of PG staining in patient skin compared to control 
skin (see section 3.1.2). 
 
    A                                                                         B 
    
 
Figure 3.7. Clinical and histological features of the Kuwaiti patients. (A) The distinct 
phenotype of skin fragility, woolly (sparse) hair, and plantar keratoderma is shown in one 
affected patient from the Kuwaiti family. Figure courtesy of Prof. John McGrath. (B) 
Histology of lesional skin showing widening of spaces between suprabasal keratinocytes and 
loss of cell-cell adhesion. Figure courtesy of Dr. Beatrice Winik (Servicio de Microscopía 
Electrónica, INSIBIO, Universidad Nacional de Tucumán—CONICET, Tucumán, Argentina). 
 
Skin transmission electron microscopy of Argentinean and Kuwaiti patients 
revealed very similar ultrastructural features (Cabral et al., 2010) (see Figure 3.8). 
These included loss of inter-keratinocyte adhesion, most prominent in spinous layers, 
accompanied by some perinuclear aggregation of the keratin IF network. Desmosomes 
were under-developed and lacked defined insertions of keratin IFs. Instead of defined 
regions of homogenous electron density which are seen in normal desmosomes (i.e the 
IDP and ODP), these defective desmosomes showed a disorganised and heterogeneous 
combination of lighter and denser regions. This was particularly evident within the 
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Figure 3.8. Electron microscopy of keratinocytes in the mid-spinous layer from 
acantholytic ectodermal dysplasia and control epidermis. Widening of intercellular spaces 
and underdeveloped desmosomes are observed in the epidermis of an Argentinean (A, left 
panels) and a Kuwaiti patient (B, left panels) compared with controls (A and B, right panels). 
The keratin IF network is not closely associated with cell membranes in patient skin and shows 
perinuclear aggregation (A and B, upper left panels) compared with controls (A and B, upper 
right panels). High magnification of patient skin (A and B, bottom left panels) reveals 
hypoplastic desmosomes with unclear sites of keratin IF insertion. Notably, disruption to the 
structural organization of the desmosomal inner plaques is evident (arrows). Scale bars: (A) 
1μm, upper panels; 100nm lower panels; (B) 2.5μm, upper panels; 0.25μm, lower panels. Figure 
courtesy of Patricia Dopping-Hepenstal (National Diagnostic Epidermolysis Bullosa 
Laboratory, GSTS Pathology, St Thomas’ Hospital, London, UK). 
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3.3.1.2. Similarities and differences between acantholytic ectodermal dysplasia 
patients and patients with other known genodermatosis 
Interestingly, common clinical and histopathological characteristics are observed 
between patients with acantholytic ectodermal dysplasia (Argentinean and Kuwaiti 
patients described here) and patients with three different types of genodermatosis 
associated either with or without heart disease, namely ectodermal dysplasia-skin 
fragility syndrome, Carvajal syndrome and Naxos disease. 
Patients with ectodermal dysplasia-skin fragility syndrome, which is caused by 
recessively inherited mutations in the PKP1 gene (McGrath et al., 1997; McGrath & 
Mellerio, 2010), also exhibit very severe skin fragility observed shortly after birth, with 
blisters and erosions in heals and soles. Later in life, severe hyperkeratosis, scaling and 
cracking of palms and soles are observed, as well as crusts and erosions in scalp and 
face, trunk and limbs. Patients with this condition usually have total loss of scalp hair, 
as well as eyebrows and eyelashes, in contrast with the Argentinean patients described 
here who have abundant curly hair. However, the Kuwaiti patients also showed sparse 
scalp hair (Figure 3.7A). Skin histological and ultrastructural features of patients with 
ectodermal dysplasia-skin fragility syndrome are very similar to those of the 
Argentinean and Kuwaiti patients, including thickening of the epidermis with widening 
of intercellular spaces and loss of cell-cell adhesion in suprabasal keratinocytes. 
Desmosomes are immature and reduced in number and their connections with IFs are 
defective (McMillan et al., 2003). 
Patients with Carvajal syndrome, which is caused by a homozygous nonsense 
mutation in DSP leading to truncation of the C-terminus of DP (Norgett et al., 2000), 
also present with woolly hair and striate (focal) PPK (SPPK). In some instances 
blistering is observed on the trunk and extremities (Bolling & Jonkman, 2009). 
Additionally, Carvajal patients exhibit left ventricular dilated cardiomyopathy (LVDC), 
in contrast with patients with ectodermal dysplasia-skin fragility syndrome as well as 
the Argentinean and Kuwaiti patients who have no heart defects. Despite the clinical 
differences between Carvajal patients and the Argentinean or Kuwaiti patients, similar 
skin histopathological and ultrastructural features are observed between these two 
groups of patients. Carvajal patients’ skin is thickened compared to normal skin and 
large intercellular spaces are seen between suprabasal keratinocytes. Acantholysis is 
observed in spinous layers, a feature which is not observed in Naxos patients (see 
below). Lesional palm skin also reveals clumping of desmosomes in suprabasal 
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keratinocytes, which are only present in infrequent sites of cell-cell adhesion. 
Immunohistochemistry of suprabasal layers of palmoplantar epidermis revealed 
condensed keratin filaments with membranous and perinuclear distribution, suggesting a 
collapsed IF network (Norgett et al., 2000). Immunohistochemistry of Carvajal patients’ 
hearts showed reduced DP and PG signal and loss of desmin attachment to desmosomal 
plaques (Kaplan et al., 2004). 
Naxos disease is another autosomal recessive disorder caused by a C-terminal 
truncating deletion in the JUP gene (McKoy et al., 2000). Patients with this disorder 
have arrhythmogenic right ventricular cardiomyopathy (ARVC) associated with diffuse 
non-epidermolytic PPK (NEPPK) and woolly hair (Protonotarios et al., 1986). Although 
this phenotype is similar to the one of patients with Carvajal syndrome, the 
cardiomyopathy in Naxos disease affects predominantly the right ventricle (ARVC), is 
generally less severe and appears later in adolescence. The hallmark of the 
cardiomyopathy in Naxos patients, or ARVC, is the presence of adipose depositions in 
the ventricles. This is not observed in the heart of Carvajal patients. Additionally, Naxos 
patients have a diffuse NEPPK whereas Carvajal patients have striate PPK (SPPK), 
which is a focal keratoderma. The skin phenotype shown by the Argentinean and 
Kuwaiti patients, which is a diffuse keratoderma with skin fragility, resembles more the 
Naxos skin phenotype but is however much more severe and shows additional blistering 
and erosions. Histological analysis of Naxos skin shows severe hyperkeratosis but in 
contrast with the patients described here, no skin blistering or erosions are observed 
(Coonar et al., 1998). Although no detailed histopathology or electron microscopy 
analysis have been carried out in the skin of Naxos patients, intercellular widening 
appears to be a hallmark of desmosomal disease in general and is certainly common to 
the conditions described above. 
Despite clinical and histopathological similarities between the Argentinean and 
Kuwaiti patients and patients with Carvajal, Naxos and ectodermal dysplasia-skin 
fragility syndromes, the Argentinean and Kuwaiti patients present with a distinct 
phenotype. However, a desmosomal adhesion defect in the skin is common to all these 






3.3.2. Candidate gene approach led to identification of homozygous nonsense 
mutation in JUP 
Immunohistochemistry of the Argentinean patients’ skin with antibodies raised 
against desmosomal components showed normal PKP1 and DSC1-3 staining, so a 
mutation in the genes encoding these proteins was not suspected. However, disrupted 
expression of DP, DSG1 and PG was observed, indicating that a mutation in any of 
these genes was likely. Moreover, PG expression was strikingly reduced, and the little 
PG observed was not membrane bound. These results, coupled with the homozygosity 
SNP array data, indicated that JUP was the most likely candidate gene for this 
genodermatosis. Therefore, a candidate gene approach was undertaken and a novel 
homozygous nonsense JUP mutation (c.71C>A, p.S24X) was found in all three patients 
and heterozygous family members. 
 
3.3.3. p.S24X mutation results in detectable mutant transcript and reduced levels 
of truncated PG protein in the skin 
The c.71C>A mutation generates a PTC in the first coding exon of JUP, 137 
nucleotides upstream of the next exon-exon junction (Figure 3.5A). Therefore, it would 
be expected to activate the NMD pathway leading to degradation of the mutant 
transcript (Le Hir & Seraphin, 2008) (see section 3.3.4). However, RT-PCR and 
sequencing analysis revealed that the mutant transcript is normally produced and no 
abnormal 5’ splicing events were detected. Although the RT-PCR was not quantitative, 
mRNA levels in patient skin were higher than those of control and maternal skin 
samples (Figure 3.5B). This increase could possibly reflect a mechanism of 
compensation for the low protein levels produced from the mutant allele (see 3.3.5), but 
further studies would be needed to confirm this hypothesis. 
Western blotting of skin proteins revealed very low levels of expression of a 
truncated PG protein in both homozygous and heterozygous carriers of the mutant 
allele. The low expression levels of this truncated protein observed by western blot are 
consistent with the low levels of PG seen in the patients’ skin by immunofluorescence 





3.3.4. Alternative initiation of translation generates an N-terminally truncated PG 
(PGΔN42) 
The NMD pathway is a surveillance mechanism which ensures that mRNAs 
containing PTCs are rapidly degraded. It is currently accepted that in mammalian cells, 
NMD activation is dependent upon the assembly of protein exon junction complexes 
(EJCs), during mRNA splicing, 20-24 nucleotides upstream of each exon-exon junction. 
These EJCs stay associated with the mature mRNA until it reaches the cytoplasm, but 
are removed from the mRNA in ribosomes during the first round of translation. The 
presence of a PTC positioned more than 50-54 nucleotides upstream of an exon-exon 
junction will prevent the disassembly of at least one EJC downstream of the PTC. 
Retention of EJCs, which associate with other protein factors, will trigger NMD leading 
to the rapid degradation of mutant transcripts (Le Hir & Seraphin, 2008). Therefore 
generally only PTCs located downstream, or less than 50 nucleotides upstream of the 
next exon-exon junction will escape NMD.  
As mentioned in section 3.3.3, the PTC in the c.71C>A mutant mRNA is located 
137 nucleotides upstream of the next exon-exon junction and therefore should be 
targeted by the NMD pathway. However, exceptions to this rule have been observed, in 
particular when a PTC is located in close proximity to the translation initiation codon, 
which is the case in c.71C>A mutant mRNA. Work from different laboratories has 
shown that PTCs localised at the 5’ end of the coding region inhibit mRNA 
destabilisation and this effect appears to overcome the previous rule. The mechanism 
used to circumvent NMD in these cases was shown to be by re-initiation of translation 
downstream of the stop codon (Howard et al., 2004; Inacio et al., 2004; Zhang & 
Maquat, 1997). 
Analysis of in-frame AUG codons downstream of the c.71C>A mutation 
revealed three potential translation initiation sites. However, the first AUG codon 
downstream of the native translation start, encoding M43, is included in the strongest 
Kozak consensus sequence, identical to the Kozak sequence containing the M1-
encoding AUG. Translation starting from the AUG codon encoding M43 would produce 
an N-terminally truncated protein in agreement with the results obtained by western blot 
(Figure 3.6A). These findings strongly suggest that translation of the PTC-containing 
JUP mRNA is initiating from this alternative start site and generates a truncated protein 
that lacks the first 42 amino acids (PGΔN42).  
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In agreement with other reports, evidence is shown here which supports 
alternative initiation of translation from mRNAs containing PTCs in close proximity to 
the first AUG (encoding M1), as a mechanism used by cells to overcome NMD. This 
mechanism may allow some level of phenotypic rescue compared to the damage 
predicted to be caused by the complete absence of PG in these patients. In support of 
this hypothesis, PG null mice die between embryonic days E10.5 and E16 with ruptured 
hearts and those that survive until birth exhibit severe epidermal blistering (Bierkamp et 
al., 1996; Ruiz et al., 1996). The fact that the Argentinean patients have a normal heart 
development may suggest that very low levels of the N-terminally truncated PG produce 
less harmful effects than complete absence of PG in the skin and heart. Likewise, very 
low levels of wild type PG in Kuwaiti patients might be less harmful than total absence 
of PG (see also section 3.3.7). 
Wild type and c.71C>A mutant JUP constructs have been generated and 
PGΔN42 was shown to be efficiently translated in human dermal fibroblasts (see 
section 3.3.5). In order to confirm that translation of c.71C>A JUP mRNA starts at the 
AUG encoding M43, it would have been interesting to express wild type and c.71C>A 
JUP constructs as well as a c.71C>A JUP construct harbouring a nucleotide substitution 
in the ATG encoding M43 and investigate their initiation sites for translation. 
Translation from the latter construct would be expected not to occur or to start from an 
AUG codon downstream of the one encoding M43. Given that the Kozak consensus 
sequences in exon three are weaker than that of M43 (Figure 3.6B), translation from 
AUG codons downstream of M43 is likely to be reduced or absent. Therefore, if 
translation from M43 occurs, the band observed by western blot corresponding to 
PGΔN42 should disappear when the ATG encoding M43 is mutated. These results 
would ultimately confirm that in the presence of c.71C>A, the most favorable 
translation start site is the AUG encoding M43.  
 
3.3.5. PGΔN42 is expressed at very low levels compared to wild type PG and is not 
incorporated into junctions 
PGΔN42 is expressed in the skin at much lower levels then wild type PG. 
Furthermore, very little junction incorporation of PG was shown by 
immunohistochemistry in the patients’ skin (Cabral et al., 2010; Winik et al., 2009). 
This difference in expression levels could be due to a decrease in translation efficiency 
or in protein stability. It was demonstrated by Dr. Andrew South that recombinant 
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PGΔN42 is efficiently translated in dermal fibroblasts (Cabral et al., 2010), strongly 
suggesting that the reduced protein levels observed in patient skin are due to decreased 
protein stability, which could be caused by lack of junction incorporation. 
It has been reported that in the absence of junction assembly in Madin-Darby 
canine kidney (MDCK) cells, the rate of metabolic turnover of desmosomal proteins is 
increased. For the glycoprotein components, this represents a dramatic increase in 
degradation and subsequent decrease in relative levels. These proteins are, however, 
synthesised and transported to the plasma membrane (Penn et al., 1987). This evidence 
suggests that in the absence of junction assembly, the components are susceptible to 
accelerated proteolysis. It is possible, therefore, that PGΔN42 is less stable than wild 
type PG due to lack of junction incorporation and stabilisation by junctional binding 
partners. This could lead to increased PGΔN42 metabolic turnover in the skin. 
Greatly reduced membrane bound PGΔN42 in the skin of patients homozygous 
for p.S24X indicates that PGΔN42 is hardly incorporated into adherens junctions or 
desmosomes. Immunofluorescence staining with E-cadherin and β-catenin antibodies in 
the epidermis of patients homozygous for p.S24X showed normal distribution of these 
adherens junction proteins (Cabral et al., 2010). These results indicate that the lack of 
PG does not interfere with adherens junction assembly and function. Similar results 
have been observed in keratinocyte cultures established from the skin of PG knock-out 
(JUP-/-) mice (Yin et al., 2005). Given that PGΔN42 only differs from wild type PG in 
the first 42 amino acids, it is possible to conclude that these 42 amino acids are essential 
for PG incorporation into both desmosomes and adherens junctions of the skin. 
The c.468G>A homozygous mutation is hypothesised to lead to activation of the 
NMD pathway and subsequent degradation of the mutant transcripts; however lack of 
patient biopsy material prevented confirmation of this event. If this is the case, it is 
possible to speculate that the reduced levels of PG in the Kuwaiti patients’ skin might 
result from low levels of leaky splicing from the mutant donor splice site of the second 
coding exon (where the c.468G>A mutation lies). This would explain the low levels of 
PG immunoreactive signal and lack of junction incorporation observed by 
immunohistochemistry in the skin of Kuwaiti patients. Further studies will be needed to 





3.3.6. Functional domains in the N-terminus of PG might account for lack of 
PGΔN42 junction incorporation 
PG interacts with other proteins through its central arm-repeat and C-terminal 
domains (Holthofer et al., 2007; see Figure 3.9). Arm-repeats one to three were found to 
be necessary for interactions with DSGs and DSCs (Chitaev et al., 1998). This same 
region is also involved in binding to α-catenin (Chitaev et al., 1998). Furthermore, the 
interaction with DSC1a is abolished when either end of the central arm-repeat domain is 
deleted, suggesting that the whole arm-repeat domain might be necessary for interaction 
with DSC1a (Witcher et al., 1996). Interactions with E-cadherin are thought to be 
dependent upon arm-repeats four and five (Troyanovsky et al., 1996b). A stretch of 
amino acids (K673-Q683) in the C-terminus of PG prevents interaction with DSGs 
because it interacts with upstream binding sites for DSGs and inhibits their activity 




Figure 3.9. Schematic diagram of PG showing regulatory domains in the N-terminus and 
described mutations. Positions of p.S24X (boxed) as well as the three previously identified 
mutations are shown as well as the O-glycosylation site and the destruction box. 
 
These findings suggest two interesting aspects. Firstly, overlapping PG binding 
sites exist for DSGs and α-catenin as well as for DSCs and E-cadherin. This might 
explain why PG forms mutually exclusive complexes either with α-catenin and classical 
cadherins in adherens junctions or with DSGs and DSCs in desmosomes (Aberle et al., 
1996; Chitaev et al., 1998; Miravet et al., 2003; Sacco et al., 1995). Secondly, 
intramolecular interactions within PG might occur and might be important regulators of 
PG interactions (Wahl et al., 2000; Zhurinsky et al., 2000), explaining why sequences in 
the C-terminus of PG interfere with cryptic DSG binding sites which are located within 
arm-repeats 6-13 (Troyanovsky et al., 1996a). 
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In light of these published studies, the known protein-protein interactions occur 
through regions which lie outside of the first 42 amino acids of PG. However, the lack 
of the first 42 amino acids of PG prevents its incorporation into both desmosomes and 
adherens junctions (see section 3.3.5). It is therefore possible that PGΔN42 has a 
different spatial conformation than wild type PG which could sterically hinder the 
association of binding partners, prevent its trafficking to junctions or interfere with 
intramolecular interactions. Furthermore, it was suggested by (Solanas et al., 2004) that 
the N- and C-terminal domains of both PG and the closely related β-catenin have 
important regulatory functions which influence the affinity for different ligands. These 
authors showed that replacement of the central arm-repeat domain of β-catenin by that 
of PG generated a chimeric protein with the same ligand specificity as the native β-
catenin. 
PG is a target for both serine/threonine and tyrosine phosphorylation as well as 
for O-glycosylation (Yin & Green, 2004). Although the first 42 amino acids of PG are 
not known to participate in protein interactions, this region contains two possible 
regulatory sites of interest. The first is a consensus sequence for glycogen synthase 
kinase-3β (GSK-3β) phosphorylation, found within amino acids 22-39 of PG 
(Rubenstein et al., 1997) (Figure 3.9). This GSK-3β phosphorylation site, also 
designated as destruction box, is highly conserved in PG, β-catenin and other proteins of 
the armadillo family, and it is well characterised in β-catenin (Aberle et al., 1996). In 
the presence of axin, β-catenin and PG are phosphorylated by GSK-3β in residues 
within the destruction box, subsequently ubiquitinated and then degraded by the 
proteasome machinery. However, PG is less sensitive to degradation then β-catenin 
(Kodama et al., 1999). The fact that PGΔN42 lacks this motif and is expressed at very 
low levels in the skin of these patients suggests degradation and turnover of PGΔN42 is 
not dependent on the destruction box sequence. 
The second site of interest within the first 42 amino acids of PG is an O-
glycosylation site. PG is known to be modified by the addition of O-N-
acetylglucosamine (O-GlcNAc) at threonine 14 (Figure 3.9), close to the destruction 
box (Hatsell et al., 2003). O-glycosylation is thought to be a mechanism to counteract 
phosphorylation and thus protect proteins from degradation by the proteasome (Hatsell 
et al., 2003), however the effects of O-glycosylation in this particular residue of PG are 
not clear. Whether it is the lack of these two regulatory domains in the N-terminus of 
PG that prevents junction incorporation of PGΔN42 in the skin is not known. 
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It has also been reported that epithelial A-431 cells expressing a recombinant PG 
lacking the first 122 amino acids (PGΔN122), show an increase in the cytosolic pool of 
endogenous and ectopic PG (Gaudry et al., 2001; Palka & Green, 1997b). Nevertheless, 
deletion of the N-terminus did not prevent ectopic or endogenous PG in these cell lines 
from incorporating into intercellular junctions. PGΔN122 was able to co-
immunoprecipitate with classical and desmosomal cadherins. Also, PGΔN122 was able 
to bind to DSG1 and DP when these proteins were co-expressed in mouse L-fibroblasts 
(which do not form desmosomal junctions), but whether PGΔN122 was able to localise 
to junctions as wild type PG does was not described (Kowalczyk et al., 1997). Given 
that the mutant PGΔN42 still harbours amino acids 43-122 and is not efficiently 
incorporated into junctions, it is possible that this region is preventing junction 
incorporation of PGΔN42 in the skin of these patients. 
 
3.3.7. PGΔN42 and c.468G>A enable normal heart development in contrast with 
previously published JUP mutations 
Two human mutations have been previously reported in the JUP gene both 
causing cardiomyopathy (Asimaki et al., 2007; McKoy et al., 2000), in contrast with 
p.S24X and c.468G>A (Cabral et al., 2010). The first mutation is a homozygous two bp 
deletion (JUP2157delTG) causing a C-terminal truncation associated with autosomal 
recessive syndromic ARVC (Naxos disease) (McKoy et al., 2000) (see section 1.7.2.2). 
The second mutation is a heterozygous insertion of three bp leading to insertion of a 
serine residue after amino acid 39 (p.S39_K40insS) and causes dominant non-
syndromic ARVC (Asimaki et al., 2007) (this mutation does not affect the skin).  
The possibility of PGΔN42 and c.468G>A patients developing cardiomyopathy 
later in life cannot be ruled out, as the eldest patient to be examined by a cardiologist 
was 14 years old. Naxos patients usually develop cardiomyopathy in adolescence or 
early adulthood (Protonotarios & Tsatsopoulou, 2005), however in a study of Naxos 
patients minor cardiac abnormalities were identified in one five-year-old individual 
(Protonotarios et al., 2001), and all homozygous individuals over the age of 13 met 
“Task Force” criteria for ARVC classification (McKenna et al., 1994). None of the five 
patients described here exhibit cardiac abnormalities. In addition, unlike heterozygous 
carriers of the Naxos disease allele, individuals heterozygous for either mutant allele do 
not present with woolly hair (Protonotarios et al., 2001). These observations coupled 
 
 119
with the lack of skin blistering in Naxos patients, indicate that the two JUP mutations 
described here cause a separate phenotype. 
 
3.3.8. ARVC pathology and mechanisms 
Although ARVC is known to be a disease mainly caused by defects in 
desmosomal genes, the molecular mechanism underlying the fibrofatty replacement of 
ventricular myocytes and consequent arrhythmias is not clear. Myocyte degradation and 
fibrofatty replacement could be a result of weakened cell adhesion or a defect in cell 
signalling or both, one leading to the other. 
The p.S39_K40insS mutation (see section 3.3.7) was proposed to cause 
cardiomyopathy through the creation of additional binding partners in the N-terminus 
and/or disruption of normal function resulting in reduced stability of mutant PG. The 
authors identified reduced PG levels in the patient’s heart tissue. Additionally, human 
embryonic kidney (HEK293) cells expressing a p.S39_K40insS mutant construct 
showed that the mutant protein was preferentially ubiquitinated and located for the most 
part in the cytoplasm. Increased proliferation and decreased apoptosis were also 
observed in these cells expressing the mutant protein (Asimaki et al., 2007). Therefore, 
an insertion of a single amino acid into the N-terminus of PG allows normal skin 
development yet compromises heart whilst reduced levels of PG leads to skin disease 
with normal heart development. This observation supports the notion that ARVC in 
patients harbouring p.S39_K40insS results from a dominant negative effect of the 
mutant PG protein. This is interesting in light of the absence of NMD activation in the 
skin of PGΔN42 patients. If this is also the case in the heart of these patients, then 
reduced levels of PG in cardiomyocytes is supposedly more favourable than complete 
absence of PG or a dominant negative effect. Figure 3.9 shows the four mutations 
discovered so far in JUP as well as known PG regulatory domains. 
Cell-cell junctions in the intercalated disc of the heart muscle were shown by 
immune oelectron microscopy to contain a combination of both desmosomal and 
adherens junction proteins (Franke et al., 2006) (see section 1.3.2.2.2). Therefore, their 
composition is different from the typical desmosomes and adherens junctions observed 
in epithelial tissues. It is possible that some of the requirements for junction 
incorporation in the intercalated disc, such as binding affinity for other proteins, are 
different from those of epithelial junctions. The data shown here supports this idea in 
that it suggests the first 42 amino acids to be essential for junction incorporation in the 
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skin, but not in the heart. Since PG knock-out mice die from embryonic day E10.5 
onwards due to severe heart defects, PG is important for normal murine heart 
development. However, it is also possible that PG is not essential for the formation of 
heart junctions in humans and is compensated for by other proteins in these junctions. 
Recently, a mechanism for the pathology of ARVC has been proposed based on 
PG signalling (Garcia-Gras et al., 2006). These authors showed that conditional ablation 
of DP in cardiomyocytes leads to translocation of PG into the nucleus and reduction in 
canonical Wnt/β-catenin signaling (see section 1.3.2.2.1). Suppression of this signaling 
pathway is known to cause a switch from myogenesis to adipogenesis and fibrogenesis 
and these authors showed increased expression levels of genes associated with 
adipogeneses and fibrosis in DP-null cardiomyocytes. These findings suggest that the 
fibrofatty replacement of cardiomyocytes seen in ARVC might result from altered 
Wnt/β-catenin signaling due to increased levels of non-junctional PG, as opposed to an 
adhesion defect. In light of these findings, PGΔN42 might still contribute to normal 
signalling functions in the heart, allowing normal Wnt signalling to occur, even if it has 
altered adhesion properties. One possible explanation for the lack of heart phenotype in 
c.468G>A is that PG is greatly reduced and therefore cannot interfere with canonical 
Wnt signaling.  
Further functional studies will be necessary to unveil the role of PGΔN42 in 
keratinocyte and cardiomyocyte biology; nevertheless results shown here suggest the 
functional properties of PG and the domains which are important in normal function and 
development of skin and heart differ considerably. 
 
3.3.9. PG as a diagnostic test for ARVC 
A new diagnostic test for ARVC has been proposed based on reduction of PG 
expression in immunohistochemical analysis of endomyocardial biopsy samples 
(Asimaki et al., 2009b). These authors tested myocardium tissue samples for PG 
expression in 11 individuals with ARVC, 10 control individuals and 15 individuals with 
distinct types of cardiomyopathy (hypertrophic, dilated, or ischemic). All individuals 
with ARVC, but not control individuals or individuals with other types of 
cardiomyopathy showed reduced levels of PG immunoreactive signal in the heart.  
If PGΔN42 expression levels and localisation are similar in the skin and heart, 
the results shown here suggest that a diagnostic test for ARVC based on the observation 
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of reduced levels of PG might not be suitable. Likewise, the low levels of PG in the skin 
of c.468G>A patients and lack of heart phenotype support this hypothesis, if these 
patients also have low levels of PG in the heart. Given that cardiac biopsy samples from 
neither patient were available, it is not possible to definitely answer this question; 
however lack of PG immunostaining in the skin is certainly not an indicator of ARVC 
pathology. 
Another study described a patient who died of cardiomyopathy and whose heart 
tissue showed fibrofatty replacement in both ventricles, characteristic of ARVC. This 
patient carried compound heterozygous mutations in the region encoding the C-terminus 
of DP. Interestingly, immunofluorescence microscopy of this patient’s heart showed PG 
expression levels that were similar to those of control heart tissue (Mahoney et al., 
2009). These results indicate that individuals with ARVC may not present with reduced 
PG expression levels in the heart, supporting the hypothesis that reduced levels of PG in 
the heart might not be the most adequate diagnosis for ARVC. 
 
3.4. Summary 
This chapter describes a novel homozygous nonsense mutation, p.S24X, in the 
JUP gene. As hypothesised, this mutation was found in three non-consanguineous 
patients from Argentina and heterozygous family members. p.S24X causes a distinct 
clinical phenotype, designated as acantholytic ectodermal dysplasia, which consists of 
skin fragility, PPK and woolly hair but normal heart development. A homozygous 
splice site mutation in JUP, c.468G>A, was found in a parallel study leading to the 
same clinical phenotype in patients form Kuwait. pS24X was shown to result in very 
low levels of a N-terminally truncated protein, PGΔN42, which does not incorporate 
into skin junctions in vivo. c.468G>A also results in very low levels of PG in patient 
skin. These results demonstrate that PG is necessary for maintenance of skin integrity 
and the lack of heart disease in these patients suggests that normal levels of PG might 
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Identification of DPIb – A Novel 
Desmoplakin Splice Variant 




 In order to study the molecular mechanisms of DP in cultured human 
keratinocytes, DSP cDNA constructs had first to be generated (see section 1.9.1). 
During the process of cloning DSPI, a novel DSP isoform generated through alternative 
pre-mRNA splicing of the DSP gene was discovered, which had not been previously 
reported. This chapter describes the identification and characterisation of this novel DSP 
isoform. The generation and expression of wild type- and I608ins10-DSPI constructs 
and subsequent functional studies will be described in Chapter 5. 
 
4.1.1. Alternative pre-mRNA splicing 
Alternative pre-mRNA splicing is a mechanism of post-transcriptional 
regulation of gene expression which occurs in approximately 75% of human genes 
(Johnson et al., 2003). This mechanism allows human cells to synthesize over 90,000 
proteins out of approximately 26,000 coding genes, by generating multiple isoforms 
from a single pre-mRNA transcript (Ast, 2004). These alternative splice variants are 
differentially expressed according to tissue types and developmental stages. Among the 
mechanisms that contribute to protein diversity, alternative splicing is considered to be 
the most powerful contributor to the functional complexity of the human genome 
(Black, 2000).  
Pre-mRNA splicing is the mechanism whereby non-coding introns are excised 
and exons are joined to form a mature mRNA transcript. This process involves 
sequential phosphodiester transfer reactions which are catalysed by a large 
ribonucleoprotein complex, the spliceosome. Alternative splicing allows different 
combinations of exons to be joined together. There are four main sub-types of 
alternative splicing, namely exon skipping, alternative 5’ splice site selection, 
alternative 3’ splice site selection and intron retention (Ast, 2004). Three consensus 
sequences within each introns are required for splicing to occur: the 5’ and 3’ splice 
sites (donor and acceptor sites, respectively), which flank each intron, and a branch 
point which is located more than 18 nucleotides upstream of the 3’ splice site and more 
than 48 nucleotides downstream of the 5’ splice site. The donor and acceptor splice sites 
almost always include the nucleotides GU at the 5’ end and AG at the 3’ end of the 
intron, characteristic of canonical splicing, and regulate assembly of the spliceosome 
complex (Matlin et al., 2005). 
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It has been extremely challenging to decipher the “splicing code” due to the 
complex network of regulatory steps which coordinate the final splicing event (Moore 
& Silver, 2008). Although the relative strength of splice sites influences the frequency 
of exon selection, this requirement is not sufficient to define an exon; many “pseudo-
exons” flanked by strong splice sites exist that are not spliced. Besides the consensus 
splice site sequences, other more variable regulatory elements are known to be involved 
in defining both constitutive and alternative exons. These auxiliary sequences are 
known as exon and intron splicing enhancers and silencers (ESE/ISE and ESS/ISS, 
respectively) and can have positive or negative effects in splicing events. In addition to 
these sequences within the pre-mRNA, there are cellular factors (RNA or protein) 
which are additional players in splicing regulation. Different combinations of RNA-
binding proteins, including serine/arginine-rich (SR) proteins and heterogeneous nuclear 
ribonucleoproteins (hnRNPs), can interact with regulatory elements close to splice sites 
and promote or inhibit their use. Another level of regulation includes many post-
transcriptional and post-translational mechanisms which regulate RNA-binding protein 
expression and cellular localisation. These mechanisms are in turn dependent upon 
different signalling pathways, tissue-specific factors and developmental stages (for 
reviews about mechanisms of splicing regulation see Moore & Silver (2008) and Matlin 
et al. (2005)). 
Due to this large complexity, different approaches have been undertaken to gain 
further insight into the understanding of alternative splicing regulation, which together 
may enable prediction of the splicing pattern of each individual pre-mRNA. The 
traditional approach consists of genetic and biochemical studies in individual model 
systems to characterise regulatory sequences in pre-mRNAs (cis-acting regulatory 
elements) and protein factors (trans-acting elements) which together regulate splicing 
events. Although this approach is important and necessary, it is not sufficient to 
understand the complex nature of splicing regulation. Global scale approaches are also 
being used which enable genome-wide identification of cis- and trans-acting regulatory 
elements, splice variants in different organisms and cell types, pre-mRNAs which are 
regulated by individual trans-acting factors, as well as signalling pathways, 
developmental stages or differentiation stages which influence splicing events (Matlin et 
al., 2005; Moore & Silver, 2008). 
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4.1.1.1. Alternative splicing within the DSP gene 
As mentioned in Chapter 1 the DSP gene, like the majority of human genes, is 
subject to alternative pre-mRNA splicing. This gene gives rise to two known transcripts, 
DSPI and DSPII. DSPI results from use of the constitutive donor splice site at the 
exon23/intron 23 junction and is translated into a 332 KDa protein. DSPII is produced 
due to in frame alternative 5’ splice site selection in exon 23, which lies upstream of the 
constitutive one (Figure 4.2B), producing a protein 72 KDa shorter than DPI. The 3’ or 
acceptor splice site within the intron 23/exon 24 junction is common to both splice 
variants. No other DP isoforms were known prior to this study. 
While DPI proteins are present in all desmosome-bearing tissues, expression of 
DPII is variable; this shorter isoform is widely expressed in epithelial tissues, but barely 
detectable in cardiac muscle (Green & Hobbs, 2006; Uzumcu et al., 2006). In this 
chapter, the expression profiles of the previously unknown DSPIb isoform were 
investigated in different tissues and keratinocytes cell lines to assess whether they are 
similar or differ from those of the known DSPI and DSPII isoforms. DPIb protein levels 




4.2.1. cDNA amplification of a novel DSP alternative transcript, DSPIb, in primary 
normal human keratinocytes 
With the purpose of generating a wild type DSPI cDNA construct, three 
overlapping RT-PCR reactions were performed using total RNA from primary normal 
human keratinocytes (NHK). Amplification of DSPII was excluded by using the 
forward oligonucleotide 2F (depicted in red, Figure 4.1A) which hybridises specifically 
with DSPI. PCR amplification of the first and third fragments generated cDNA products 
which migrated according to the expected sizes. However, amplification of the middle 
fragment (fragment 2) with the primer pair 2F/2R (depicted in red, Figure 4.1A) 
generated a single PCR product of approximately 850 bp (Figure 4.1B). This fragment 
was shorter than the expected 2196 nucleotide fragment of DSPI mRNA, based on the 
NCBI database (accession number NM_004415.2).  
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A – Expected 
 
 
B - Observed 
 
 
Figure 4.1. Initial DSPI cloning strategy led to identification of a novel DSP splice variant. 
(A) Schematic diagram of DSPI cDNA showing three primer pairs used to PCR amplify three 
overlapping fragments. Primers 1F/1R (in green), 2F/2R (in red) and 3F/3R (in blue) were used 
to amplify fragment 1 (predicted to be 4111 bp), fragment 2 (predicted to be 2196 bp) and 
fragment 3 (predicted to be 3028 bp), respectively. The DSPII cDNA is shown to illustrate that 
primer 2F (in red) was designed to hybridise specifically with DSPI cDNA and not with DSPII 
(see discontinuous vertical lines). (B) RT-PCR products following agarose gel electrophoresis, 
corresponding to each of the three amplified fragments. The PCR reaction that generated 
fragment 1 also resulted in two other fragments, probably due to non-specific binding of primers 
1F/1R. Note that fragment 2 is observed at approximately 850 bp in contrast with the predicted 
size of 2196 bp. M = molecular weight marker. 
 
Sequencing analysis of this PCR product confirmed that it comprises 867 bp. 
Alignment of the sequence traces with the wild type sequence of DSPI revealed 
homology at both ends, but a 1329 bp region was missing in the centre (Figure 4.2A). 
As the difference between the DSPI and DSPII transcripts is 1797 nucleotides, and 
because the forward primer (2F) used to amplify this fragment does not have sequence 
homology with DSPII, these results demonstrated the presence, at the mRNA level, of a 
















Figure 4.2. DSPIb is generated through the use of a novel alternative 5’ splice site in the 
DSP gene. (A) Sequence alignment (using the Multalin Interface Page, 
http://bioinfo.genotoul.fr/multalin/multalin.html) of PCR amplified fragment 2 (see Figure 4.1) 
with the wild type sequence of DSPI reveals that the novel splice variant lacks a region from 
position 4330 to 5658 (position numbers according to accession number NM_004415.2 of 
NCBI database). (B) Genomic illustration of exons 22 to 24 of the DSP gene, showing 
sequences of three alternative donor splice sites in exon/intron 23 which produce the DSPI, 
DSPIb and DSPII isoforms. The donor splice site that generates DSPIb is nearly identical to the 
one that produces DSPII. The conserved nucleotides are illustrated in red. 
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The newly identified DSP transcript is composed of 7284 coding nucleotides 
and was designated as DSPIb. The genomic and mRNA sequences of DSPI and DSPII 
present in the NCBI database (accession numbers NM_004415.2 and 
NM_001008844.1, respectively) were examined and compared with the DSPIb 
sequence. This analysis revealed that DSPIb is generated due to the use of an in-frame 
alternative donor splice site in exon 23, located 468 bp downstream of that of DSPII and 
1329 bp upstream of that of DSPI (Figure 4.2B). The alternative donor splice sites 
which originate DSPI and DSPII were also examined and compared to that of DSPIb. 
Interestingly, it was found that the 5’ alternative splice sites of DSPII and DSPIb share 
90% of the sequence (9 out of 10 bp, Figure 4.2B) according to the genomic structure of 
DSP described by Whittock et al. (1999). The acceptor splice site is common to all three 
splice variants. 
 
4.2.2. Splice prediction and EST analysis 
As DSPIb and DSPII are generated due to the use of alternative donor splice 
sites in exon 23, two different splice site predictor programs were used to investigate 
whether additional 5’ alternative splice sites were predicted in this region.  
Analysis of the whole DSPI mRNA sequence using the Splice Site Prediction by 
Neural Network (Reese et al., 1997) revealed only two 5’ alternative splice sites close to 
the DSPI/DSPIb-specific region (in exon 23), both of which had the highest possible 
score (1.00). The first one is the donor splice site which originates DSPII (starting at 
nucleotide 3855) and the second gives rise to DSPIb (starting at nucleotide 4323) 
(highlighted in blue, Figure 4.3A).  
Analysis of nucleotides 3852 to 5174 using the Alternative Splice Site Predictor 
(ASSP) (Wang & Marin, 2006) showed the alternative 5’ splice sites that originate 
DSPII (starting at nucleotide 3852) and DSPIb (starting at nucleotide 4320), also both 
with the highest score within this region (13 and 12, respectively, highlighted in blue, 
Figure 4.3B). This program also revealed six additional alternative donor sites within 
this region, four of which would give rise to in-frame splice variants intermediate in size 
between DSPIb and DSPI, assuming that the constitutive acceptor site common to all 
three isoforms is used (Figure 4.3B, highlighted in yellow and Figure 4.2B). These 
results suggest there might be additional DSP splice variants. However, it is noteworthy 
that the constitutive donor splice site for DSPI is identified by the ASSP program with a 
score of only 8.7 compared with 13.2 for the donor splice site of DSPII, and is not even 
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predicted by the Neural Network program. This suggests that splice predictions by these 
programs do not include all the variables that contribute to the final splicing event in 
vivo (see section 4.1.1) and might not always be a direct indicator of the likelihood of a 
splicing event. 
Expressed sequence tag (EST) analysis was also performed to determine the 
number of transcripts representing the different regions of DSP as well as to investigate 
the existence of ESTs unique to DSPIb and DSPII on the NCBI EST-database. To this 
end, the 5’ and 3’ ends of DSP as well as five 50 bp stretches in different regions of the 
DSP mRNA were blasted against the NCBI human EST-database. 
As shown in Figure 4.3D, a similarly high number of ESTs is found within the 
5’ end (comprising 3861 nucleotides) and 3’ end (comprising 4071 nucleotides) of DSP 
(102 and 99 ESTs, respectively, depicted in purple), which are regions common to all 
three splice variants. Likewise, 50 bp stretches in three DSPI- (or DSPI/DSPIb-) 
specific regions (depicted in orange, yellow and green, Figure 4.3D) were also 
represented by a high and similar number of ESTs (31, 37 and 36 ESTs, respectively). 
In contrast, only 5 ESTs were found to span the DSPII-specific exon 23/24 junction 
(orange/green junction, Figure 4.3D) and only 1 EST spans the DSPIb-specific exon 
23/24 junction (yellow/green junction, Figure 4.3D). Comparison between the DSPII-
specific junction (orange/green junction, Figure 4.3D) and the corresponding DSPI 
junctions depicted in orange and green (Figure 4.3D) suggests a DSPII:DSPI ratio of 1:6 
and 1:7, respectively. In a similar way, comparison between the DSPIb-specific junction 
(yellow/green junction, Figure 4.3D) and the corresponding DSPI-specific junctions 
depicted in yellow and green (Figure 4.3D) suggests a DSPIb:DSPI ratio of 1:37 and 
1:36, respectively. Figure 4.3C depicts the alignment of part of the DSPIb-specific EST 
with the DSPI cDNA sequence. This clone lacks nucleotides 4330 to 5658, which is a 
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A (Neural Network)                                   B (ASSP) 




Figure 4.3 Alternative splice prediction and EST analysis in DSP. Alternative splice site 
predictions within DSPI cDNA from nucleotides (A) 1-9730 using the Splice Site Prediction by 
Neural Network (http://www.fruitfly.org/seq_tools/splice.html) and (B) 3852-5174 using the 
Alternative Splice Site Predictor (ASSP, http://www.es.embnet.org/~mwang/assp.html). (A and 
B) The predicted 5’ alternative splice sites which originate DSPII and DSPIb are highlighted in 
blue. Exon/intron boundaries are shown in bold. (B) Four predicted in-frame alternative donor 
splice sites within nucleotides 3852-5174, which would generate DSP splice variants 
intermediate in size between DSPI and DSPIb, are highlighted in yellow. (C) Sequence 
alignment (using the multalin interface page, http://bioinfo.genotoul.fr/multalin/multalin.html) 
of part of the DSPIb-specific EST (accession number AI525952) with DSPI shows that this 
clone lacks nucleotides 4330 to 5658, which is characteristic of DSPIb (D) Schematic diagram 
of DSP splice variants showing ESTs found in the NCBI database. 5’ and 3’ regions (depicted 
in purple) are represented by 102 and 99 ESTs, respectively. The DSPIb- and DSPII-specific 
junctions (yellow/green and orange/green) are spanned by 1 and 5 ESTs, respectively. The 
corresponding DSPI-specific junctions are represented by 37 (yellow) and 31 (orange) ESTs, 
respectively. The DSPI-specific exon 23/24 junction (green) is represented by 36 ESTs. Each 
coloured square comprises 25 bp on each side of the dashed line. 
Start End Score Exon    Intron 
128 142 0.61 ggcccaggtagcgag
360 374 0.45 ctacgaggtgaccag 
1587 1601 0.69 gaacttggtaaacaa 
1751 1765 0.98 gcaagtggtacgtga 
2580 2594 0.93 atgcacagtaagggc 
3855 3869 1.00 ggcaaaggtaagaaa
4323 4337 1.00 gagtaaggtaagaaa 
6016 6030 0.71 tgcaggcgtaagctg 
6142 6156 0.76 actgagtgtgagtgg 
6813 6827 0.88 aaagaaggtcagtta 
7008 7022 0.61 tgacgaggttggtga 
7629 7643 0.42 gaaacaggtgcagac
8040 8054 0.95 tgaatcagtaagtaa 
8179 8193 0.73 acagaaggtatagag 
8212 8226 0.42 atcacgggtcagagg 
Start End Score Exon         Intron 
3852 3871 13.23 gctggcaaaggtaagaaacc 
4320 4339 12.01 actgagtaaggtaagaaaca 
4656 4675 6.02 agaggagagcgtaagatata 
4724 4743 7.44 agatagaaaggttaaaacaa 
4802 4821 4.77 aaagggtccagtatgacctg 
4857 4876 5.97 caaactgaaggttcaggagc 
4986 5005 5.16 gaagcagaaggtggaagagg
5155 5174 6.28 aagaagaggagtgaggatga 
C 
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Overall, the splice predictions and EST analysis of this central alternatively 
spliced region of DSP suggest some interesting points. Firstly, that DSPIb is a third 
DSP splice variant which is represented by only 1 EST, possibly due to its low 
expression level when compared to that of DSPI, in the cells or tissues where these 
ESTs were found. Identification of the DSPIb-specific EST is an independent 
confirmation of DSPIb existence. Secondly, that a reduced amount of information is 
available about the DSPIb- and DSPII-specific regions, as well as other potential 
splicing events in this region. These suggestions were taken as reasons to investigate 
this region further. 
 
4.2.3. Expression profiles of alternative DSP transcripts in different tissues and 
different regions of the heart 
To examine DSPIb mRNA expression levels in different types of tissue, an RT-
PCR based method was designed to specifically amplify and distinguish between each 
of the DSP transcripts (Figure 4.4A). The reverse primer (depicted in grey, Figure 4.4A) 
hybridises with the 5’ end of exon 24 and the three forward primers anneal with 
different regions of exon 23. The first primer (depicted in green, Figure 4.4A) is DSPI-
specific, as the other isoforms lack the 3’ portion of exon 23, where this primer anneals. 
The second primer (depicted in red, Figure 4.4A) can anneal with both DSPI and 
DSPIb, but generates PCR products of different sizes, the shortest of which will 
correspond to DSPIb. Likewise, the third primer (depicted in blue, Figure 4.4A) can 
amplify all isoforms, but the shortest product corresponds to DSPII. By shortening the 
PCR extension time in each reaction, it was possible to amplify only the required 
smaller fragments. Also, because the distance between each primer and the 
corresponding exon 23/24 border was different, the required fragments had different 
sizes, each one representative of one DSP isoform. Figure 4.4B shows the three 
resulting PCR products amplified from primary NHK cDNA. 
Using the same set of primers and PCR conditions, the different DSP splice 
variants were amplified from a human multiple tissue cDNA panel and a human 
cardiovascular cDNA panel. The multiple tissue panel included different types of 
epithelial as well as non-epithelial tissues. The cardiovascular cDNA panel comprised 
various regions of the adult heart and aorta, as well as foetal heart. Primers which 
amplified the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH) 
were used as a control of cDNA abundance. 









Figure 4.4. RT-PCR based method to specifically amplify each of the DSP splice variants 
from NHK. (A) Schematic diagram of DSP isoforms showing primers used to specifically 
amplify and distinguish between the different isoforms. The reverse primer (DSPR, depicted in 
grey) is common to all isoforms. Three different forward primers (DSPIF in green, DSPIbF in 
red and DSPIIF in blue) were designed to specifically amplify DSPI (179 bp), DSPIb (383 bp) 
and DSPII (530 bp), respectively. (B) RT-PCR products and respective negative water controls 
amplified from DSPI (lanes 1 and 2), DSPIb (lanes 3 and 4) and DSPII (lanes 5 and 6) RNA 
from primary NHK. M = molecular weight marker. 
 
All three DSP isoforms were shown to be expressed throughout the majority of 
epithelial tissues with similar expression patterns. They were predominant in the lung, 
liver and prostate. Low levels of expression of the three isoforms were also seen in the 
brain but not in skeletal muscle (Figure 4.4A). All three isoforms were also expressed 
throughout the various compartments of the heart. However, DSPIb was the only 
isoform to be detected in the aorta. The three DSP isoforms showed different expression 
patterns in the different cardiac compartments and aorta. DSPI was mostly expressed in 
the left and right ventricle and foetal heart, whereas DSPIb was mainly present in the 
aorta, right auricle, left atrium as well as in the right ventricle and foetal heart. DSPII 













Figure 4.5. DSPIb transcript is expressed in several epithelial tissues and in various 
compartments of the heart and the only DSP isoform detected in the aorta. (A) Specific 
amplification of the different DSP transcripts across different types of tissue using a human 
multiple tissue cDNA panel. DSPIb (383 bp) was shown to be expressed throughout the 
majority of epithelial tissues with similar expression patterns to those of DSPI (179 bp) and 
DSPII (530 bp). (B) DSPIb was the only isoform detected in the aorta. DSPI was mostly 
expressed in the left and right ventricle and foetal heart, whereas DSPIb was mainly present in 
the aorta, right auricle, left atrium as well as in the right ventricle and foetal heart. DSPII was 
expressed at higher levels in the right auricle, left atrium, and right ventricle. Primers to amplify 
the G3PDH gene (983 bp according to NM_002046.3) were used as a control of cDNA 
abundance. Water = negative control. 
 
Expression of DSPIb mRNA in normal human skin and in normal human 
keratinocyte cell lines was also investigated using the RT-PCR strategy described 
above. Total RNA isolated from normal skin and from cell lines was reverse transcribed 
and the resulting cDNA was used as template to amplify all three isoforms with the set 
of primers depicted in Figure 4.4A. As shown in Figure 4.6, all three isoforms were 
detected in normal skin, in the spontaneously immortalised human skin keratinocyte cell 
line HaCaT and in the HpV immortalised human breast keratinocyte cell line K1. 
 





Figure 4.6. DSPIb mRNA is expressed in normal skin as well as in normal human 
keratinocyte cell lines. RT-PCR of total RNA from normal skin shows expression of DSPI 
(179 bp), DSPIb (383 bp) and DSPII (530 bp). All three isoforms are also expressed in the 
spontaneously immortalised normal keratinocyte cell line HaCaT and in the HpV immortalised 
normal breast keratinocyte cell line K1. Primers to amplify the G3PDH gene (983 bp according 
to NM_002046.3) were used as a control of cDNA abundance. M = molecular weight marker; 
water = negative control. 
 
4.2.4. mRNA and protein quantification of DP splice variants in human 
keratinocyte cell lines 
Quantitative RT-PCR with SYBR Green was performed in collaboration with 
Clare Cole (Department of Surgery & Molecular Oncology, University of Dundee, 
Ninewells Hospital & Medical School, Dundee, UK) to analyse the mRNA levels of the 
different DSP splice variants relative to DSPI in HaCaT, K1 and NHK keratinocytes 
(Figure 4.7B). The cDNA primers described in section 4.2.3 were used for this purpose. 
The DSPIb:DSPI mRNA ratios were found to be similar among HaCaT, K1 and NHK 
cells (1:20, 1:33 and 1:14, respectively). These ratios are within the same order of 
magnitude as the DSPIb:DSPI ratios calculated based on the EST analysis (see section 
4.2.2). 
Expression of DPIb at the protein level was also examined in HaCaT and K1 
cells in order to determine whether translation of DSPIb was observed in these cell 
lines. Additionally, the expression levels of DPIb were compared to those of DPI and 
DPII. Total DP was assessed in whole cell extracts using a C-terminal DP antibody 
(clone 11-5F, see Table 2.7) (Parrish et al., 1987) which detects both DPI and DPII. 
Samples were separated by 3-8% gradient SDS-PAGE over a period of six to seven 
hours, in order to resolve these high molecular weight proteins. DPI and DPII were 
observed at 332KDa and 260KDa, respectively, as expected. Two additional 
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immunoreactive bands were detected with sizes between those of DPI and DPII (Figure 
4.7A). DSPIb mRNA is 468 bp longer than DSPII. This difference corresponds to 156 
amino acids and approximately 19KDa, according to the protein molecular weight 
prediction of The Sequence Manipulation Suite bioinformatics program 
(http://www.bioinformatics.org/sms/index.html). Based on the migration of the marker 
proteins of known molecular weight, the immunoreactive band immediately above DPII 
is predicted to be approximately 19KDa larger than DPII and is therefore the most likely 
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Figure 4.7. Western blot and quantitative RT-PCR analysis of DP splice variants. (A) 
Western blot of HaCaT and K1 total proteins with a C-terminal DP antibody (11-5F) directed 
against DPI and DPII. Left panel = low exposure, right panel = high exposure. DPI and DPII are 
observed at 332KDa and 260KDa, respectively. Two additional immunoreactive bands are 
observed between DPI and DPII. The band directly above DPII is calculated to be 279KDa and 
to correspond to DPIb, based on its predicted number of amino acids (2428 amino acids) and on 
the migration of the molecular weight marker (KDa). The band directly below DPI could 
correspond to a fourth DP splice variant, to a break down product of DPI or to western blot 
artefacts. This band was provisionary designated as DPIa. (B) SYBR Green quantitative RT-
PCR using forward primers DSPIF, DSPIbF and DSPIIF and the reverse primer DSPIR was 
performed to amplify DSPI, DSPIb and DSPII, respectively, from HaCaT, K1 and NHK 
keratinocytes. The mRNA expression levels (mean±SEM) of DSPIb and DSPII are shown 
relative to DSPI levels (n=3). Ct refers to threshold cycle. (C) Protein quantification 
(mean±SEM) of DPIb and DPII relative to DPI in HaCaT and K1 cells using densitometry 
analysis (n=2). 
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The identity of both this band and the one directly below DPI needed however to 
be investigated further, as they could represent breakdown products of DPI, could be the 
result of non-specific binding of the DP antibody or artefacts arising from the western 
blot procedure and the fact that the SDS-PAGE gels had to be run for long periods of 
time (see section 4.2.5). The band directly below DPI was provisionary designated as 
DPIa.  
Densitometry measurements of the western blot using an image analysis 
program (Image J, v.1.34s) were used to calculate the protein levels of DPI, DPIb and 
DPII in HaCaT and K1 cells (Figure 4.7C). These protein levels are presented as a fold 
change of DPI protein levels for each sample. DPIb expression levels (relative to DPI) 
were similar between HaCaT and K1 cells and lower then DPII levels in both cell lines. 
DPIb:DPI ratios of 1:14 in HaCaT cells and 1:25 in K1 cells were observed. These 
ratios were similar to the mRNA DSPIb:DSPI ratios, suggesting that DPIb is efficiently 
translated. 
 
4.2.5. Confirmation that DPIb is a novel splice variant 
Two experiments were carried out to confirm that the immunoreactive band 
observed by western blot above DPII corresponds to DPIb and is a novel DP splice 
variant. First, to address whether the endogenous protein predicted to be DPIb in HaCaT 
cells is the same size as a recombinant DPIb protein, a full length DSPIb cDNA 
construct was over-expressed in HaCaT cells and western blots were performed (section 
4.2.5.1). Second, RNAi technology was used to selectively down-regulate different DP 
isoforms and ultimately prove that DPIb is a splice variant and not a DP breakdown 
product (section 4.2.5.2). 
 
4.2.5.1. Over-expression of recombinant DPIb proteins in HaCaT cells 
 
4.2.5.1.1. Generation of a pBabe-DSPIb expression vector 
A DSPIb cDNA construct was generated from primary NHK RNA. Due to the 
large size of the DSPIb coding region (8401 bp), three overlapping fragments were PCR 
amplified across two restriction enzyme sites, using primer pairs described in section 
4.2.1 (Figures 4.1A and 4.8A). The resulting PCR products are shown in Figure 4.1B. 
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Because of non-specific hybridisation of primers 1F/1R (Figure 4.1B) the largest PCR 
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Figure 4.8. Cloning of DSPIb into the pCRII-TOPO cloning vector. (A) Schematic diagram 
of the cloning strategy used to generate the DSPIb construct. Primers 1F/1R (in green), 2F/2R 
(in orange) and 3F/3R (in blue) were used to amplify fragment 1 (4111 bp), fragment 2 (867 bp) 
and fragment 3 (3028 bp), respectively, by RT-PCR of total RNA isolated from primary NHK. 
(B) RT-PCR products of the three fragments following TA cloning into the pCRII-TOPO 
cloning vector. (C) Restriction enzyme digests of the cloned fragments: fragment 2 with EcoRI 
(3955 bp and 885 bp, lane 1) and EcoRV (4110 bp and 730 bp, lane 2); fragment 1 with HindIII 
(6423 bp, 852 bp and 809 bp, lane 3) and SpeI/XbaI (3885 bp, 3416 bp and 783 bp, lane 4); 
fragment 3 with HindIII (5037 bp, 1733 bp and 231 bp, lane 5) and EcoRI (3955 bp, 2882 bp 
and 164 bp, lane 6). (D) Fragment 1 in pCRII-TOPO cloning vector digested with AfeI, NotI and 
NcoI (4030 bp, 2503 bp and 1551 bp, lanes 1 and 2). The 4030 bp band corresponds to fragment 
1 and was recovered from the gel. Fragment 2 in pCRII-TOPO vector digested with AfeI and 
NotI (4665 bp and 175 bp). The 4665 bp band corresponds to pCRII-TOPO vector containing 
fragment 2 and was recovered from the gel. (E) Fragment 1 (lane 1) and fragment 2 in pCRII-
TOPO vector (lane 2) after gel purification and prior to ligation. 
 
Each of the three fragments was TA cloned into a shuttle vector. Following 
transformation of competent bacteria, positive clones were selected. To confirm the 
presence of the desired insert, a diagnostic PCR was performed on boiled bacterial 
lysates using the same primers which amplified the original fragment to be cloned. The 
resulting PCR products are shown in Figure 4.8B. Plasmid DNA from bacterial cultures 
of clones containing the required fragment was isolated and restriction enzyme digests 
were performed to confirm the presence of the right inserts and to determine their 
orientation (Figure 4.8C). Finally, the three fragments were joined together following 
specific restriction digests. Figures 4.8D and 4.8E show an example of part of this 
procedure, which involves digest of the vectors containing fragments 1 and 2, excision 
of the required bands from an agarose gel and ligation to generate a vector containing 
both fragments 1 and 2. Full length DSPIb cDNA was then sub-cloned into the pBabe-
puro retroviral expression vector and confirmed by sequencing analysis (for more 
details see Chapter 2). 
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4.2.5.1.2. Generation of a HaCaT stable cell line over-expressing DSPIb 
Phoenix amphotropic retroviral packaging cells were transiently transfected with 
either the pBabe-DSPIb construct or a pBabe-GFP control plasmid. Whole cell DP 
proteins from transfected Phoenix cells were assessed by immunoblotting using the DP 
C-terminal antibody (11-5F). Expression of recombinant DPIb proteins was observed in 
the pBabe-DSPIb transfected Phoenix cells, which migrated at approximately 279KDa, 
as expected. This immunoreactive band was not observed in the pBabe-GFP transfected 
Phoenix cells (Fig.4.9A).  
Following puromycin selection (see Chapter 2), transfected Phoenix cells were 
grown to confluency and allowed to produce virus. HaCaT cells were then transduced 
with pBabe-DSPIb and pBabe-GFP containing virus. 
 
4.2.5.1.3. HaCaT endogenous DPIb proteins migrate alongside recombinant DPIb 
proteins on SDS-PAGE 
Total DP proteins from transduced HaCaT cells were assessed by western blot 
with the DP C-terminal antibody (Figure 4.9B). As expected, recombinant DPIb 
proteins were observed in pBabe-DSPIb transduced HaCaT cells at approximately 
279KDa. Recombinant DPIb proteins were expressed at higher levels than endogenous 
DPIb proteins present in pBabe-GFP transduced cells. Although these endogenous 
DPIb proteins were barely detectable on the western blot depicted in Figure 4.9B, a 
higher exposure of the same blot (Figure 4.9C) shows their presence in pBabe-GFP 
transduced HaCaT cells. Moreover, this blot shows that the immunoreactive band 
representing recombinant DPIb proteins migrates alongside the immunoreactive band 
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Figure 4.9. Potential DPIb proteins endogenously expressed in HaCaT cells are the same 
size as recombinant DPIb proteins over-expressed in HaCaT cells. Western blot of total 
proteins from Phoenix (A) and HaCaT cells (B) with a DP C-terminal antibody (11-5F) which 
detects DPI (332 KDa) and DPII (260KDa). (A) Phoenix cells were transiently transfected with 
a pBabe-GFP control vector (GFP) and the pBabe-DSPIb construct (DPIb). Recombinant DPIb 
expression is observed in pBabe-DSPIb transfected cells at approximately 279 KDa, but not in 
pBabe-GFP transfected cells. (B) HaCaT cells transduced with the pBabe-DSPIb construct 
(DPIb) show expression of recombinant DPIb at higher levels than those of the endogenous 
putative DPIb band in pBabe-GFP transduced cells (GFP). (C) Higher exposure of the same 
blot shows recombinant DPIb proteins migrate alongside endogenous potential DPIb proteins. 
Vinculin (117KDa) was used as loading control. The predicted molecular weight of each 
isoform is indicated on the left (KDa). 
 
4.2.5.2. siRNA mediated knock-down of DSP splice variants in HaCaT cells confirms 
identity of DPIb 
To further confirm that DPIb is represented by the immunoreactive band 
observed directly above DPII on western blots, three different groups of siRNAs were 
used which target: (1) the DSPI-specific region (siDSPI 1 and siDSPI 2); (2) a region 
common to both DSPI and DSPIb (si2, si3 and si4); and (3) a region in exon 11 
common to all three splice variants (siI/II), respectively. Figure 4.10A depicts these 
siRNA sequences and targeting sites within the alternative DSP mRNAs. siRNAs si2, 
si3 and si4 were pooled and the pool was designated as siI. siRNAs siDSPI 1 and 
siDSPI 2 were used individually and also as a pool and this pool was designated siDSPI 
1/2. siRNA siI/II was previously published (Wan et al., 2007). Individual siRNAs and 
respective pools, as well as the transfection conditions used are described in Chapter 2. 
Following siDSPI 1 or siDSPI 2 transfection into HaCaT cells, DPI was 
expected to be down-regulated but DPIb and DPII to remain unaffected. Likewise, siI 
transfection should result in DPI and DPIb down-regulation whilst leaving DPII intact. 
In contrast, if the immunoreactive band predicted to be DPIb was a breakdown product 
of DPI, then this band would also be down-regulated with DSPI-specific siRNAs. 
Transfection of HaCaT cells with siI/II should lead to down-regulation of all three 
isoforms, including DPIb, and if so the immunoreactive band predicted to be DPIb 
Chapter 4 – Identification of DPIb 
 
 141
would be confirmed to be DP-specific and not a result of non-specific binding of the DP 
antibody. Therefore, this experiment was conducted to demonstrate that the 
immunoreactive band observed above DPII is DP-specific (and not non-specific 
antibody cross reactivity) and to exclude the possibility of it being a break-down 
product of DPI. 
As expected, the band directly above DPII was observed in control cells and in 
cells transfected with siDSPI 1 and siDSPI 2. This band was not observed in cells 
transfected with siI or siI/II (Figure 4.10C and 4.10D). To confirm that recombinant 
DPIb proteins are also down-regulated with the same siRNAs that down-regulate 
endogenous DPIb, stable HaCaT cell lines over-expressing either GFP or recombinant 
DPIb were transfected with the different siRNAs. Similarly to endogenous DPIb, 
recombinant DPIb proteins are expressed in cells transfected with the DSPI-specific 
siRNA pool (siDSPI 1/2) and are down-regulated with siRNAs specific to both DSPI 
and DSPIb mRNAs (siI) (Figure 4.10D). In cells transfected with siI/II all 
immunoreactive bands were down-regulated including the fourth band directly below 
DPI. Interestingly, in contrast with the DPIb immunoreactive band, the band directly 
below DPI (potential DPIa isoform, see section 4.2.4) is down-regulated with siRNAs 
which were thought to target only the DPI splice variant (siDSPI 1 and siDSPI 2) 
(Figure 4.10C and 4.10D). These results indicate that this band is either a breakdown 
product of DPI or a fourth DP splice variant, intermediate in size between DPI and 
DPIb.  
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Figure 4.10. siRNAs directed against DSP splice variants show that DPIb is a novel DP 
splice variant and the immunoreactive band directly above DPII (continues). 
 










Figure 4.10. siRNAs directed against DSP splice variants show that DPIb is a novel DP 
splice variant and the immunoreactive band directly above DPII. (A) Sense strand 
sequences of six siRNAs directed against DSP splice variants. siDSPI 1 and siDSPI 2 siRNAs 
were designed to target DSPI only. A pool of these two siRNAs was also used which was 
designated siDSPI 1/2. si2, si3 and si4 were designed to target both DSPI and DSPIb. A pool of 
these three siRNAs (siI) was used. siI/II targets all three splice variants. (B) Schematic diagram 
of exons 22 to 24 of the DSPI, DSPIb and DSPII mRNAs showing the siRNA targeting sites 
(red stars). siI/II is not represented as it targets exon 11 which is common to all three splice 
variants. (C) Western blot of HaCaT whole cell lysates with the DP C-terminal antibody (11-
5F). DPI (332KDa), DPIb (279KDa) and DPII (260KDa) are shown. Vinculin (117KDa) was 
used as loading control. The predicted molecular weight of each isoform is indicated on the left 
(KDa). The immunoreactive band directly above DPII (DPIb) is present in cells transfected with 
siDSPI 1, siDSPI 2 and the siDSPI 1/2 pool (which target DSPI) but is down-regulated in cells 
transfected with the siI pool (which targets DSPI and DSPIb) and with siI/II (which targets all 
three splice variants). In contrast, the band directly below DPI is down-regulated by all siRNAs. 
Mock refers to control cells that were incubated with DharmaFECT transfection reagent only. 
NT refers to control cells which were transfected with a pool of non-targeting siRNAs. (D) 
Western blot of whole cell lysates from wild type HaCaT cells and HaCaT cells transduced with 
either the pBabe-GPF or the pBabe-DSPIb construct. Both endogenous and recombinant DPIb 
proteins are down-regulated with siRNAs which target the predicted DSPIb sequence but not 
with siRNAs which are DSPI-specific.  
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This experiment confirms that DPIb is a novel splice variant of approximately 
279 KDa and not a breakdown product of DPI or a result of non-specific antibody cross 
reactivity or other western blot artifacts. 
 
4.2.6. Over-expression of DPIb in HaCaT cells does not change the expression level 
of other junctional or cytoskeletal proteins 
 To investigate whether over-expressing DPIb in HaCaT cells changes the 
expression levels of other desmosomal, adherens junctions or cytoskeletal proteins, 
western blots were performed on whole cell lysates from GFP and DPIb over-
expressing cells (Figure 4.11A and B).  
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Figure 4.11. Over-expression of recombinant DPIb in HaCaT cells does not cause 
significant changes in the expression levels of other junctional or cytoskeletal proteins. (A) 
Western blots of whole cell lysates from HaCaT cells transduced with pBabe-GFP and pBabe-
DSPIb plasmids. Antibodies raised against desmosomal (PKP1, PKP2, PKP3, PG, DSC3 and 
DSG3), adherens junctions (β-catenin) and IF (keratin 14) proteins were used. No major 
changes were observed in expression levels of these proteins between GFP and DPIb over-
expressing cells. The predicted molecular weight of each protein is indicated on the left (KDa). 
(B) Protein quantification (mean±SEM) of junctional molecules relative to vinculin (loading 
control) in GFP and DPIb overexpressing HaCaT cells using densitometry analysis (n=2). 
 
 No significant changes were observed in the expression levels of the DP binding 
partners PKP1, PKP2, PKP3, PG or keratin 14 between GFP and DPIb over-expressing 
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cells. The expression levels of the basal desmosomal cadherins DSC3 and DSG3, as 
well as the adherens junction protein β-catenin were also not significantly altered 
(Figure 4.11A and B).  
 
4.2.7. Normal human atrium expresses DPI and low levels of a smaller DP 
immunoreactive band  
 DP expression is prominent in epithelial and cardiac tissues (Green & Hobbs, 
2006) (see Chapter 1) and DPIb was observed to be expressed at the mRNA level in 
normal human atrium, predominantly in the left atrium (Figure 4.5B). Therefore, 
expression of DPIb proteins in human atrium was investigated by western blot. Whole 
cell lysates from normal human atrium were resolved alongside total cell lysates from 
HaCaT cells in SDS-PAGE and subsequently blotted with the C-terminal DP antibody 
(11-5F) (Figure 4.12A). DPI was observed in human atrium, which migrated alongside 
the DPI immunoreactive band of HaCaT cells. Below this band, another 
immunoreactive band was observed at low levels compared to those of DPI. However, 
due to the fact that these high molecular weight DP isoforms are very similar in size and 
difficult to resolve in SDS-PAGE, it was not clear whether this band is the same size as 
DPIb or the potential DPIa splice variant observed in HaCaT cells on western blot 
above the DPIb immunoreactive band (see section 4.2.4). DPII was barely detected in 
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Figure 4.12. Expression of DP splice variants in normal human atrium. (A) Western blot of 
total proteins from HaCaT cells (first and second lanes) and normal human atrium (third and 
fourth lanes). The predicted molecular weight of each protein is indicated on the left (KDa). 
DPIb (279KDa) is observed in HaCaT cells, along with DPI (332 KDa) and DPII (260KDa). 
Expression of DPI is observed in the normal human atrium at 332 KDa. Below DPI, low levels 
of another immunoreactive band are observed. DPII is barely detectable in this tissue. (B) 
Protein quantification (mean±SEM) of DP isoforms relative to DPI in HaCaT cells and human 
atrium using densitometry analysis (n=2). 
 
4.2.8. Mapping of the putative DPIa splice variant 
The immunoreactive band observed on western blot directly below DPI (which 
was provisionary designated as DPIa, see section 4.2.4) was down-regulated with 
siRNAs which were thought to be DSPI-specific (section 4.2.6). These results indicate 
that this band is either a breakdown product of DPI or a fourth DP splice variant. If this 
band represents a DP isoform, then its corresponding mRNA has to be longer than 8401 
(which corresponds to DSPIb) and shorter than 9730 (which corresponds to DSPI) 
nucleotides in length. If this isoform, like the others, is produced due to the use of an in 
frame alternative donor splice site in exon 23, then its exon 23/24 junction has to lie 
between nucleotides 4329 and 5659 (Figure 4.13A). This boundary would have to lie 
downstream of the region where siDSPI 1 (nucleotides 4488-4506) and siDSPI 2 
(nucleotides 4651-4669) siRNAs hybridise, as the putative DPIa isoform is down-
regulated when using these siRNAs (Figure 4.10 and 4.13A). 
Four alternative donor splice sites were predicted by the ASSP predictor 
program, which would originate four in-frame alternative DP isoforms intermediate in 
size between DPIb and DPI and which could be detected with the DP C-terminal 
antibody (Figure 4.3B). This observation supports the hypothesis that this fourth DP 
specific immunoreactive band could be a DP isoform. Of these four in-frame 5’ splice 
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sites, only the three that lie downstream of siDSPI 2 (i.e, downstream of nucleotide 
4669, see Figures 4.13A and 4.3B) could represent the fourth immunoreactive band 
predicted to be DPIa.  
To investigate whether it was possible to PCR amplify this putative DSP splice 
variant, a pair of primers was designed. The forward primer was expected to hybridise 
with a region in exon 23 just downstream of the DSPIb exon 23-24 border and upstream 
of the target site for the siRNA siDSPI 1 (Figure 4.13A). The reverse primer hybridised 
within the 5’ end of exon 24. RT-PCR amplification of primary NHK using this primer 
pair was performed. When an annealing temperature of 56°C and extension time of 60 
seconds was used, the only PCR product observed was a 1.3 Kb fragment, which 
corresponds to DSPI mRNA (Figure 4.13B). The annealing temperature was then 
decreased to 53°C and the extension time was shortened in 10 second increments to 
favor amplification of the shorter product (Figure 4.13C). Under these conditions, for 
extension times of 30 and 40 seconds, two bands were observed, the 1.3 Kb DSPI-
specific band and a ~500 bp band (lanes 5 and 6, Figure 4.13C). For extension times of 
10 and 20 seconds, the ~500 bp band was the only band observed (lanes 2 and 3, Figure 
4.13C) and no PCR products were obtained when the extension step was omitted (lane 
1, Figure 4.13C). Although the ~500 bp band was predicted to correspond to the 
potential DSPIa isoform, sequencing analysis of this PCR product revealed that it 
consisted of a DSPIb fragment, even though the forward primer was designed not to 
hybridise with DSPIb (Figure 4.13A). Therefore, the only possible explanation is if the 
forward primer was hybridising to a homologous sequence upstream of the DSPIb 
junction. This was demonstrated by the alignment with five mismatched bases of the 
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Figure 4.13. Strategy used to map the putative DPIa splice variant. (A) Schematic diagram 
of exons 22 to 24 of DSPI, DSPIb and DSPII mRNAs showing siDSPI 1 and siDSPI 2 siRNA 
targeting sites (red stars) and a primer pair designed to map the putative DSPIa splice variant. 
RT-PCR amplification of NHK RNA with the primer pair depicted in red results in (B) a 1.3 Kb 
DSPI-specific fragment (lane 1), when annealing temperature of 56°C and extension time of 60 
secs are used in the PCR cycle and (C) the 1.3 Kb fragment as well as a ~500 bp fragment 
predicted to correspond to DSPIa when annealing temperature of 53°C and extension times of 
30 secs (lane 5) and 40 secs (lane 6) are used, and only the ~500 bp fragment when the same 
annealing temperature and extension times of 20 secs (lane 4) and 10 secs (lane 3) are used. No 
PCR products are observed when the extension time step is omitted (lane 2). M (lane 1) = 
molecular weight marker. (D) Alignment of the forward primer with DSPI mRNA using the 
blast program multalin reveals that it hybridises with nucleotides 3904-3924 (instead of the 
required nucleotides 4372-4392) with 5 mismatches and amplifies a 472 bp product which 
corresponds to DSPIb. The expected product of ~ 500 bp corresponding to the putative DSPIa 
splice variant could not be amplified under these conditions. 
 
Under the PCR conditions described here, and even though the extension time of 
the PCR cycle was reduced in an attempt to favour amplification of the desired shorter 
fragment, it was only possible to amplify DSPI and/or DSPIb cDNA. Although the 
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forward primer used here hybridised with mismatches to a homologous region upstream 
of the desired region, the fact that this primer pair did not amplify the putative DSPIa 
isoform suggests this isoform is not present in NHK. These results suggest that the 
fourth immunoreactive band observed with the DP antibody is a breakdown-product of 
DPI and not a DP splice variant. 





4.3.1. DSPIb is a novel alternative transcript produced from the DSP gene 
In this chapter, the existence of a third alternative DSP transcript, DSPIb, 
identified from primary NHK cDNA whilst generating recombinant DSP, is described 
for the first time. As shown by sequencing analysis, this splice variant is produced by an 
in-frame splicing event using a third alternative 5’ (donor) splice site in exon 23, 468 bp 
downstream of that of DSPII. Therefore, this alternative transcript is 468 nucleotides 
longer then DSPII, but still lacks 1329 nucleotides which are present in the DSPI 
transcript (Figure 4.4A).  
All three splice isoforms are generated through canonical splicing, with the 
intronic flanking sequences following the GU-AG rule (see section 4.1.1). Furthermore, 
the 5’ splice sites in exon 23 used to generate DSPIb and DSPII are virtually identical 
(nine out of ten nucleotides are conserved; Figure 4.2B), suggesting similar strengths for 
these consensus sequences. However, these consensus sequences appear to confer 
different specificity for the splicing machinery, as discussed below. 
 
4.3.2. Splice prediction and EST analysis suggest there might be additional novel 
splice variants besides DSPIb 
Alternative splice site predictions within the DSPI coding region were 
performed using two different programs. The donor splice site that generates DSPIb was 
predicted by both programs with a score similar to that of the corresponding splice site 
that generates DSPII (highlighted in blue, Figure 4.3A and 4.3B). This is not surprising, 
as the sequences of these two donor splice sites are virtually identical. In addition to the 
5’ splice sites that generate DSPIb and DSPII, one of the programs (ASSP) suggested 
six alternative donor splice sites within the DSPI specific region (Figure 4.3B). Four of 
these six donor sites would generate splice variants in-frame with DSPI, DSPIb and 
DSPII, if the common acceptor splice site on exon 24 is used. Additionally, under these 
circumstances, the potential additional splice variants would only differ from each other 
and from DSPI, DSPIb and DSPII in the central alternatively splice region. These 
results suggest that besides DPIb, there might be additional DP splice variants, that 
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could be detected with the C-terminal DP antibody (11-5F), which was though to be 
worthwhile investigating. 
EST analysis of DSP splice variants also revealed interesting results. Firstly, one 
EST spanning the DSPIb exon23/24 junction was found on the NCBI human EST 
database, which represents further independent evidence that the DSPIb transcript 
exists, has been shotgun cloned and is expressed in a prostate tumour cell line (cells 
where the mRNA that generated this EST was extracted from). Secondly, the fact that 
only one DSPIb-specific EST and five DSPII-specific ESTs were found in the database, 
compared to 31-37 ESTs in DSPI-specific regions suggests that DSPIb and DSPII are 
expressed at lower levels than that of DSPI in the cells or tissues used to construct the 
cDNA library. These results were also suggested by quantitative RT-PCR, where 
DSPIb:DSPI mRNA ratios of 1:20, 1:33 and 1:14 and DSPII:DSPI ratios of 1:3, 1:4 and 
1:2 were found in HaCaT, K1 and NHK cells, respectively (sections 4.2.2 and 4.2.4 and 
see also section 4.3.4). 
 
4.3.3. DSPIb transcript is expressed in epithelial, brain and heart tissue and the 
only DSP isoform detected in the aorta 
As revealed by RT-PCR using a commercially available multiple tissue panel, 
DSPIb is expressed along with DSPI and DSPII in a range of epithelial tissues including 
simple columnar (small intestine and colon), simple squamous (lung and spleen), simple 
cuboidal (liver, thymus) and stratified (prostate) epithelium. Among these tissues, all 
three DSP isoforms were most abundant in the lung, liver and prostate. Additionally, 
little expression of all three isoforms was observed in the brain. 
Because this RT-PCR method is non-quantitative, it is only possible to compare 
the relative expression of each isoform across the range of tissues. A direct comparison 
between the three isoforms in each tissue is not possible, because these relative levels 
will also depend upon the efficiency of primer pairs and PCR conditions used in each 
case. mRNA expression profiles of DSPI, DSPIb and DSPII across the range of tissues 
were comparable, i.e. tissues that showed highest expression of DSPI also had highest 
levels of DSPIb and DSPII. Very subtle variations to this pattern were observed in some 
tissues. For instance, DSPIb was expressed at slightly higher levels in the brain 
compared to the colon or small intestine, in contrast with DSPI and DSPII, which were 
expressed in the brain at lower levels than in the colon or small intestine (Figure 4.5A). 
This divergence supports the observation that distinct splicing specificities can occur in 
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the presence of virtually identical consensus splice sites. These results further suggest 
that a single differing nucleotide within the 5’ splice site of DSPIb could be important to 
confer splicing specificity. 
Using a cardiovascular cDNA panel, expression of DSPIb at the mRNA level 
was observed in diverse compartments of adult heart, as well as in foetal heart. Similar 
expression profiles were observed in the heart for DSPIb and DSPII, which however 
differed from that of DSPI. Surprisingly, DSPIb was the only isoform detected in the 
aorta. The identical expression profiles for DSPIb and DSPII in the heart suggest similar 
splicing specificity for these two splice variants. However, the fact that only DSPIb was 
detected in the aorta suggests that despite the virtually identical splice sites, there are 
further more subtle levels of regulation which confer differing splicing specificities. As 
described before by many authors, splicing regulation is a very complex mechanism 
depending not only upon the relative strength of consensus sequences in the pre-mRNA, 
but also upon the many levels of regulation of RNA-binding proteins, which in turn 
depend upon signalling pathways, tissue-specific factors and differentiation stages 
(Matlin et al., 2005; Moore & Silver, 2008). An example of tissue-specific regulation of 
splice isoform expression is shown by the high expression of DPII in the skin, whereas 
it is virtually absent in the heart(Angst et al., 1990; Uzumcu et al., 2006). It is therefore 
possible to conclude based on previous observations and results shown here that 
consensus sequences in the pre-mRNA molecule are important, but not sufficient, to 
predict which alternative splice variant will be preferentially expressed in a specific 
tissue or cell at a specific time point. It is also important to mention that other levels of 
post-transcriptional (as well as post-translational) regulation may also be involved in the 
relative expression levels of splice variants, such those affecting mRNA (and protein) 
stability. 
In agreement with results shown here, both DPI and DPII have been shown to be 
expressed in simple and stratified epithelia (Angst et al., 1990). Additionally, DPI is 
known to be an obligatory component of desmosomes and therefore present in all 
desmosome-bearing tissues, including skin, heart, lymph nodes and meninges (Green & 
Hobbs, 2006). Some of these tissues contain desmosome-like junctions that differ in 
ultrastructure from epithelial desmosomes. Complexus adherents are an example of this 
type of junction which are present in vascular and lymphatic endothelial cells and 
contain VE-cadherin together with DP and PG as well as several adherens junction and 
tight junction proteins (Moll et al., 2009). Cardiomyocyte cell junctions also contain a 
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mixture of desmosomal and adherens junction proteins which localise to the “area 
composita” of the intercalated disc connecting cardiomyocytes (Borrmann et al., 2006); 
see Chapter 1). Although these junctions are known to contain DPI, expression of DPII 
was observed at the mRNA level but barely detectable at the protein level (Uzumcu et 
al., 2006). As shown here, DSPIb is also expressed at the mRNA level in epithelial, 
brain and heart tissue. 
A similar RT-PCR method to specifically amplify DSPI and DSPII has been 
described, where the same cardiovascular cDNA panel was used (Uzumcu et al., 2006). 
In this report, DSPI was shown to be ubiquitously expressed throughout all regions of 
the heart, including the aorta, in contrast with the observations described here. However, 
the primer pair used by this group to specifically detect DSPI amplifies an 800 bp 
region (from positions 3268 to 4068 according to accession number NM_004415.2 of 
the NCBI database) which is common to both DSPI and DSPIb (Figure 4.4A). 
Therefore, the reported DSPI expression across the different regions of the heart is a 
combination of DSPI and the previously unknown DSPIb isoform. This explains the 
differences between the published DSPI expression profile in the heart and the data 
presented here, and it is therefore plausible that DSPIb is the only transcript present in 
the aorta. Moreover, it is possible that, if synthesised, DPIb has a specific function in 
the aorta which may not be fully accomplished by DPI or DPII. 
 
4.3.4. DSPIb transcript is expressed in human skin as well as HaCaT, K1 and NHK 
keratinocytes 
DSPIb mRNA was also detected in normal human skin and keratinocyte cell 
lines along with DSPI and DSPII, using the same RT-PCR method. Taken together, 
these results demonstrate that a third DSP splice variant, DSPIb, is physiologically 
expressed at the mRNA level in normal skin and in other simple and stratified epithelia, 
in cardiac tissue, as well as in human keratinocyte cell lines and in primary NHK in 
culture, where it was first identified. This indicates that expression of DSPIb in cultured 
keratinocytes is not a result of aberrant splicing due to adaptation of these cells in 
culture. 
Quantification of mRNA expression of the three DSP isoforms revealed that the 
levels of DSPIb (relative to DSPI) are similar among NHK, HaCaT and K1 
keratinocytes. The DPIb protein levels observed by western blot were also similar 
between HaCaT and K1 cells, suggesting that there is a correlation between mRNA and 
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protein levels of this isoform (Figure 4.7). These results suggest that DPIb is efficiently 
translated in HaCaT and K1 cells. The DPIb protein levels were very low compared to 
those of DPI and DPII in both HaCaT and K1 cells. Similarly, quantitative RT-PCR 
suggested that the mRNA levels of DSPIb are lower than those of DSPI and DSPII. 
However, the quantitative RT-PCR experimental conditions used here are not ideal to 
compare expression levels of different mRNAs in the same type of cell or tissue because 
different primer pairs may have different effects on the PCR reaction efficiency. A 
confirmation of these results using techniques such as TaqMan assay, northern blot or 
an RNase protection assay would be more adequate to directly compare the mRNA 
levels of the different isoforms in the same cell type. 
 
4.3.5. Western blot of DP proteins in keratinocyte cell lines revealed an additional 
immunoreactive band which represents the novel DPIb splice variant 
Immunoblotting of DP proteins from HaCaT and K1 cells revealed DPI and 
DPII as well as two additional immunoreactive bands with sizes between those of DPI 
and DPII. Based on the calculated size of DPIb, this isoform was hypothesised to 
correspond to the band directly above DPII. However, this immunoreactive band could 
also represent: (1) a breakdown product of DPI (hence recognised by the DP antibody); 
(2) a modification of the DPI or DPII isoforms (such as phosphorylation); (3) the result 
of non-specific binding of the DP antibody used; or (4) artefacts arising from the 
western blot process and the fact that SDS-PAGE gels were resolved for long periods of 
time.  
To confirm the initial hypothesis and to exclude these other possibilities, two 
experiments were conducted. Firstly, recombinant DPIb was retrovirally expressed in 
HaCaT cells and immunoblotted alongside endogenous HaCaT DP proteins. This 
experiment showed that recombinant DPIb proteins migrate alongside the endogenous 
immunoreactive band above DPII. Secondly, RNAi technology was used to specifically 
knock-down DPI only (siDSPI 1 and siDSPI 2), both DPI and DPIb (siI) and all three 
isoforms (siI/II). This experiment was performed in both wild type HaCaT cells and in 
HaCaT cells over-expressing either GFP (control) or recombinant DPIb, to demonstrate 
that both endogenous and recombinant DPIb proteins behave in the same way. As 
expected, this experiment showed down-regulation of both endogenous and 
recombinant DPIb proteins in HaCaT cells transfected with siI and siI/II, but not with 
siDSPI 1 or siDSPI 2. Interestingly, this experiment also showed down-regulation of the 
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immunoreactive band below DPI with all three groups of siRNAs used. This result 
indicates that this immunoreactive band corresponds either to a fourth DP splice variant, 
which shares with DPI the region targeted by siRNAs siDSPI 1 and siDSPI 2, or to a 
breakdown product or a modified version of DPI. 
DPIb is expressed at the protein level in HaCaT and K1 immortalised 
keratinocyte cell lines, as demonstrated by immunoblotting. Taken together, RNAi and 
recombinant expression clearly demonstrated that the 279KDa band is DP-specific and 
corresponds to DPIb proteins, as opposed to a breakdown product, a modified version or 
an artefact. Given the high molecular weight of DP isoforms and their proximity in size, 
these proteins had to be resolved for long periods of time by SDS-PAGE in order to 
detect DPIb with good resolution. This, coupled with the low expression level of DPIb 
in these cell lines compared to those of DPI and DPII, might be the reasons why DPIb 
has been previously missed. However, a previous study where expression of DPI and 
DPII was investigated by immunoblotting in cells derived from different epithelia 
showed weak expression of an immunoreactive band of similar size to DPIb in cells 
from human pharyngeal squamous cell carcinoma (stratified or pseudostratified 
epithelium) (Angst et al., 1990). 
 
4.3.6. Expression levels of other junctional and cytoskeletal proteins are unaltered 
by over-expression of DPIb in HaCaT cells 
 The expression levels of DP binding partners and other junctional proteins were 
investigated in HaCaT cells over-expressing DPIb and compared to vector only control 
cells (HaCaT cells transduced with pBabe-GFP control vector). Since DP is a crucial 
component of desmosomes and its down-regulation leads to decreased expression levels 
of some other desmosomal proteins (see Chapter 5), it was hypothesised that over-
expressing a DP isoform would increase desmosome stability. However, no significant 
differences in the expression levels of other desmosomal and adherens junction proteins 
or keratin 14 were observed between DPIb and GFP over-expressing HaCaT cells 
(Figure 4.11). It would have been interesting to investigate whether DPIb has any effect 
on the expression level of other adherens junctions’ proteins, such as E-cadherin and N-
cadherin, given the interdependence between adherens junctions and desmosomes. 
 No phenotypic changes were observed either between wild type and DPIb 
expressing Phoenix cells. These cells are derived from human embryonic kidney cells 
(HEK293T cells). They are more dendritic in shape and less adhesive then keratinocytes 
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and their morphology, as observed by phase contrast microscopy, did not change when 
DPIb was over-expressed (data not shown). 
 A number of reasons might possibly explain the results observed. First, the 
pBabe mammalian expression vector is a low expression vector where transcription is 
driven by the LTR promoter. Therefore, the difference in DPIb protein levels between 
wild type HaCaT cells and cells expressing recombinant DPIb might not be sufficient to 
cause a detectable effect. Second, over-expression of DPIb might have some subtle 
effects on HaCaT and/or Phoenix cell-cell adhesion which were not detectable with the 
methods used in this study. For instance, DPIb expression might interfere with the 
solubility of some desmosomal proteins, such as PG or PKPs, without changing total 
protein levels or it might have signalling effects. Third, it is possible that, although no 
effects were observed with the experimental conditions used in this study, other 
conditions may exist where DPIb expression is important. The observation that DPII is 
widely expressed in epithelial tissues, in particular in the skin, but barely detectable at 
the protein level in human heart supports this hypothesis. Furthermore, the fact that 
DSPIb was the only DSP transcript observed in the aorta supports a biological role for 
this isoform. Fourth, it is not possible to rule out the hypothesis that DPIb has a 
redundant function similar to that of DPI or DPII. More studies will be necessary to 
understand the function (if any) of DPIb.  
 
4.3.7. Normal human atrium expresses DPI and low levels of immunoreactive band 
which is not DPII 
Expression of DP isoforms was investigated in normal human atrium. As shown 
by western blot, high levels of DPI were observed in this tissue but, in agreement with 
previous observations (Uzumcu et al., 2006), DPII was virtually absent. In addition to 
DPI, a shorter immunoreactive band was detected, which was expressed at very low 
levels. Although total lysates from atrium tissue were resolved alongside total HaCaT 
cell lysates, it was not clear whether this immunoreactive band is the same size as DPIb 
or as the potential DPIa isoform. This could be due to the fact that it is difficult to 
compare the mobility of proteins isolated from different cell types, as different 
modifications (such as phosphorylation) could affect protein migration on SDS-PAGE. 
Further experiments would be needed to confirm these results. Nevertheless, it is 
tempting to speculate that this immunoreactive band corresponds to DPIb, given that 
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mRNA expression of this isoform was observed in human atrium (Figure 4.5B) and that 
it was not possible to prove the existence of DPIa (sections 4.2.8 and 4.3.8). 
 
4.3.8. Mapping of potential DPIa isoform 
As shown by western blot of HaCaT cell lysates, the immunoreactive band 
observed below DPI is down-regulated with siRNAs which were predicted to be DSPI-
specific. This result, coupled with the prediction of four possible in-frame alternative 
splice variants (section 4.3.2 and Figure 4.3B) and the observation when western 
blotting protein lysates from human atrium of an additional immunoreactive band below 
DPI, led to an attempt to map a potential fourth DSP isoform. A pair of oligonucleotides 
was designed which could amplify both a DSPI and/or a DSPIa fragment with different 
sizes. Because DSPI is probably in far greater abundance then the proposed DSPIa in 
NHK, RT-PCR conditions were used which did not enable amplification of DSPI and 
even under these conditions it was not possible to amplify a DSPIa-specific product. 
Given that the product corresponding to the proposed DSPIa isoform is shorter than that 
of DSPI, it is possible to conclude that DSPIa either does not exist or is due to an 
alternative splicing event which maps to a different region. If the former hypothesis is 
the case then the immunoreactive band observed above DPI is either a breakdown 
product of DPI or simply a western blot artefact. The fact that no 5’ splice sites other 
than the ones that originate DSPIb and DSPII were presented by the Neural Network 
splice predictor program (Figure 4.3A) supports the RT-PCR result and the conclusion 
that DPIa (if existent) does not map to this region. 
 
4.3.9. Hypothesis regarding possible function of DPIb 
The C-terminal domain of DP is responsible for mediating interactions with 
different types of IFs: vimentin in meninges and dendritic cells of lymph nodes, desmin 
in the myocardium and a variety of keratins in epithelial tissues (Fontao et al., 2003; 
Kouklis et al., 1994; Meng et al., 1997; Stappenbeck et al., 1993; Stappenbeck & 
Green, 1992). The N-terminal plakin domain is important for targeting DP to the 
junctional plaque through interactions with PG and PKPs (Bornslaeger et al., 2001; 
Kowalczyk et al., 1997). As the DPIb isoform shares these two domains with DPI and 
DPII, it probably interacts with the same binding partners in the desmosome.  
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The central α-helical rod domains of two or more DP molecules are predicted to 
form coiled-coil interactions with one another (Bornslaeger et al., 1996). DP molecules 
have also been reported to interact with each other through head-head associations 
(Smith & Fuchs, 1998). These higher order aggregates of DP form a filamentous 
network within the IDP which interacts with other plaque proteins between the 
membrane and IFs. However, while interactions with binding partners are known to be 
facilitated by the N- and C-terminal domains of DP, the rod domain is only known to be 
important for self-associations. While the DPI splice variant contains the entire rod 
domain, DPII lacks two thirds of this domain, and thus is likely to form less-stable 
dimers through coiled-coil interactions (Green et al., 1990). The functional 
consequences of shortening the rod domain are unknown, but it is thought that DPII 
may govern the thickness of the desmosomal plaque (North et al., 1999).  
The ratio between DPI and DPII varies among different tissues and different cell 
types; DPII, which is abundantly expressed in complex epithelial tissues, is expressed at 
lower levels in cells derived from some other epithelial tissues such as epidermoid 
carcinoma (vulva) and human bladder carcinoma (transitional epithelium) (Angst et al., 
1990) as well as in the heart (Uzumcu et al., 2006). Interestingly, Phoenix cells which 
are derived from a simple cuboidal epithelium (kidney) also show lower DPII 
expression levels than HaCaT cells (see Figure 4.9). Therefore DPII could have a 
functional significance (yet to be understood) which might not be fully accomplished by 
DPI alone in some tissues. Although it probably shares overlapping functions with DPI, 
DPII might play a unique role in desmosome assembly and maintenance in these tissues 
(Angst et al., 1990).  
The novel DPIb isoform described here contains half of the rod domain. 
Therefore, it can be hypothesised that DPIb will form more stable self associations than 
DPII but less stable than DPI. DPIb might also be important to stabilise DPI and DPII 
and different isoforms might play different roles in the stabilisation and adhesive state 
of the desmosome, which could be important to modulate the strength of the plaques in 
different tissues or during development and wound healing. Although DPIb was 
expressed at low levels in HaCaT and K1 keratinocytes, it might possibly be up-
regulated under certain conditions and/or take over the function of other splice variants, 
for instance in cases of a DSPI-specific mutation. Nine mutations have been reported so 
far within the rod domain. Two of these mutations (p.R1113X and p.R1934X) affect all 
three isoforms; another three (p.R1255K, p.R1267X and p.N1324fsZ23) affect DPI and 
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DPIb and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DPI whilst 
leaving DPIb and DPII intact (Figure 1.8). It is interesting to note that all mutations 
affecting only DPI are missense mutations causing dominant ARVC possibly through a 
dominant negative effect on cardiac junctions, except for the nonsense mutation 
(Q1446X) which only caused cardio-cutaneous disease when in a compound 
heterozygous background (Figure 1.8). This contrasts with the p.R1113X nonsense 
mutation which affects all three isoforms and leads to dominant non-syndromic ARVC 
(Figure 1.8) and with the p.R1267X nonsense mutation (described in Chapter 5) which 
leads to complete absence of both DPI and DPIb and results in skin and heart disease. 
These observations suggest that some degree of compensation by DPIb and DPII might 
occur in invividuals heterozygous for the Q1446X mutation (carriers), which are 
completely healthy. In fact there is a suggestion of slight DPIb up-regulation in HaCaT 
cells with DSPI down-regulation (Figure 4.10). However, further studies would be 
needed to confirm this hypothesis. It is possible that a higher degree of up-regulation 
and compensation occurs under mechanical stress. 
The majority of desmosomal genes are alternatively spliced and little is known 
about the role of some of these splice isoforms, such as DSC ‘b’ proteins or DPII. A 
large volume of research has been published using recombinant DPI, however 
recombinant DPII has not been used. The importance of DPI during development and in 
the adult has been highlighted by observations from mouse models and human diseases 
of skin, hair and heart (Green & Hobbs, 2006). Further work will be necessary to 
investigate in more detail the importance and function of the DPII and DPIb isoforms 
and to investigate differences in isoform-specific adhesion properties. 
 
4.4. Summary 
This chapter describes a novel DP splice variant, DPIb, which has a molecular 
weight intermediate between those of DPI and DPII. This novel isoform is generated 
through alternative splicing of the DSP gene, using a third alternative 5’ splice site and 
the common 3’ splice site which generates also DPI and DPII. DSPIb transcript is 
expressed in several epithelial and cardiovascular tissues and the only DSP isoform 
detected in the aorta. DPIb protein was observed by western blot in HaCaT and K1 
keratinocytes which has been previously missed, probably due to its similarity in size to 
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Thirty-six different mutations have been published to date in the gene encoding 
DPI and DPII, leading to a variety of different cardio-cutaneous syndromes (Figure 1.8). 
Although there are in vivo and/or in vitro data on some of these DSP mutations, the 
molecular mechanisms that lead to skin and/or heart disease are not fully understood 
and it is not clear why mutations in the same gene can lead to such different phenotypes. 
Additionally, the functional significance of the DPII splice variant, and to what extent it 
can compensate for DPI defects, is not clear. The goals of the work presented in this 
chapter are to mimic three DSP mutations in HaCaT keratinocytes to investigate their 
molecular mechanisms. Additionally, an indirect goal using this approach is to gain 
further insight into the functional significance of DPI and DPII. Although all three 
mutations affect the DPIb splice variant (Chapter 4), the work described in this chapter 
was directed at investigating the functional differences between the DPI and DPII 
isoforms as these are the predominant isoforms expressed in skin. 
Heterozygous mutations (nonsense and splice site mutations) resulting in DPI 
(DPIb) and DPII haploinsufficiency and causing non-syndromic SPPK (p.Q331X and 
939+1G>A) were modelled by using a siRNA targeting all three DSP isoforms. A 
homozygous DSPI/DSPIb-specific nonsense mutation (p.R1267X) leading to absence of 
DPI (and DPIb) in the skin and causing PPK, woolly hair and early lethal 
cardiomyopathy was also modelled by using siRNAs targeting DSPI/DSPIb. These loss 
of function mutations were investigated to understand the differences between the 
dosage effect of total DP (including DPI and DPII) and the dosage effect of each 
isoform (DPI or DPII) as well as to gain further insight into isoform-specific functions. 
Heterozygous carriers of the DSPI-specific nonsense mutation, p.R1267X, who have 
reduced expression levels of the DPI isoform and normal expression levels of DPII, are 
totally normal (Uzumcu et al., 2006); patients who have DPI/DPII haploinsufficiency 
have skin disease (Armstrong et al., 1999; Whittock et al., 1999); and the patient with 
absence of DPI and normal expression levels of DPII (homozygous carrier of the DSPI-
specific nonsense mutation p.R1267X; (Uzumcu et al., 2006) has skin and heart disease, 
even though the total amount of DP produced in this case is predicted to be equivalent 
to that of patients with DP haploinsufficiency. In addition, patients with SPPK caused 
by DP haploinsufficiency mutations show adhesion defects in the skin including hyper-
proliferative epidermis with loss of cell-cell adhesion and widening of intercellular 
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spaces (see below). However, it is not clear whether the DSPI-specific nonsense 
mutation has the same effect on desmosomal adhesion (Uzumcu et al., 2006). 
The third mutation studied is a heterozygous insertion of 30 bp leading to the 
presence of 10 additional amino acids in the N-terminus of both DPI and DPII. This 
autosomal dominant mutation leads to skin disease coupled with a very severe 
cardiomyopathy similar to the nonsense mutation that leads to absence of the DPI 
isoform (p.R1267X, see above). A more detailed background description on these three 
different DSP mutations is given in the following introductory sections. 
 
5.1.1. Nonsense and haploinsufficiency DSP mutations result in different 
expression levels of DPI and DPII and lead to cardiac and/or cutaneous disease 
Uzumcu et al. (2006) described a Turkish patient with a Naxos-like syndrome 
characterised by recessively inherited arrhythmogenic dilated cardiomyopathy, 
epidermolytic PPK (EPPK) and woolly hair. The patient presented with a very severe 
and early onset heart disease involving both ventricles, which rapidly progressed to 
heart failure and death at the age of four. A homozygous nonsense mutation, p.R1267X 
(c.3799C>T), in DSPI was found to be associated with this phenotype. This C to T 
transition generates a PTC in a region of exon 23 which is specific to DSPI, but absent 
from DSPII mRNA. Immunohistochemistry and western blot analysis of protein from 
the patient’s skin with antibodies specific to DPI only and to both DPI and DPII 
revealed that DPI is below detectable levels in this patient’s skin. Semi-quantitative RT-
PCR showed the mutant DSPI transcript is unstable and likely to be rapidly degraded by 
the nonsense mediated decay (NMD) pathway (see below) (Uzumcu et al., 2006). 
As described in section 3.3.4, NMD is a mechanism of mRNA surveillance 
which detects mRNAs containing PTCs and targets these mutant transcripts for rapid 
degradation. The presence of an exon junction complex (EJC) downstream of a PTC is 
identified by NMD factors and leads to the activation of the NMD pathway resulting in 
the rapid decay of the PTC-containing transcripts (Maquat, 2004; Silva & Romao, 
2009). The p.R1267X DSPI-specific nonsense mutation generates a PTC 1581 
nucleotides upstream of the next exon-exon junction, which is hypothesised to trigger 
the NMD pathway. This mutation will be designated as DSPI-nonsense mutation 
throughout this chapter. 
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Two heterozygous mutations in DSP were described leading to DP 
haploinsufficiency and associated with dominantly inherited striate PPK (SPPK). One 
of these mutations is a splice site transition (939+1G>A) causing retention of intron 
seven which contains a PTC (Whittock et al., 1999). The other is a C>T transition in 
exon four which substitutes a glutamine amino acid by a PTC (p.Q331X) (Armstrong et 
al., 1999). Both dominant mutations affect all known DSP isoforms transcribed from 
the mutant allele and lead to decay of the mutant transcripts possibly through activation 
of the NMD pathway. Therefore, a reduced amount of each isoform is expressed in 
patients harbouring these mutations compared to normal individuals (Wan et al., 2004). 
There is variable penetrance in these SPPK patients suggesting other genetic and/or 
environmental factors may contribute to the severity of the keratoderma (Whittock et 
al., 1999). Ultrastructural analysis of these patients’ skin showed loss of cell-cell 
contacts, under-developed desmosomes and retraction of the keratin IF network towards 
the nucleus (Armstrong et al., 1999; Wan et al., 2004; Whittock et al., 1999). 
Immunohistochemistry of these patients’ skin showed decreased expression of PKP1, 
DSC1 and DSC3, especially in the spinous layer (Wan et al., 2004). This group of DSP 
mutations leading to haploinsufficiency will be designated as haploinsufficiency 
mutation throughout the chapter. 
To mimic the DSPI-nonsense and haploinsufficiency DSP mutations, RNAi 
technology was used. DSPI was specifically down-regulated in HaCaT cells to resemble 
the p.R1267X DSPI-nonsense mutation and both DSPI and DSPII were partially down-
regulated to mimic the haploinsufficiency mutation. This approach was used to 
investigate whether down-regulation of DPI has the same effect in HaCaT cells as 
partial reduction of both DPI and DPII in terms of expression of other components of 
the desmosomal complex and of cell-cell adhesion properties. 
 
5.1.2. Heterozygous 30 bp-insertion mutation in DSP results in cardio-cutaneous 
disease 
An insertion mutation in DSP, p.I608ins10, was previously identified in the 
Centre for Cutaneous Research (Norgett et al., 2006). This heterozygous insertion of 30 
bp into exon 14 of DSP (resulting in the insertion of 10 extra amino acids into the N-
terminus of the protein) was associated with dominant SPPK, woolly hair and 
cardiomyopathy with left and right ventricular involvement. The cardiomyopathy 
resulted in heart failure and death of this patient at the age of 18. This patient’s father 
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had also died suddenly from arrythmogenic right ventricular dysplasia (ARVD). The 
patient had a noticeable skin phenotype since the third year of life, consisting initially of 
hyperkeratosis and fissuring of the skin on palms and soles, and woolly hair. Later on in 
adolescence, the hyperkeratosis was observed on the knees, elbows, shins and ankles, 
and the patient had absent molars and pre-molars. The hair was woolly and kinky and 
the frontal scalp had short sparse hairs. Immunofluorescence staining of patient skin 
biopsies revealed a discontinuous distribution of DP and PG around the cell membrane, 
with some cytoplasmic localization, especially in the basal and lower supra-basal layers 
of the epidermis. Keratin 1 staining showed a slight reduction in expression and 
desmosomal attachment, only apparent in the lower regions of the epidermis (Norgett et 
al., 2006). This mutation will be designated as insertion mutation throughout the 
chapter. 
To study the I608ins10 insertion mutation, DSPI was cloned and the pBabe-puro 
retroviral system was used to generate HaCaT stable cell lines over-expressing wild 
type and mutant pBabe-DSP constructs (see sections 2.2.1 and 2.2.2 in Chapter 2). The 
effect of this mutation on the localisation of DP and pan-cytokeratin proteins in HaCaT 
cells was investigated using immunocytochemistry. An adhesion assay was used to 
study the effect of this mutation in HaCaT keratinocytes. 
 
5.1.3. Flexcell adhesion assay to study mechanical properties of DP mutant cells 
The skin phenotype observed in patients harboring these three types of DSP 
mutations is prominent in sites exposed to intense and constant mechanical pressure, 
such as palms and soles. In the case of the patient harboring the insertion mutation, 
involvement of other sites that are subject to physical trauma such as the knees, elbows, 
shins and ankles is also observed. To reproduce the in vivo physiological environment 
of these sites of pressure or abrasion, HaCaT cell monolayers, either with reduced 
expression of DP isoforms or over-expressing the insertion mutation, were subject to 
repeated cycles of radial stretch and relaxation for different periods of time, using the 
Flexcell FX-4000 Tension System. This system is a computer-regulated bioreactor that 
works by applying cyclic or static vacuum pressure onto silicone deformable matrix 
coated wells of tissue culture plates where cells are seeded (Flexcell International 
Corporation, http://www.flexcellint.com/). This system allows investigation of physical 
and biochemical cellular changes in response to mechanical stress. 




This chapter is focused on the study of three distinct DSP mutations – DSPI-
specific nonsense, haploinsufficiency and insertion mutations – in HaCaT keratinocytes 
in order to gain a deeper understanding of their molecular mechanisms leading to 
disease. Additionally, this study is aimed to provide further understanding about the 
specific functions of DPI and DPII. Different approaches were undertaken to study the 
molecular mechanisms of these mutations according to the different in vivo 
observations. The DSPI-nonsense and haploinsufficiency mutations are hypothesised to 
influence the expression levels of other desmosomal proteins and also keratinocyte 
adhesion properties. The insertion mutation is hypothesised to result in the abnormal 
distribution of other desmosomal-associated proteins. All mutations affect palmoplantar 
epidermis in particular, which is continuously subject to mechanical stress. Therefore, 
the influence of the DSPI-nonsense and haploinsufficiency mutations on the expression 
levels of other junctional proteins was investigated in HaCaT cells by western blot and 
densitometry analysis; the insertion mutant was over-expressed in HaCaT cells and its 
effects were investigated by immunocytochemistry; the Flexcell adhesion assay was 




5.2.1. Transient siRNA down-regulation of DP isoforms in HaCaT keratinocytes  
mimics DSPI-nonsense and haploinsufficiency mutations 
The DSPI-nonsense mutation targets both DSPI and DSPIb (DPIb is described in 
Chapter 4) mRNAs (Figure 5.1B). To faithfully mimic this mutation, siRNAs were 
designed to specifically target the 648 bp region, from nucleotides 3861 to 4329, which 
is common to both splice variants (Figure 5.1A and 5.1B). Three of four designed 
siRNAs were shown to be functional and were pooled together in subsequent 
experiments. The sequences and targeting sites of these three functional siRNAs (si2, 
si3 and si4) as well as the position of the DSPI-nonsense mutation (c.3799C>T; 
R1267X) are shown in Figure 5.1. Cells transfected with the pool of functional siRNAs 
(siI) used to mimic the DSPI-nonsense mutation in HaCaT cells were designated as siI 
cells (Figure 5.1A and 5.1B).  
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Figure 5.1. Nucleotide sequences of three siRNAs directed against DSPI/DSPIb and their 
targeting sites. (A) Sense strands of three individual siRNAs (si1, si2 and si3) designed to 
specifically target DSPI and DSPIb mRNAs. The three siRNAs were used as a pool designated 
as siI. (B) Schematic diagram of a portion of the DSPI, DSPIb and DSPII mRNAs including 
exons 22 to 24 and the position of the p.R1267X (c.3799C>T or 4078C>T) nonsense mutation. 
4078C>T refers to nucleotide numbering commencing from the transcript’s first nucleotide. 
Alternative donor splice sites around positions 5659, 4329 and 3861 (position numbers 
according to accession number NM_004415.2 of NCBI database) originate three different splice 
variants (DSPI, DSPIb and DSPII respectively). The p.R1267X mutation occurs in nucleotide 
position 4078 within a region common to both DSPI and DSPIb mRNAs, and therefore siRNAs 
were designed in this region to knock-down DSPI and DSPIb and mimic this mutation. The 
targeting sites of each individual siRNA are indicated with red stars. 
 
A number of optimisations were performed prior to the siRNA experiments 
described in this chapter, including optimisation of transfection conditions, testing of 
the four designed siRNAs, optimisation of the siI pool concentration and time course 
analysis of DPI down-regulation in HaCaT cells. Optimisation of transfection 
conditions was carried out to find the highest transfection efficiency whilst maintaining 
cell viability. The four siRNAs were tested to determine which ones were functional, 
i.e. resulted in significant down-regulation of DPI. The concentration of siI pool was 
varied to determine the lowest concentration resulting in significant down-regulation of 
DPI in order to reduce off-target effects. A time course analysis was performed to 
determine the duration of DPI down-regulation. These optimisations, as well as the 
procedure used to design the four DSPI siRNAs, and respective results are described in 
Appendix B.  
The haploinsufficiency mutation was mimicked using a siRNA that has been 
described by Wan et al. (2007), to down-regulate all DSP isoforms to about 50% in 
HaCaT cells. Cells transfected with this siRNA were designated as siI/II cells. A pool of 
four non-targeting (NT) siRNAs was used as a negative control (NT cells). A western 
blot showing down-regulation of DPI (which mimics the DSPI-nonsense mutation) in 
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siI cells and down-regulation of DPI and DPII (mimicking the haploinsufficiency 
mutation) in siI/II cells with a C-terminal DP antibiody (11-5F, Parrish et al., 1987) is 




Figure 5.2. Western blot of DPI and DPII in HaCaT cells following siI and siI/II siRNA 
transfections to mimic the DSPI-nonsense and haploinsufficiency mutations, respectively. 
Total proteins from HaCaT cell lysates four days after transfection with non-targeting (NT) 
control siRNAs (lane 1), siI pool (lane 2) and siI/II siRNA (lane 3) with a C-terminal DP 
antibody (11-5F) which recognises both DPI (332KDa) and DPII (260KDa). Down-regulation 
of DPI with siI mimics the DSPI-nonsense mutation and down-regulation of DPI and DPII with 
siI/II mimics the haploinsufficiency mutation. Vinculin (117KDa) was used as loading control. 
 
5.2.2. Characterisation of DPI and DPI/II down-regulation in HaCaT cells 
 
5.2.2.1. Influence of DSPI-nonsense and DSP haploinsufficiency mutations on the 
expression levels of desmosomal associated proteins 
The first goal of this chapter was to investigate the influence of the DSPI-
nonsense and haploinsufficiency mutations on the expression levels of DP binding 
partners and other junctional proteins. This was performed by western blot and 
compared between the two DP knock-down situations and to the NT control cells. 
Two independent siRNA knock down experiments were conducted and two to 
four replicate western blots were carried out for each protein in each experiment. 
Figures C1 and C2 (Appendix C) show representative western blots for each analysed 
protein in the first and second experiments, respectively. Protein levels, calculated from 
densitometry measurements of western blots using an image analysis program (Image J, 
v. 1.34s) are also graphically depicted for DPI and DPII, total DP (DPI+DPII expression 
levels), and for the proteins that showed reduced expression levels following DP knock-
down (Figures C1 and C2, Appendix C). These protein levels were normalised to the 
loading control (vinculin) for each individual sample, and are presented as a fold change 
of the NT control for each western blot. For the DPI/DPII graphs (Figures C1C and 
C2C, Appendix C), DPI and DPII protein levels are presented as a fold change of the 
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DPI level of NT cells, as this reflects the DPI:II ratio that is present in wild type control 
cells. The t-test for matched pairs was used to compare the means of two samples in 
each western blot (Appendix C). 
No detectable differences were observed in the expression levels of PKP2, 
PKP3, PG, β-catenin, keratin 14 and DSG3 between siI or siI/II (which mimic the 
DSPI-nonsense mutation and the haploinsufficiency mutation, respectively) and NT 
control cells, in any of the independent knock-down experiments. Variable results were 
observed for DSG2 expression levels between the two independent experiments 
(Figures C1A and C2B, Appendix C), and further experiments would be necessary to 
confirm these results.  
Both independent knock-down experiments showed consistent results for the 
expression levels of PKP1, DSC2 and DSC3, which were reduced in siI and siI/II cells 
compared to NT cells. Therefore, the decision was made to pool western blot results 
from the two independent experiments for these three proteins as well as for DP. This 
procedure allowed for a larger number of data points to increase the confidence in the 
results. Figure 5.3 depicts protein levels of DP, PKP1, DSC2 and DSC3 calculated from 
the western blots of the two independent knock-down experiments. 
Total DP expression levels were reduced, on average, to 50% in siI cells and to 
40% siI/II cells when compared to NT control cells (p<0.001) (Figure 5.3A). Likewise, 
expression of PKP1, DSC2 and DSC3 was significantly reduced in siI and siI/II cells 
compared to NT cells (Figure 5.3B). Although the difference in total DP levels between 
siI and siI/II cells is not statistically significant (Figure 5.3A), the DPI and DPII 
expression levels between siI and siI/II cells changed significantly (p<0.05). The 
DPI:DPII ratios also changed from 1:8 in siI cells to 4:1 in siI/II cells (Figure 5.3A). 
Figure 5.3B shows that, similarly to the total DP levels, PKP1 and DSC2 levels are not 
significantly different between siI and siI/II cells. In contrast, DSC3 expression levels 
are significantly higher in siI/II cells than in siI cells (p<0.05). These results suggest that 
despite the intrinsic variability associated with all experimental procedures, PKP1 
expression levels are not influenced by the DPI:DPII ratios. In contrast, DSC3 








































































































Figure 5.3. Protein levels of desmosomal proteins following DSPI and DSPI/DSPII knock-
down suggests that DSC3 expression levels are influenced by the DPI:DPII ratios in 
contrast with PKP1. (A) Protein levels of DPI and DPII (n=6 blots) and of total DP 
(DPI+DPII) calculated from densitometry measurements of western blots (mean±SEM) and 
normalised to loading control (vinculin). DPI and DPII expression levels are presented as a 
fraction of the DPI levels of NT cells. Total DP expression levels are presented as a fraction of 
the DP levels of NT cells. (B) Protein levels (mean±SEM) of PKP1 (n=7 blots), DSC2 (n=5 
blots) and DSC3 (n=6 blots) normalized to the loading control and presented as a fraction of the 
respective NT control levels. PKP1 levels do not change between siI and siI/II cells; in contrast 
DSC3 levels are significantly higher in siI cells than in siI/II cells. Statistical significance 
between siI or siI/II and NT following paired t-test is shown with black stars. Red stars 
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5.2.2.2. Influence of the DPI:DPII ratios on DSC3 and PKP1 expression 
To confirm the previous results (section 5.2.2.1) which suggest that DSC3 
expression is dependent on the DPI:DPII ratios in contrast with PKP1, the influence of 
DPI:DPII ratios on the expression levels of DSC3 and PKP1 was further investigated 
using different concentrations of siI and siI/II siRNAs. DPI expression was gradually 
reduced by increasing concentrations of the siI pool (lanes a-d, Figure 5.4A), and both 
this pool and increasing concentrations of siI/II were used to progressively down-
regulate DPII whilst leaving DPI unchanged (lanes e-h, Figure 5.4A). Figure 5.4B 
shows total DP expression levels as well as DPI and DPII levels relative to NT cells 
(lane i, Figure 5.4A and 5.4B).  
Figure 5.4C and 5.4D show that the DSC3 and PKP1 expression profiles differ 
considerably. Whilst DSC3 expression shows a progressively decreasing trend similar 
to DPI, PKP1 expression is relatively stable in lanes a-d and decreases by approximately 
half from lane d to lane e. This abrupt reduction parallels the reduction in the total DP 
levels from lanes d to e. These results suggest that DSC3 and PKP1 expression are 
differently affected by the DPI:DPII ratios. 
To further investigate whether it is the DPI:DPII ratio that influence DSC3 
expression levels rather than total DP levels, three additional replicate western blots 
were performed for DSC3 and PKP1 from HaCaT cells transfected with 2, 4 and 6 nM 
of siI (conditions b, c and d, Figures 5.4A and 5.4B). A representative western blot is 
shown in Figure C3 (Appendix C). Under these conditions, the total DP levels did not 
change significantly but the DPI:DPII ratios differed. Figure 5.4E shows protein levels 
of DSC3 and PKP1 (six western blots for each protein) under these conditions. A 
statistically significant difference in the levels of DSC3 is observed between conditions 
b and c and between b and d. However, the differences in PKP1 expression levels under 
these conditions are not statistically significant. These results suggest that DSC3 
expression levels are more influenced by the DPI:DPII ratios whereas the expression 








































































Figure 5.4. Variation of the DPI:DPII ratio has different effects on the expression 





















































































Figure 5.4. Variation of the DPI:DPII ratio has different effects on the expression levels of 















































Figure 5.4. Variation of the DPI:DPII ratio has different effects on the expression levels of 
DSC3 and PKP1. (A and C) Western blots of desmosomal proteins from total HaCaT cell 
lysates, four days after transfection with 0 (a), 2 (b), 4 (c) and 16 (d) nM of siI and 16nM siI + 5 
(e), 10 (f), 40 (g) and 100 (h) nM of siI/II. 140nM of NT pool (i) was used as negative control 
(A) DPI and DPII expression levels are shown. (B) Protein levels of DPI and DPII (n=3 blots) 
and of total DP (DPI+DPII) calculated from densitometry measurements (mean±SEM) and 
normalised to loading control. DPI and DPII levels are presented as a fraction of the DPI levels 
of NT cells (i). Total DP levels are presented as a fraction of DP levels of NT cells. (C) Protein 
levels of DSC3 and PKP1 are shown. Vinculin was used as loading control. (D) Protein levels 
(mean±SEM) of DSC3 (n=3 blots) and PKP1 (n=3 blots) normalized to the loading control and 
presented as a fraction of the respective NT control levels (i). (E) Representative western blot of 
HaCaT cells transfected with 2 (b), 4 (c) and 6 (d) nM of the siI pool. (F) Protein levels 
(mean±SEM) of DSC3 and PKP1 for conditions b, c and d (n=6 blots). Statistical significance 
between c or d and b following paired t-test: * (p<0.05). 
 
5.2.3. Influence of DSPI-nonsense and haploinsufficiency mutations in HaCaT 
intercellular adhesion 
The FX-4000T™ Cell Stretcher was used to investigate and compare the effects 
of mechanical stress in HaCaT cells transfected with siRNAs that mimic the DSPI-
nonsense and DP haploinsufficiency mutations. Optimisations of this adhesion assay 
were first performed (see section D1, Apendix D) in order to find experimental 
conditions where NT control cells showed some degree of mechanical stress but 
remained attached to the culture dish. Under these conditions, DP knock down cells 
were predicted to have more altered mechanical properties than wild type cells. 
Following these optimizations, siI and siI/II HaCaT cells (mimicking the DSPI-
nonsense mutation and the haploinsufficiency mutation, respectively) were subjected to 
mechanical stretch with a frequency of 2 Hz (i.e. two cycles of stretch and relaxation per 
second) and an elongation of amplitude ranging from 11% to 14% (i.e. increase in 
diameter across the silicone deformable membrane from 11% to 14%). Cells were 
*
*
Chapter 5 – Functional Studies 
 
 174
stretched for 30 minutes, one hour and two hours. Western blots of siI/II and siI HaCaT 
cell lysates were performed with a DP C-terminal antibody (11-5F) to confirm that 
knock-down of DPI/DPII and DPI, respectively, had been successfully achieved prior to 
the stretch assay. Figures 5.5A and 5.5B demonstrate down-regulation of DPI and DPII 
in siI/II cells (which mimic the haploinsufficiency mutation) and Figures 5.6A and 5.6B 
show knock-down of DPI in siI cells (which mimic the DSPI-nonsense mutation), both 
before and after two hours of mechanical stretch. 
Double immunocytochemistry of siI and siI/II cells was performed using 
antibodies raised against DPI (in green) and keratin 14, pan-cytokeratin, PG and 
DSG1/2 (in red) (Figures 5.5, 5.6 and D2, D3 and D4, Appendix D). DAPI stain was 
used to label the nuclei and care was taken to keep its intensity constant between control 
and knock down cells to reflect the same focal plane of cells across different conditions. 
However this was not possible at all times due to slight variability in DAPI staining 
across different samples. Before any stretch was applied (0h), NT control, siI and siI/II 
cells exhibited a normal network of keratin IFs (as shown by immunocytchemistry with 
keratin 14 and pan-cytokeratin antibodies) which extended from the nucleus to the cell 
periphery (Figures 5.5D, 5.5E and 5.6C). However, among some siI/II cells, widening 
of intercellular spaces were observed which were more pronounced in regions where 
there was no expression of DPI at cell-cell junctions (arrow heads, Figure 5.5D and 
5.5E). Keratin IFs appeared slightly thicker and IF attachment appeared stronger in 
regions where DPI expression levels were higher. Despite the wider intercellular spaces 
and loosening of IF attachment, these cells still appeared connected to each other 
through intercellular junctions (Figure 5.5D and 5.5E). 
Following a 30-minute-stretch, NT cells had slightly thicker and more compact 
keratin 14 IFs, particular around the nucleus (arrows, Figure 5.5D). These thicker IFs 
were more prominent in the perinuclear region of siI/II cells (arrows, Figure 5.5D). 
However, close to the cell membrane of siI/II cells keratin IFs were thinner, particularly 
along free edges (arrow head, Figure 5.5D). In contrast with NT cells, wider 
intercellular spaces were observed among these cells, particularly in regions where DPI 
was absent (arrow head, Figure 5.5D). 
After a one-hour-stretch, NT cells showed thickening of the keratin 14 IFs which 
were denser around the nuclei (arrow, Figures 5.5D) and the DPI puncta at cell-cell 
contacts became elongated (arrow, Figure 5.5C). There was no longer a homogenous 
network of keratin IFs from the membrane to the nucleus of NT cells. These changes in 
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the keratin IF network were more prominent after two hours of stretch (arrows, Figures 
5.5D and 5.5E). In contrast with NT cells, although some siI/II cells still showed thick 
IFs, most siI/II cells had IFs that appeared thinner and more fragile (Figure 5.5E) and in 
some cases even deformed and retracted towards the nucleus (arrow, Figure 5.5D). 
Large intercellular gaps were observed among some cells, particularly after two hours 
of stretch (arrow heads, Figure 5.5D and Figure D2B, Appendix D). 
These results suggest that in contrast with NT cells which showed thickening of 
keratin IFs with increased exposure to mechanical stretch, siI/II cells exhibited thinner 
and more fragile filaments and wider intercellular spaces. These observations were 
prominent in siI/II cells that express lower levels of DPI. 
Before stretch (0h), NT cells showed continuous immunofluorescence staining 
around the cell membrane with a PG antibody. In contrast, siI/II cells showed some 
discontinuous peripheral PG staining, mostly in regions with reduced DPI expression 
(arrows, Figure 5.5F). Following one and two hours of stretch, siI/II cells showed loss 
of cell-cell contacts (arrow heads, Figures 5.5E and 5.5F) and PG staining was only 
present at the less frequent sites of cell-cell adhesion (arrow, Figure 5.5F and Figure D3, 
Appendix D). A slight increase in intracellular PG staining was also observed in some 
siI/II cells compared to NT cells, predominantly following two hours of mechanical 
stretch (Figure 5.5F). 
No major differences in DSG1/2 staining were observed between NT and siI/II 
cells either before or after stretch. These desmosomal cadherins remained associated 
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Figure 5.5. Mechanical stress causes reduced cell-cell adhesion in siI/II HaCaT cells. 
HaCaT cells transfected with a pool of four non-targeting siRNAs (NT control cells) and a 
siRNA which targets both DSPI and DSPII (siI/II) were subject to cyclic mechanical stress of 
frequency 2 Hz and amplitude 11-14% using the Flexcell FX-4000 Tension System for 0h 
(unstretched), 30 min, 1h and 2h. (A) Western blot of total proteins from NT and siI/II cells 
following 0h and 2h of stretch with a DP antibody (11-5F) that recognises both DPI (332KDa) 
and DPII (260KDa) shows reduction of DP levels in siI/II cells compared to NT control cells. 
Immunocytochemistry of NT and siI/II cells with 11-5F DP antibody (B) shows decrease in DP 
staining in siI/II cells compared to NT cells. Scale bar = 50µm. (C) Double 
immunocytochemistry of NT cells with antibodies against DPI (green) and keratin 14 (red) 
shows elongation of DP puncta along intercellular junctions (arrow) after 1h of stretch. Scale 
bar = 10 µm. Double immunocytochemistry of NT and siI/II cells with antibodies against DPI 
(green) and keratin 14 (red) before (0h) and after 30 min, 1h and 2h of stretch (D) and with 
antibodies against DPI (green) and pan-cytokeratin (red) (E) and DPI (green) and PG (red) (F) 
before and after 2h of stretch. siI/II cells show decrease of cell-cell adhesion with widening of 
intercellular spaces between keratinocytes following 2h of mechanical stress. Scale bar = 5µm. 
 
Less evident morphological changes were displayed by siI cells (compared to 
NT cells) than siI/II cells following mechanical stretch (Figure D2A, Appendix D). 
Similarly to NT cells, thickening of keratin IFs was observed following one and two 
hours of stretch (Figure 5.6C). However, while siI/II cells showed thinner and more 
fragile IFs particularly along free edges after two hours of stretch, this was not observed 
in siI cells. Equally, although some widening of intercellular spaces was observed after 
one and two hours of stretch, these were less frequently seen than in siI/II cells (arrow 
heads, Figure 5.6 and Figure D2A, Appendix D). 
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Figure 5.6. Mechanical stress causes reduced cell-cell adhesion in siI HaCaT cells. HaCaT 
cells transfected with a pool of four non-targeting siRNAs (NT control cells) and a pool of three 
siRNA which target DSPI and DSPIb (siI) were subject to cyclic mechanical stress of frequency 
2 Hz and amplitude 11-14% using the Flexcell FX-4000 Tension System for 0h (unstretched) 
and 2h. (A) Western blot of total proteins from NT and siI cells following 0h and 2h of stretch 
with a DP antibody (11-5F) that recognises both DPI (332KDa) and DPII (260KDa). 
Immunocytochemistry of NT and siI cells with a DPI-specific antibody (B) shows decrease in 
DP staining in siI cells compared to NT control cells. Scale bar = 25 µm. Double 
immunocytochemistry of NT and siI cells with antibodies against DPI (green) and pan-
cytokeratin (red) (C) and with antibodies against DPI (green) and PG (red) (D) before and after 
2h of stretch. siI transfected cells show decrease in cell-cell adhesion however to a lesser extent 
compared to siI/II transfected cells. Scale bar = 5µm. 
 
Chapter 5 – Functional Studies 
 
 179
PG staining revealed a slight increase in cytoplasmic staining in siI cells 
compared to NT cells before stretch. This was progressively more evident in cells 
stretched for one and two hours, where cytoplasmic aggregates reactive with the PG 
antibody were observed (arrows, Figure 5.6D). 
No obvious differences in localisation of the desmosomal proteins DSC2, DSC3, 
PKP2 and PKP3 and of the adherens junction proteins E-cadherin and β-catenin were 
observed among siI, siI/II cells and NT cells, either before or after mechanical stretch 
(data not shown). 
Overall, these results suggest that the adhesive properties of desmosomes with 
approximately 50% of DPI and DPII (which mimic desmosomes with DP 
haploinsufficiency) are more impaired than those of desmosomes with DPI down-
regulation (which mimic the DSPI-nonsense mutation). 
 
5.2.4. Over-expression of recombinant I608ins10-DPI in HaCaT keratinocytes to 
mimic the DSP 30 bp-insertion mutation 
 
5.2.4.1. Generation of wild type- and I608ins10-DSPI-flag expressing stable cell lines 
HaCaT cells were transduced with virus containing pBabe-DSPI-flag, pBabe-
I608ins10-DSPI-flag or pBabe-GFP control plasmid. The generation of the constructs as 
well as transduction conditions are described in Chapter 2. Recombinant DP protein 
expression was assessed by western blot using an antibody raised against the flag tag 
epitope (Table 2.7). As expected, flag tagged-DPI was observed in HaCaT cells 
transduced with pBabe-DSPI-flag and pBabe-I608ins10-DSPI-flag, but not in cells 
transduced with the pBabe-GFP control plasmid. Wild type HaCaT total lysates were 
also immunoblotted with the C-terminal DP antibody (11-5F) for comparison (Figure 
5.7). 
 




Figure 5.7. Recombinant DPI-flag and I608ins10-DPI-flag protein expression in HaCaT 
cells. Western blot of total lysates from HaCaT cells transduced with pBabe-GFP (lane 1), 
pBabe-DSPI-flag (lane 2) and pBabe-I608ins10-DSPI-flag (lane 3) constructs with an anti-flag 
antibody and wild type HaCaT cells with the 11-5F C-terminal DP antibody (lane 4). Flag 
tagged-DPI (~332 KDa) is observed in lanes 2 and 3 but not in lane 1, as expected. DPII 
(~260KDa) is observed only in wild type cells. Vinculin (117 KDa) was used as loading control. 
Lanes 2 and 3 express also an immunoreactive band shorter than DPI at a much lower level 
which resembles the putative DPIa protein referred to in Chapter 4 seen in most western blots 
immediately below DPI (Figures 4.7B, 4.10C, 4.10D and 4.12). As these cell lysates were 
immunoblotted with a flag antibody, the faint immunoreactive band cannot be a splice variant 
other then flag-tagged DPI. These results suggest that this faint band (and possibly DPIa) is 
either a western blot artefact, or a breakdown product of DPI.  
 
5.2.5. Immunocytochemistry of wild type and I608ins10 mutant DPI in HaCaT 
cells 
Immunocytochemistry of HaCaT cells transduced with pBabe-DSPI-flag, 
pBabe-I608ins10-DSPI-flag and pBabe-GFP control vector was performed to 
investigate the cellular localisation of wild type and I608ins10 mutant flag tagged-DPI 
proteins. As expected, GFP expressing control cells showed no reactivity with the anti-
flag antibody. DPI-flag expressing cells show punctuate staining at the cell membrane, 
characteristic of DP proteins. In contrast, I608ins10-DPI-flag expressing cells show 





















Figure 5.8. I608ins10-DPI-Flag proteins form large aggregates in HaCaT cells. 
Immunocytochemistry of HaCaT cells transduced with a pBabe-GFP control vector, pBabe-
DSPI-flag and pBabe-I608ins10-DSPI-flag with an anti-flag primary antibody and a secondary 
antibody conjugated to Alexa Fluor 488 (green) (A) or 568 (red) (B). GFP expressing cells show 
no reactivity with the flag antibody, wild type DPI-expressing cells show punctate membranous 
flag staining characteristic of DP proteins and I608ins10-DPI-expressing cells show large 
aggregates at the cell membrane. Scale bar = 20µm. 
 
5.2.6. Effect of the I608ins10 DSP insertion mutation in intercellular adhesion 
The Flexcell adhesion assay was used to investigate whether I608ins10-DPI 
recombinant proteins influence HaCaT intercellular adhesion. This assay was performed 
under the conditions described in section 5.2.3 for zero hours (before stretch) and two 
hours. HaCaT cells over-expressing wild type DPI-flag or I608ins10-DPI-flag were 
subject to double immunocytochemistry with DP (11-5F) or pan-cytokeratin (green) and 
flag (red) antibodies (Figure 5.9).  
Double immunocytochemistry with DP and flag antibodies showed that 
junctional endogenous DP (green) and recombinant wild type DPI-flag (red) co-localise 
(Figure 5.9). This result indicates that recombinant flag-tagged DPI proteins localise to 
desmosomes similarly to endogenous DPI. I608ins10-DPI-flag aggregates also localise 
to the cell membrane. This result suggests that these large mutant DPI aggregates are 
still able to traffic to the cell membrane. 
Double immunocytochemistry with flag and pan-cytokeratin antibodies revealed 
that the I608ins10-DPI-flag aggregates are still able to co-localise with keratin IFs at 
intercellular junctions (Figure 5.9). Although the keratin IFs appeared slightly thicker 
following two hours of physical stretch, no major differences were observed between 
DPI-flag and I608ins10-DPI-flag expressing cells (Figure 5.9). These results suggest 
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Figure 5.9. I608ins10-DPI-Flag proteins do not appear to influence HaCaT cell-cell 
adhesion. HaCaT cells over-expresisng DPI-flag and I608ins10-DPI-flag proteins were subject 
to cyclic mechanical stress of frequency 2 Hz and amplitude 11-14% using the Flexcell FX-
4000 Tension System for 0h (unstretched) and 2h. Double immunocytochemistry of these cells 
with antibodies raised against DP (11-5F, green) and flag (red) and with antibodies raised 
against flag (red) and pan-cytokeratin (green) show that large I608ins10-DPI-flag aggregates are 
cell membrane bound and co-localise with keratin IFs. I608ins10 mutant DPI proteins do not 
appear to influence HaCaT intercellular adhesion. Scale bar = 20µm. 
 
5.2.7. Overview of the effects of the DSP mutations studied on HaCaT 
keratinocytes 
Table 5.1 summarises the changes observed in the expression levels of 
desmosomal associated proteins and in HaCaT mechanical properties in cells expressing 




Table 5.1. Summary of the effects of three DSP mutations; DSPI-nonsense mutation, DP haploinsufficiency and 30 bp-insertion mutation, modeled in 
HaCaT keratinocytes. 
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*The DSPI-specific nonsense mutation (p.R1267X) modeled by down-regulation of DPI, and the DP haploinsufficiency mutations modeled by partial down-
regulation of DPI/DPII in HaCaT cells result in decreased expression of PKP1 and DSC2 (↓). Down-regulation of DPI results in a higher reduction of DSC3 protein 
levels (↓↓) compared to those of DSC2 (↓). The haploinsufficiency mutation causes reduction in HaCaT intercellular adhesion to a higher extent (↓↓) than the DSPI-
specific nonsense mutation (↓). Both mutations cause increase in cytoplasm localisation of PG. The insertion mutation modelled by over-expression of a DPI-








The focus of this chapter was to investigate the mechanisms by which DPI and 
DPII contribute to tissue architecture and normal function, by studying the role of three 
different types of DSP mutations associated with skin and heart disease. 
Over the past 13 years, an increasing number of monogenic diseases that are 
caused by mutations in genes encoding desmosomal proteins have been revealed. 
Although the genetic defects leading to these diseases are known, the molecular 
pathogenic mechanisms are, for the most part, not completely understood. There are still 
a large number of difficult questions that remain unanswered. Firstly, it is not clear why 
mutations in DSP can give rise to different clinical presentations in patients. Some DSP 
mutations are restricted to skin, others affect only the heart and some other mutations 
result in a combination of skin and heart disease (Figure 1.8). Additionally, varying 
degrees of severity are observed in skin and heart manifestations depending on the type 
of mutation. Secondly, another complicated issue is the lack of correlation between the 
functional domain of DP encoded by the region where the mutation occurs and the 
resulting clinical outcome. For instance, mutations in regions encoding the central rod 
domain as well as the N- and C-terminal domains can lead to ARVC, whereas mutations 
in regions coding for the N-terminus of the protein can cause skin disease only, a 
combination of skin and hair abnormalities and also a combination of skin, hair and 
heart disease. Thirdly, it is interesting that mutations in different genes can result in 
similar phenotypes, suggesting that different desmosomal proteins have overlapping 
functions and may be involved in overlapping pathways. A fourth question that 
prompted the work described here is whether the different DP splice variants have 
different adhesion and/or signalling properties and whether DPI:DPII ratios influence 
normal desmosome function. 
 
5.3.1. Clinical and histopathological manifestations of DSPI-nonsense, DSP 
haploinsufficiency, and DSP insertion mutations 
The first two types of DSP mutations studied in this chapter include a 
haploinsufficiency mutation effecting both DPI and DPII and a homozygous DSPI-
specific nonsense mutation (p.R1267X) leading to loss of the DPI splice variant. The 
haploinsufficiency mutations resulted in a more severe SPPK while the DSPI-nonsense 
mutation caused a relatively mild EPPK (Armstrong et al., 1999; Uzumcu et al., 2006; 
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Whittock et al., 1999). Additionally, in contrast with the haploinsufficiency mutants, the 
DSPI-specific nonsense mutation led also to a very severe heart condition with early 
onset and rapid progression which resulted in death of this patient at four years of age 
(Uzumcu et al., 2006). 
Previous reports have described histopathological features of SPPK lesional skin 
in patients with the DSP haploinsufficiency (Armstrong et al., 1999; Wan et al., 2004; 
Whittock et al., 1999). Histological analyses revealed thickening of the epidermis and 
impaired cell-cell adhesion, with widening of intercellular spaces in suprabasal layers. 
Immunofluorescence microscopy of these patients’ epidermis showed reduced 
expression and abnormal localisation of PKP1 in the spinous layer. DSC1 and DSC3 
expression levels were also markedly reduced, particularly in the spinous layer. 
Ultrastructural analysis of spinous layers revealed reduced cell-cell contacts and 
desmosomes with variable morphological appearances. In some regions, connections 
between keratinocytes were maintained by rudimentary desmosomes that displayed 
underdeveloped cytoplasmic plaques and lack of association with the IF network, which 
appeared retracted towards the nucleus. In other regions where keratinocytes remained 
closely connected, desmosomes had a normal appearance both in size and structure, 
with well developed cytoplasmic plaques, clear electron dense midlines and insertion of 
IFs. In some regions an abnormal clustering of normal as well as less electron dense, 
underdeveloped desmosomes was also observed. The number of desmosomes was 
shown by morphometric analysis to be significantly reduced in suprabasal layers and 
this phenomenon was observed both in lesional and non-lesional SPPK epidermis 
(Armstrong et al., 1999; Wan et al., 2004; Whittock et al., 1999). 
Skin immunohistochemistry of the patient with the DSPI-specific nonsense 
mutation revealed complete absence of DPI but apparently normal expression and 
localisation of DPII, PG and keratin 1. The structural appearance of this non-lesional 
epidermis appeared normal; however no ultrastructural analysis was performed on this 
patient’s skin. Therefore, changes in desmosome ultrastructure, size, number or 
distribution might be present, as seen in the epidermis of patients with DSP 
haploinsufficiency mutations. 
The third DSP mutation studied in this chapter was a dominant insertion of 30 
bp in the region encoding the N-terminus of DP. The patient harbouring this mutation 
had SPPK accompanied by hyperkeratosis on the knees, elbows, shins and ankles, and 
absent molars and pre-molars. The patient also had a very severe bi-ventricular 
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cardiomyopathy which resulted in heart failure at the age of 18. Immunofluorescence 
microscopy of patient epidermis revealed a discontinuous distribution of DP and PG 
around the cell membrane with some cytoplasmic localisation, particularly in the lower 
layers of the epidermis. Keratin 1 staining in the patient skin was comparable to that of 
normal skin, showing only a slight decrease in expression levels and desmosomal 
attachment in the lower regions of the epidermis (Norgett et al., 2006). 
Taken together, these observations suggest different molecular mechanisms and 
clinical outcomes for these three types of DSP mutations. 
 
5.3.2. DP down-regulation results in decreased expression levels of PKP1, DSC2 
and DSC3 
Previous reports have shown down-regulation of desmosomal components in 
HaCaT cells upon DPI/DPII knock-down and in primary keratinocytes derived from 
SPPK skin (Wan et al., 2004; Wan et al., 2007). The first question of this chapter was 
whether down-regulation of DSPI (without targeting DSPII) would cause similar effects 
on HaCaT cells. This experiment was performed not only to study the DSPI-specific 
loss of function mutation, but also to gain further insight into the functional significance 
of the DPII splice variant. 
In a previous study, western blotting and densitometry analysis of total lysates 
from primary keratinocytes derived from SPPK lesional skin revealed reduced 
expression levels of DPI and DPII. DPI expression was reduced to a higher extent than 
DPII compared to control cells (Wan et al., 2004). Here, DPI expression levels were 
reduced to 55% and DPII expression levels to 18% in siI/II HaCaT cells compared to 
NT control cells (Figure 5.3A). Despite the difference between DPI:DPII ratios 
observed in HaCaT cells here (4:1) and in the previous report in primary SPPK 
keratinocytes (approximately 1:3; Wan et al., 2004), a significant reduction in PKP1 
and DSC3 expression was observed; 41% and 55% in HaCaT cells (Figure 5.3B) and 
56% and 17% in keratinocytes derived from SPPK skin, respectively (Wan et al., 2004). 
These results suggest that independently of the DPI:DPII ratios, reduction of total DP 
expression levels results in decreased expression of PKP1, DSC2 and DSC3. This trend 
is also observed when siI (DSPI knock-down) and siI/II (DSPI and DSPII knock-down) 
HaCaT cells, which have different DPI:DPII ratios (Figure 5.3A), are compared. Cells 
with DPI:DPII ratios of 1:8 (siI cells) and 4:1 (siI/II cells) show significantly reduced 
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expression levels of PKP1 (42% and 41%, respectively) and DSC3 (37% and 55%, 
respectively).  
As mentioned above, Wan et al.(2007) have investigated the expression levels of 
desmosomal proteins in HaCaT cells following DP down-regulation with the same 
siRNA that was used here (siI/II). In this study, reduced expression levels of DSG1/2, 
DSC2/3 and PKP1/3 were observed. Reduced levels of DSC2/3 and PKP1 were also 
observed here in agreement with this study. However, in contrast with the report by 
Wan et al.(2007), no changes in expression levels of PKP3 or DSG3 were observed in 
any of the two independent knock-down experiments, and DSG2 expression was 
reduced in one experiment but not in the other (see Appendix C). The reason for this 
discrepancy is unclear, but might be related to the efficiency of DP down-regulation or 
to the number of replicate western blots performed in each case. In Wan et al.(2007) the 
levels of PKP2 expression were slightly reduced in siI/II cells compared to control cells; 
however these changes were not statistically significant. Here, the levels of PKP2 were 
unchanged between siI/II and NT cells in both siRNA independent experiments. Despite 
this variability, the results obtained here and elsewhere (Wan et al., 2007) for the levels 
of expression of DSC2, DSC3 and PKP1 upon DPI/DPII down-regulation were 
consistent observations. 
 
5.3.3. Influence of the DPI:DPII ratios on expression levels of PKP1 and DSC3 
A reduction in expression levels of PKP1, DSC2 and DSC3 is observed upon DP 
knock-down (both in siI and siI/II cells). However, comparison between siI and siI/II 
cells revealed that, in contrast with PKP1, DSC3 expression is influenced by the 
DPI:DPII ratios. This result is shown by the statistically significant difference in DSC3 
expression levels between siI cells (37%) and siI/II cells (55%) (p<0.05, Figure 5.3B). 
This increase in DSC3 expression levels from siI to siI/II cells occurs even though total 
DP levels are higher in siI than in siI/II cells, suggesting that DPI has more influence 
than DPII in regulating the levels of expression of DSC3. The fact that PKP1, DSC2 
and DSC3 are down-regulated to some extent upon DP knock-down independently of 
the DPI:DPII ratio suggests that DPII can compensate partially but not totally for the 
lack of DPI.  
To confirm these results, HaCaT cells expressing a gradient of decreasing levels 
of DPI and constant levels of DPII, as well as decreasing levels of DPII with constant 
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levels of DPI were generated (Figure 5.4A). Under these conditions, the expression 
profiles of PKP1 and DSC3 were considerably different. The DSC3 expression profile 
showed a trend that was similar to that of DPI, whereas the trend shown by the PKP1 
expression profile was more similar to that of total DP (Figure 5.4B and 5.4D). These 
trends were confirmed by performing three additional replicate western blots for 
conditions b, c and d (Figure 5.4E), which correspond to DPI:DPII ratios of 
approximately 1:2, 1:3 and 1:15, respectively. Under these conditions, PKP1 expression 
does not vary significantly whereas DSC3 expression levels significantly decrease when 
the DPI:DPII ratio decreases. 
It is not clear why down-regulation of DP leads to decreased expression of 
PKP1, DSC2 and DSC3 but not PKP2, PKP3, DSG3 or PG (Figures C1 and C2, 
Appendix C). However, it is interesting that down-regulation of PKP1 and DSC3 was 
also observed in cultured primary keratinocytes of DP-associated SPPK (Wan et al., 
2004). The effect of DP haploinsufficiency on the expression levels of DSC2 was not 
investigated in this previous study (Wan et al., 2004). No detectable differences were 
observed in protein levels of PG and DSG3 between cultured primary keratinocytes of 
DP-associated SPPK and normal keratinocytes (Wan et al., 2007). Overall, these results 
are consistent with the results obtained here. 
Loss of function mutations in the gene encoding PKP1 have been shown to 
cause ectodermal dysplasia-skin fragility syndrome (sections 1.7.2 and 3.3.1.2), 
characterised by severe skin fragility and blistering, thickening of palmoplantar 
epidermis and abnormalities of hair development (Lai-Cheong et al., 2007). Although 
patients harboring DSP haploinsufficiency mutations or the DSPI-nonsense mutation do 
not present with skin fragility and blistering, skin disease involving PPK is a common 
feature of all these patients. These observations suggest that overlapping roles might 
exist between DP and PKP1 in the skin, involved in normal skin architecture and 
perhaps in the maintenance of the balance between proliferation and differentiation of 
epidermal keratinocytes. The fact that interactions between PKP1a and DPI have been 
identified in HaCaT cells (Hofmann et al., 2000) supports this hypothesis. Recently, a 
homozygous single bp deletion in the gene encoding DSC2 has been reported, causing 
PPK, woolly hair and ARVC (Simpson et al., 2009). This phenotype is similar to the 
one caused by the DSPI-nonsense mutation. DSC2 and DP might, therefore, also be 
involved in common pathways which, when disrupted, result in similar clinical 
outcomes. Although no direct interactions between these two proteins have been 
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reported, they co-localise within the desmosome and are linked via PG and PKPs. 
Another report described a heterozygous splice site mutation in the gene encoding 
DSC2, causing non-syndromic ARVC due to the loss of protein synthesis from the 
mutant allele (Heuser et al., 2006). These results suggest that the dose of DSC2 is 
important for normal cardiac function, but not for normal skin function, as this patient 
did not have cutaneous abnormalities (Bolling & Jonkman, 2009; Heuser et al., 2006). 
However, it is interesting that both the haploinsufficiency and DSPI-nonsense mutations 
studied here caused reduced expression of DSC2 in HaCaT keratinocytes and resulted in 
skin disease, in contrast with the patient with a DSC2 mutation. Recently, the first 
mutation in the gene encoding DSC3 was reported. This is a homozygous nonsense 
mutation causing hair loss and the development of skin vesicles (Ayub et al., 2009). The 
skin phenotype of these patients appears more severe then the skin phenotype of the 
patients described here, possibly because of complete loss of DSC3 expression in the 
skin due to NMD. However, loss of DSC3 synthesis in these patients was not confirmed 
(Ayub et al., 2009).  
Overall, these results suggest that the mechanisms leading to cardio-cutaneous 
disease might not always be straightforward and a combination of factors might 
influence the resulting clinical phenotype. Desmosomal proteins have functions in 
common but probably also diverging functions which might partially overlap with those 
of direct or indirect binding partners. 
 
5.3.4. Influence of DPI and DPII in HaCaT intercellular adhesion 
The Flexcell adhesion assay revealed some interesting adhesion properties and 
responses to mechanical stress of normal, siI and siI/II HaCaT cells. 
In response to cyclic mechanical stretch in this experimental situation, normal 
HaCaT cells exhibit thickening and wrinkling of its keratin IFs and condensation of 
bundles, particularly in perinuclear regions. Additionally, DPI puncta at the cell 
membrane became elongated suggesting that desmosomes impart some level of 
elasticity and resilience to the cells which involves at least DPI. Following two hours of 
mechanical stretch these cells no longer show a normal homogenous network of IFs as 
seen in unstretched cells. This effect is also observed in siI cells following one and two 
hours of cyclic stretch. Although some siI/II cells also exhibit thickening of keratin IFs 
around the nucleus, close to the cell membrane these filaments are thinner and appear 
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more fragile particularly along free edges. These results suggest that the position of cells 
within a colony might influence the extent or speed with which cells are affected by the 
mechanical impact. Deformation and retraction of thin keratin IFs in siI/II cells is 
prominent after two hours of stretch, especially in regions where no junctional DPI is 
observed, and coincides with increased intercellular gaps among these cells. 
These results suggest, firstly, an important role for keratin IFs in maintenance of 
structural support and stress resilience in these cells. These cytoskeletal filaments have 
the ability to reorganise during cycles of stretch and relaxation to better absorb physical 
stress. Secondly, as DP is the protein primarily responsible for anchorage of the keratin 
IF cytoskeleton to the cell membrane, it is not surprising that when DP expression levels 
are lower, the keratin IF attachment to the desmosome might be less strong, leading 
eventually to IF deformation and retraction when the levels of physical stress are above 
a certain threshold. This is probably the reason why areas where desmosomes lack or 
have reduced levels of DP are more prone to adhesion defects. The IF network of one 
cell is connected to IF networks of many other cells through desmosomes. If part of this 
chain is broken or weakened, as in the case of weakened IF-desmosome connections, 
then desmosomal connections between cells might also be weakened resulting 
eventually in loss of cell-cell adhesion.  
Two other studies support these ideas. In one, keratinocyte cell lines expressing 
a keratin 14 mutation that causes epidermolysis bullosa simplex were exposed to 
repeated stretch and relaxation cycles using the Flexcell system (Russell et al., 2004). 
Although the stretch conditions and cell lines in this study were different, these authors 
observed some cellular responses which resemble the ones observed here. First, normal 
cells after mechanical stretch showed thickening and compaction of keratin IFs. Second, 
keratin mutant cells showed IFs that were unable to withstand the levels of mechanical 
stretch used, and thus collapsed and fragmented. As a consequence, cell junctions 
started disassembling. In a similar way, the mutations in DSP studied here lead to 
decreased levels of DP which cause weakened IF-desmosome attachment resulting in 
decreased cell-cell adhesion. It is possible therefore, as suggested by (Russell et al., 
2004), that loss of IF tension is the driving force for desmosome disassembly because of 
its importance in maintaining desmosomal junctions. Norgett et al. (2000) also support 
this idea by showing that a recessive mutation in the C-terminus of DP which 
compromises IF attachment leads to loss of cell-cell adhesion and large intercellular 
spaces among keratinocytes. 
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It is not clear why cells with down-regulation of DPI (siI cells) showed less 
adhesion defects than cells with DPI/DPII haploinsufficiency (siI/II cells). These trends 
are simply qualitative, as no quantification of cells with loss of contacts with other cells 
was performed. However, these trends resemble some aspects of the in vivo phenotypes 
of patients harbouring these mutations. In particular, IFs that are unable to withstand 
mechanical stress and show condensation and retraction towards the nucleus as well as 
widening of intercellular spaces and loss of cell-cell adhesion are characteristic of SPPK 
epidermis (see section 5.1.1) (Armstrong et al., 1999; Wan et al., 2004; Whittock et al., 
1999; Whittock et al., 2000). The patient harbouring the DSPI-nonsense mutation 
presents with a less severe keratoderma than the patients with DP haploinsufficiency. 
Both phenotypes are prominent in palms and soles, suggesting they are observed only in 
sites of pressure or abrasion. This probably explains why siI and siI/II cells only showed 
a phenotype when induced by mechanical stretch. 
Immunocytochemistry of HaCaT siI and siI/II cells before and after stretch was 
also performed with antibodies against PG, and DSG1/2. PG staining in stretched siI/II 
cells was only observed at the cell membrane in regions where cells were still connected 
and a slight increase in cytoplasmic staining was observed in these cells. It is possible 
that PG stays attached to IFs when these retract towards the nucleus after mechanical 
stretch. No major differences in PG staining were observed between siI and NT cells, 
suggesting that IF detachment in these cells was not enough to cause PG re-localisation. 
These results contrast with data from (Garcia-Gras et al., 2006) who have shown that 
siRNA down-regulation of DP in atrial cardiomyocyte cell lines causes PG re-
localisation to the nucleus, which subsequently leads to increased expression of 
adipogenic and fibrogenic genes. PG was not observed in the nucleus of siI or siI/II 
keratinocytes, suggesting different roles for DP in keratinocytes and cardiomyocytes. 
These differences might be related to the different environments these different types of 
cells are exposed to, or to the different types of mechanical stress perhaps leading to 
activation of different signalling pathways. DSG1/2 staining was similar in siI, siI/II and 
NT cells before and after stretch, suggesting that DSGs stay associated with 
desmosomes (or half-desmosomes) after exposure to mechanical stress. 
 
5.3.5. I608ins10 mutant DPI forms abnormal aggregates at the cell membrane 
Immunocytochemistry of HaCaT cells over-expressing I608ins10 mutant, flag 
tagged-DPI proteins using an anti-flag antibody revealed the presence of atypical 
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aggregates that localised to the cell membrane. The molecular composition of these 
aggregates is unknown. It would have been interesting to perform double 
immunocytochemistry in these cells using a flag antibody in conjunction with 
antibodies targeting PG, PKP 2/3 or DSGs/DSCs to investigate whether these proteins 
co-localise with mutant DPI proteins, but time did not permit these experiments. The 
DPI aggregates formed by the mutant proteins in HaCaT keratinocytes resemble 
observations from in vivo skin of the patient harbouring this mutation, which include 
discontinuous membranous staining for DP and PG (Norgett et al., 2006). These 
observations suggest that PG co-localises with mutant DP proteins, but further studies 
are needed to clarify this. 
I608ins10 results in the insertion of 10 new amino acids into the N-terminus of 
DPI and DPII. Although the N-terminal domain of DP is involved in interactions with 
PG and the PKPs, the DP binding sites for these proteins lie within the first 584 amino 
acids. As the mutation affects the region just downstream of the stretch encoding the 
first 584 amino acids, mutant DPI might still be able to interact with PG and the PKPs. 
Likewise, the mutation might result in a conformational change that prevents DP from 
interacting with some of its binding partners or it may generate new binding sites for 
additional binding partners. 
I608ins10 mutant DPI was shown to retain the ability to co-localise with keratin 
IFs at the cell membrane. This is not surprising as the amino acids that are necessary for 
IF binding lie within the C-terminus of DP (Green & Hobbs, 2006). Additionally, 
supporting these results, keratin 1 staining in the skin of the patient harbouring this 
mutation was comparable to normal skin. No major adhesion defects were observed in 
HaCaT cells over-expressing these mutant DPI proteins (Norgett et al., 2006). Likewise, 
no loss of cell-cell contacts was seen in the skin of this patient. Nevertheless, 
immunohistochemistry was only performed in this patient’s non-lesional skin and it is 
possible that adhesion defects occur when the skin is exposed to mechanical stress. The 
results shown here in mutant HaCaT cells exposed to cyclic stretch suggest, however, 
that the main defects caused by this mutation are not structural defects leading to loss of 
desmosomal cell-cell adhesion. Further studies will be necessary to understand the 
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5.3.6. Insights into the functional significance of DPI and DPII in skin and heart 
Both the DSPI-specific nonsense mutation (p.R1267X) and the DSP 
haploinsufficiency mutations affect the skin, but only the former leads to heart disease. 
The reason for this is probably because the DPII splice variant is virtually absent in the 
heart (see Chapter 4; Uzumcu et al., 2006) and hence cannot compensate for the lack of 
DPI, as probably occurs to some extent in the skin. Therefore, as p.R1267X results in 
complete absence of DPI likely through activation of the NMD pathway, assuming this 
also occurs in the heart, this patient will have very low levels of DP. This said, it is 
interesting that this patient survived until four years of age in contrast with what is seen 
in DP knock-out mice which die before birth (Gallicano et al., 1998). These 
observations suggest pathophysiological differences between humans and mice.  
The functional studies performed with these mutations suggest that they affect 
the skin by causing reduced inter-keratinocyte adhesion due to a dosage defect of DP 
splice variants. This was particularly prominent in cells with DSP haploinsufficiency. 
Although the DPI:DPII ratios in DP haploinsufficient cells are predicted to be similar to 
those of wild type cells, the total amount of DP does not seem to be enough to maintain 
normal skin function, in particular in palms and soles which are areas subject to 
constant physical assaults. This amount of DP seems to be enough, however, for normal 
heart function. The observation that p.R1267X still affects the skin, although 100% of 
DPII is still expressed in this tissue, suggests that compensation of DPII for the lack of 
DPI is only partial. Both these mutations resulted in decreased expression levels of 
some desmosomal components, DSC3, DSC2 and PKP1, and decreased cell-cell 
adhesion, in agreement with observations in SPPK skin (Wan et al., 2004). The 
difference in DSC3 expression levels between siI and siI/II cells suggests that the 
different DP splice variants might have some specific functions that are not redundant 
and cannot be completely compensated for by another splice variant. The fact that DPII 
cannot totally compensate for the lack of DPI in the patient with the DSPI-nonsense 
mutation supports this hypothesis. 
In contrast with the previous mutations, the dominant insertion mutation 
(I608ins10) does not seem to cause adhesion defects in keratinocytes, as suggested by in 
vitro (here) and in vivo (Norgett et al., 2006) studies. This mutation affects the N-
terminus of the DP protein and interactions with PKPs or PG, which are involved in 
targeting DP to the desmosomal plaque, might be affected. Further studies will be 
necessary to unveil the pathogenic mechanism of this mutation. However, the fact that it 
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causes a very severe heart disease suggests that it affects interactions with DP binding 
partners in the heart. The observation of bright membranous aggregates in cells 
expressing this mutant, which are still able to co-localise with keratin IFs at the cell 
membrane suggests a dominant negative effect. Table 5.1 summarises the effects of the 
three modelled DSP mutations in HaCaT keratinocytes. 
 
5.4. Summary 
In this chapter, the functional consequences of three different types of DSP 
mutations causing PPK associated or not with cardiomyopathy were studied in HaCaT 
keratinocytes and compared with each other (Table 5.1).  
Mutations causing DP haploinsufficiency (modelled in siI/II cells) and DPI 
down-regulation (DSPI-nonsense mutation modelled in siI cells) were found to result in 
decreased expression levels of PKP1, DSC2 and DSC3 in this experimental system, as 
previously observed in keratinocytes derived from SPPK skin. Significant differences in 
DSC3 expression levels were observed between siI and siI/II cells, suggesting that DPI 
and DPII have different influences in DSC3 expression. Besides DPI and DPII common 
(redundant) functions, there might be isoform-specific functions which may account for 
the phenotypic variation of DSP mutations. Both haploinsufficiency and nonsense 
mutations resulted in decreased HaCaT cell-cell adhesion, as shown with the Flexcell 
adhesion assay, which was however more pronounced in DP haploinsufficient cells, 
consistent with previous in vivo observations. 
Over-expression of recombinant DPI harbouring a 30 bp insertion mutation, 
I608ins10, in HaCaT cells resulted in the formation of large junctional aggregates, not 
observed in wild type DPI over-expressing cells. No adhesion defects were observed in 
cells expressing this insertion mutation, in contrast with the other two mutations 
studied, suggesting a different molecular mechanism for this mutation. Further studies 
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Desmosomes are crucial links between neighbouring cells, whereby several 
proteins cooperate to support tissues such as the epidermis and the myocardium. These 
tissues need to be flexible and at the same time resistant to stress. Although the precise 
roles of desmosomes as adhesion structures and as signalling centres are not entirely 
defined, it is currently accepted that these junctions perform both structural and 
signalling functions. They are involved not only in physical adhesion but also in tissue 
differentiation and morphogenesis (Garrod & Chidgey, 2008; Getsios et al., 2004b; 
Green & Simpson, 2007). Mouse models as well as human genetic and autoimmune 
disease involving desmosomal components provide us with clues as to some of these 
functions. 
This thesis is focused on the effects of human genetic mutations in desmosomal 
components and on the contributions of different DP splice variants to desmosomal 
function. Mutations affecting most of the major desmosomal proteins, including the 
desmosomal cadherins and plaque proteins (of the armadillo and plakin families) as well 
as in the desmosomal-associated IF proteins, can lead to cardio-cutaneous diseases. The 
molecular mechanisms of these mutations in the development of disease are 
continuously being uncovered and provide valuable information about the importance of 
these intercellular junctions. 
 
6.2. Homozygous nonsense mutation in JUP results in skin fragility, 
PPK and woolly hair but normal heart development 
 Two mutations in the gene encoding PG, JUP, have been previously published 
and in both instances individuals who harbour these mutations suffer from ARVC, with 
or without skin abnormalities (Table 6.1). Here, a novel homozygous nonsense mutation 
in the first coding exon of JUP was identified with leads to skin fragility and PPK but, 
in contrast with previous mutations, results in normal heart development (Table 6.1). 
This clinical phenotype is designated as acantholytic ectodermal dysplasia and can also 
be caused by a recessively inherited JUP mutation, c.468G>A predicted to affect 
splicing. This predicted splice site mutation was found in Kuwaiti patients during the 
course of this study (Table 6.1). 
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Table 6.1. Currently known mutations in the gene encoding PG, JUP, and corresponding 








Naxos disease: diffuse NEPPK, woolly hair and 
ARVC 
S39_K40insS Dominant ARVC 
S24X Recessive 
Acantholytic ectodermal dysplasia: skin fragility, 
diffuse PPK and woolly hair 
c.468G>A Recessive 
Acantholytic ectodermal dysplasia: skin fragility, 
diffuse PPK and woolly hair 
 
The two JUP mutations described here are thought to lead to skin disease 
through a common molecular mechanism involving three main steps. First, both 
mutations result in remarkably low levels of PG (wild type or PGΔN42, see Chapter 3) 
in patient skin which is barely present at intercellular junctions. Second, these low 
levels of PG in the skin affect the ultrastructure of desmosomes, although they do not 
appear to interfere with normal adherens junction structure or function. Finally, the low 
levels of PG in the skin of these patients lead to an adhesion defect resulting in the 
clinical features of skin fragility which is aggravated by mechanical stress. These 
mutations cause a more severe skin disease than the mutation causing Naxos disease 
(which results in PG C-terminal truncation), including blistering and acantholysis which 
are not observed in the skin of Naxos patients. The less severe phenotype in the skin of 
Naxos patients could be due to partial functionality of the truncated PG protein. 
Therefore, although both types of mutations lead to skin disease, the severity of the 
phenotype might vary in response to different functional levels of the mutant proteins. 
It is interesting that there is no evidence of heart abnormalities in the patients 
described here, despite the very low levels of PG. However, given that the oldest patient 
was only 14 years-old at the time of the last cardiac examination, the possibility of 
developing cardiomyopathy later in life cannot be ruled out. ARVC in Naxos patients is 
probably not related to low expression levels of the C-terminally truncated PG, as 
suggested by western blot which showed equivalent levels of PG in normal heart and in 
the heart of a Naxos patient (McKoy et al., 2000). This observation together with 
observations described here and elsewhere (Mahoney et al., 2009) suggest that low 
expression levels of PG in the heart may not be a suitable diagnostic test for ARVC as 
suggested by Asimaki et al. (2009) (see Chapter 3). Mahoney et al. (2009) described a 
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patient with compound heterozygous DSP mutations affecting the C-terminus of both 
DPI and DPII and leading to heart failure but who showed bright PG immunoreactivity 
at the cardiac intercalated discs. ARVC in this patient is suggested to result from 
defective DP-IF attachments. ARVC in Naxos patients could be due to altered binding 
properties of the mutant PG caused by the presence of five additional amino acids in its 
C-terminus (McKoy et al., 2000). ARVC caused by the dominant insertion mutation, 
S39_K40insS, appears to be related to the creation of additional binding partners. The 
lack of a heart phenotype in the patients described here suggests four different 
hypotheses. First, PG might not be essential for normal heart development, and the fact 
that heart intercellular junctions are formed by a mixture of desmosomal and adherens 
junction proteins may allow for compensation for lack of PG by other junctional 
molecules. However, even if PG does not contribute with normal adhesion properties 
within junctions, its correct signalling functions in the heart might still be important. In 
this respect, the presumably low levels of PG in the heart of the patients described here 
might still contribute to normal signalling in contrast with other cases where aberrant 
signalling of PG is suggested to lead to ARVC (Garcia-Gras et al., 2006). Therefore, the 
mutant PG proteins expressed by the patients described here are proposed to contribute 
to normal Wnt/β-catenin signalling functions in the heart, thereby allowing normal heart 
development. The second and third hypotheses are, assuming that PG is essential for 
normal heart development, that cardiomyopathy might still develop in these patients 
later in life or PGΔN42 has different binding partners in skin and heart and is therefore 
incorporated into heart junctions and stabilised leading to normal heart function. A 
fourth hypothesis is that the lack of heart phenotype is due to incomplete penetrance of 
ARVC (which means that not all patients with this mutation will develop the disease), 
which has been reported to be below 50% (Vatta et al., 2007). 
Further studies will be necessary to test these hypotheses and fully understand 
the lack of heart phenotype in these patients, including determining PGΔN42 binding 
partners in keratinocytes and cardiomyocytes, investigating whether PGΔN42 is 
incorporated into cardiomyocyte junctions and the testing of PGΔN42 signalling 
properties in both types of cells. 
 
 
Chapter 6 – Final Discussion  
 
 199
6.3. Identification of a third alternative DP splice variant and its 
possible functions 
In Chapter 4, the identification of a novel DP splice variant, DPIb, was 
described. DSPIb mRNA was detected in a range of epithelial and cardiovascular 
tissues as well as in the brain, and was the only transcript observed in the aorta. DPIb 
protein expression was observed in HaCaT and K1 keratinocytes and western blot 
analysis of human atrium suggested presence of this novel isoform. Although DPIb was 
expressed at low levels compared to those of DPI and DPII in the cell and tissue types 
tested here (as suggested by western blot and qRT-PCR), the possibility that it is 
expressed at higher levels in other tissues cannot be excluded. Supporting this 
hypothesis is the observation of virtually absent DPII protein in heart tissue (Uzumcu et 
al., 2006 and Figure 4.12) whereas the DPII expression level observed in the skin is 
similar to that of DPI (Uzumcu et al., 2006). Given the fact that DSPIb was the only 
transcript detected in the aorta, it is hypothesised that this tissue will express higher 
levels of DPIb than the levels observed in the cells and tissues tested here, but further 
studies will be needed to confirm this hypothesis. As the size of DPIb is close to that of 
DPII, the function of DPIb might be similar to that of DPII. DPIb might be able to 
provide some degree of compensation for defects in DPI or in the case of DPI absence, 
in the same way as DPII can partially compensate for the lack of DPI (see below). This 
is not the case in cells harbouring the DSPI-nonsense mutation (p.R1267X) because this 
mutation also causes DPIb knock-down (see Chapter 5). Further studies will be 
necessary to understand the functions of DPIb and also the functions of DPII, which are 
for the most part unknown.  
A possible way to dissect the functions of DPIb and DPII within the desmosome 
would be to generate an in vitro reconstitutional model of the desmosome where a 
desmosomal cadherin (e.g. DSG1), together with PG, a PKP (e.g. PKP1) and either 
DPIb or DPII would be co-expressed in a cell line that does not express desmosomal 
proteins (e.g. L-fibroblasts). Subsequently, immunocytochemistry could be performed 
to determine the localisation (and co-localisations) of these proteins, as well as co-
immunoprecipitation studies to determine interactions among these proteins. These 
experiments were previously described in studies where the interactions between the N-
terminus of DPI and the desmosomal plaque proteins were determined (Kowalczyk et 
al., 1997; Kowalczyk et al., 1999). However, these experiments were only performed 
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using DPI. Although DPII has now been cloned (see section 2.2.1 in Chapter 2), time 
did not permit experiments using this construct. 
Western blotting proteins with a C-terminal DP antibody suggested the presence 
of a fourth DP splice variant in HaCaT cells, which was provisionary designated as 
DPIa. This immunoreactive band was demonstrated to be down-regulated with siRNAs 
which were thought to be DSPI-specific. However, attempts to amplify this potential 
isoform at the mRNA level with primers flanking the known DSP alternatively spliced 
region in exon 23 failed to amplify this fourth splice variant. These results suggested 
that the immunoreactive band observed by immunoblotting between DPI and DPIb is a 
breakdown product of DPI or a western blot artefact. 
 
6.4. Insights into the molecular mechanisms of three different DP 
mutants 
Three different DSP mutations were studied as described in Chapter 5. The first 
mutation leads to DPI and DPII haploinsufficiency resulting in SPPK in patients 
(Armstrong et al., 1999; Whittock et al., 1999), and was predicted to result in reduced 
desmosomal adhesion, deficient IF attachment and widening of intercellular spaces, as 
previously demonstrated in vivo by electron microscopy and immunohistochemistry in 
patient skin (Armstrong et al., 1999; Wan et al., 2004; Whittock et al., 1999). The 
second mutation is a DSPI-specific nonsense mutation which is predicted to activate the 
NMD pathway leading to complete absence of DPI in the patient (Uzumcu et al., 2006). 
This mutation results in skin and heart disease but little was known to date about its 
molecular mechanisms. These two mutations were modelled in HaCaT keratinocytes 
using siRNA transfections and their effect on the expression levels of other junctional 
proteins and in intercellular adhesion were investigated.  
In this in vitro experimental system, both DSPI-nonsense and DP 
haploinsufficiency mutations resulted in reproducible reduction of DSC3, DSC2 and 
PKP1 expression levels compared to control cells. Moreover, the DSPI-nonsense 
mutation (modelled in siI transfected cells, Chapter 5) results in significantly lower 
levels of DSC3 compared to the haploinsufficiency mutation (modelled in siI/II 
transfected cells, Chapter 5). No significant differences in the expression levels of PKP1 
and DSC2 were observed between siI and siI/II transfected cells. These results suggest 
that DSC3 expression is influenced by the DPI:DPII ratios, in contrast with PKP1 and 
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DSC2. Furthermore, these experiments suggested that DPI has more influence on the 
expression levels of DSC3 than DPII. This is an interesting observation in light of 
possible functional differences between the DPI and DPII isoforms, and suggests that 
although DPII can partially compensate for DPI, the latter might have a specific role in 
stabilising DSC3 within the desmosome, but further studies are needed to confirm this. 
The re-constitutional model of the desmosome described in section 6.3 could be a 
possible starting point to confirm and further investigate these observations. 
As expected, in this experimental system the haploinsufficiency mutation 
resulted in reduced cell-cell adhesion and IF attachment in an in vitro adhesion assay. 
Adhesion defects were less prominent in cells mimicking the DSPI-nonsense mutation, 
which is consistent with in vivo observations which show that the skin of patients 
harbouring this mutation has an apparently normal structure (Uzumcu et al., 2006). It is 
interesting to note that more pronounced adhesion defects are observed in cells with DP 
haploinsufficiency than in cells with DPI down-regulation despite the lower levels of 
DSC3 in the latter case. These results suggest that the adhesion defects in DP 
haploinsufficient cells are not directly dependent on the expression levels of DSC3.  
The third mutation studied here results in the insertion of 10 amino acids into the 
N-terminus of DP. The N-terminus is involved in targeting DP to the desmosome via 
interactions with PG, PKPs 1-3 and DSC1a. As the insertion mutation occurs 
downstream of the critical region for DP’s interactions with PG, PKPs 1-3 and DSC1a, 
this mutation is not expected to cause disruption of these protein-protein interaction. A 
recombinant DPI protein harbouring these 10 extra amino acids was over-expressed in 
HaCaT cells and shown to form abnormal aggregates in these cells. These aggregates 
still appeared associated with keratin IFs at the cell membrane and no obvious adhesion 
defects were observed in these cells when subject to mechanical stretch. Further studies 
will be necessary to investigate the molecular nature of these DP aggregates and 
whether the insertion mutation results in higher affinity of DPI for known binding 
partners, for instance due to a conformational change of the protein, or generates new 
protein-protein interactions. Possible experiments in cells over-expressing this mutant 
include co-localisation studies between DPI and known binding partners such as PG, 
PKPs and DSC1a as well as immunoprecipitation studies to determine protein 
interactions. It would have been interesting to also study the effects of this mutation in 
the DPII protein and whether these effects are similar or differ from those related to 
DPI. Additionally, the effects of this mutation in vivo, including clumping of DP and 
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PG at cell borders, are observed predominantly in the lower layers of the epidermis 
whereas the upper layers, which are more exposed to mechanical stress, appear to have 
a normal structure and distribution of these proteins (Norgett et al., 2006). Considering 
these results obtained prior to the work described here, it would be interesting to 
investigate the direct or indirect effects of this mutant in signal transduction. A strong 
first candidate would be PG, as its signalling activity has been suggested to be involved 
in the development of disease, such as in the case of ARVC (Garcia-Gras et al., 2006). 
A speculative hypothesis for the mechanism of disease caused by this insertion mutation 
is that DP has higher affinity for PG (possibly through interactions with novel binding 
partners expressed only in the lower layers of the epidermis) and therefore less PG is 
available to perform normal signalling (and balance β-catenin signalling). β-catenin 
over-expression has been shown to cause hyper-proliferation and hair follicle 
differentiation (Gat et al., 1998). Therefore increased Wnt/β-catenin signalling might be 
responsible for the keratinocyte hyper-proliferation observed in the skin of this patient 
and the woolly hair. However, ARVC has been associated with decreased Wnt/β-
catenin signalling and increased PG signalling in cardiomyocytes causing a switch from 
myogenesis to adipogenesis and fibrosis (Garcia-Gras et al., 2006). Although it is not 
clear whether the insertion mutation indirectly leads to increased or decreased Wnt/β-
catenin signalling, it is tempting to speculate that it leads to an imbalance between PG 
and β-catenin signalling. Further studies will be needed to clarify this mechanism. 
 
6.5. Desmosome associated genetic disease and unresolved questions 
Mutations affecting all of the main desmosomal proteins expressed in the heart 
have been associated with cardiomyopathies, PKP2 being the most common target. The 
vast majority of these mutations are inherited in an autosomal dominant fashion, 
however, variable penetrance is observed. Autosomal recessive mutations in PKP2, PG, 
DP, and DSC2, predominantly associated with syndromic cardiomyopathies (except for 
PKP2) have also been reported (Table 6.2). These observations suggest that in the heart, 
because there is only one representative of each protein sub-family (i.e. PKP2, DSC2, 
DSG2) together with the constitutive PG and DP, there might be less compensatory 
mechanisms by similar proteins in case of mutation in any of these main components.  
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Table 6.2. Desmosomal associated genetic disease and corresponding affected proteins and 
human clinical phenotypes. 
 
 Genetic disease 
Affected 
proteins 
Clinical features References 
ARVC 
DP, PG, DSC2, 
DSG2, PKP2 
Fibrofatty replacement of the 
right ventricular myocardium 
resulting in arrhythmias and 
sudden cardiac death (may 
envolve both ventricles) 
(Gerull et al., 2004); 
(Pilichou et al., 2006); 
(Rampazzo et al., 2002);
(McKoy et al., 2000); 













Dilation of ventricles leads to 
impared myocardial function 
and heart failure 
(Posch et al., 2008); 
(Norgett et al., 2000) 
SPPK DP, DSG1, DSC2 
Focal thickening of the 
palmoplantar epidermis with 
a striated pattern 
characterised by linear 
hyperkeratosis on the digits 
(Simpson et al., 2009); 
(Rickman et al., 1999); 
(Armstrong et al., 1999) 
EPPK DP, K1 
Diffuse thickening of the 
palmoplantar epidermis 
associated with perinuclear 
vacuolisation, cytolysis and 
blistering 






hair with or 
without 
cardiomyopathy 
DP, PG, PKP1 
PPK and fragile skin that 
blisters and peels 
(Tanaka et al., 2009); 
(Asimaki et al., 2009a); 
(Cabral et al., 2010); 





Skin fragility, SPPK, 
alopecia, lack of nails and 
cardiomyopathy 
(Jonkman et al., 2005) 
Woolly hair, 
PPK with or 
without 
cardiomyopathy 
DP, PG, DSC2 
Kinky and wiry hair scalpe 
hair which has a wool-like 
appearance, PPK and heart 
disease 
(Whittock et al., 2002b); 
(Norgett et al., 2000); 
(McKoy et al., 2000); 
(Cabral et al., 2010); 
(Simpson et al., 2009) 
Hypotrichosis DSG4 
Sparse, thin hair with 
atrophic hair follicles, 
impaired hair keratinization 
and epidermal 
hyperproliferation 









Sparse and fragile hair with 
normal hair follicles 
(Ayub et al., 2009) 
 
In contrast, mutations in the genes encoding DSC1, DSG3 and PKP3 have not 
been associated with human disease, even though these proteins are abundantly 
expressed in the skin. This observation suggests that mutations in the genes encoding 
these proteins either do not disrupt the skin because these proteins are compensated for 
by other similar proteins or they cause other diseases that have not yet been found.  
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The fact that more mutations have been found in genes encoding desmosomal 
proteins that are expressed in the upper epidermal layers highlights the importance of 
these proteins (such as DSG1, DSC1 and PKP1) in the maintenance of epidermal 
integrity and resistance to mechanical stress. However, the hypothesis that disease-
causing mutations in the genes encoding DSC1, DSG3 and PKP3 will be discovered in 
the future cannot be excluded.  
Mutations in the gene encoding PG have been associated with both skin and 
heart disease, however, only four mutations have been uncovered so far compared to 36 
in the gene encoding DP. The fact that 36 DSP mutations leading to disease are now 
described highlights the importance of this plakin protein within the desmosome. It is 
likely that more mutations will be discovered in the JUP gene. 
Mutations in DSP result in a variety of different phenotypes involving skin and 
heart disease (Table 6.2). This is not surprising as, together with PG, DP is expressed in 
all desmosome-containing tissues and is therefore a crucial component of these 
junctions. Interestingly, desmosomes and other junctions have been shown to be 
interdependent. Expression and localisation of connexin 43, a major gap junction 
protein, are impaired in desmosome-related cardiomyopathies, although this is also 
observed in other types of heart disease (Asimaki et al., 2009b); adherens junctions are 
disrupted in keratinocytes derived from the epidermis of conditional (epidermis-
specific) DP knock-out mice (Vasioukhin et al., 2001); and β-catenin appears to 
partially compensate for the lack of PG in keratinocytes derived from PG knock-out 
mice (Acehan et al., 2008; Bierkamp et al., 1999). Therefore, although the initial defect 
may be specific to desmosomal components, it can ultimately lead to disruption of 
related adherens and gap junctions as part of the disease manifestation. 
It is interesting that DSP mutations resulting in haploinsufficiency can lead to 
skin disease only, SPPK (Chapter 5), but can also result in ARVC without skin disease, 
as shown by a patient harbouring a DSP nonsense mutation (W233X) in the N-terminus 
of DP (Yang et al., 2006). As illustrated by the work done in cardiac-specific DSP 
haploinsufficient mice and in DSP knock down cardiomyocytes, PG is able to 
translocate to the nucleus and up-regulate genes involved in the development of ARVC 
(Garcia-Gras et al., 2006). This process might be dependent on the dosage of DP that is 
present at junctions to stabilise PG, which might vary according to different 
haploinsufficiency-causing mutations and their efficiency on the activation of the NMD 
pathway. Additionally, manifestation of the ARVC phenotype is aggravated by 
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endurance training and therefore different degrees of training might influence the 
development and severity of the heart disease (Bolling & Jonkman, 2009). It is also 
interesting to note that in other cases, DP haploinsufficiency does not result in an 
observable phenotype which shows variable penetrance (Whittock et al., 2002b). 
Likewise, heterozygous DP knock-out mice were indistinguishable form wild type mice 
(Gallicano et al., 1998). These observations suggest that in humans the dosage of DP is 
important for the maintenance of epidermal integrity. 
The most deleterious mutations found so far in DSP led to a cardio-cutaneous 
syndrome called lethal acantholytic epidermolysis bullosa in one patient (Chapter 1). 
Clinically, this patient mimics the conditional epidermis-specific DP knock-out mouse 
(Bolling & Jonkman, 2009; Jonkman et al., 2005; Vasioukhin et al., 2001). The affected 
child was a compound heterozygote for C-terminally truncating mutations affecting 
both DPI and DPII and died 10 days after birth of heart failure. The skin phenotype of 
this patient was extremely severe including skin fragility and displacement of large 
masses of skin, total alopecia and lack of nails. This phenotype is thought to be caused 
by a severe adhesion defect due to the lack of DP-mediated IF attachment to 
desmosomes. This is suggested by ultrastructural analysis of patient skin which shows a 
split between cells at the level of the cytoplasmic side of the desmosomal inner dense 
plaque (IDP) (Jonkman et al., 2005). This patient showed a much more severe skin 
phenotype then the Carvajal patients harbouring the 7901delG homozygous mutation. 
The latter mutation results in the truncation of the C-terminal tail of DP which lacks the 
C plakin repeat domain (PRD; see Figure 1.8) (Norgett et al., 2000). In contrast, the 
compound heterozygous mutations referred to above result in two C-terminally 
truncated DP proteins, of which one lacks the entire C-terminal domain and the other 
retains only the A PRD. These results suggest two important points. Firstly, as 
previously suggested by in vitro studies (Choi et al., 2002), these observations suggest 
that the combination of more than one PRD is more efficient for IF binding than 
individual PRDs (in this particular comparison, presence of PRDs A plus B appears to 
be more favourable then presence of PRD A alone). Secondly, the dosage of partially 
functional DP molecules might also contribute to the resulting phenotype, since the 
patient with the compound heterozygous mutations expresses reduced levels (~50%) of 
DP molecules containing the A PRD whereas the Carvajal disease-associated mutation 
results in 100% of DP molecules containing PRDs A plus B. These two points might 
explain why in Carvajal patients the skin phenotype is exacerbated by mechanical 
stress, whereas the patient with acantholytic epidermolysis bullosa shows a very severe 
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skin fragility and loss of barrier function that appears to occur independently of 
mechanical stress. 
 
6.5.1. Common pathways in desmosome associated disease 
The desmosomal associated genetic disease results in a phenotypic convergence 
into two major disease manifestations; the skin fragility and/or PPK which can be 
associated or not with hair abnormalities, and the desmosomal-associated 
cardiomyopathy. The epidermal hyperproliferation (which is associated with most 
desmosomal mutations affecting the skin) might be a result of loss of cell-cell adhesion 
leading to transmission of cell signals towards increased proliferation in a wound 
healing-like response. It might also be a result of signal transduction imbalance 
resulting in decreased cell-cell adhesion. Additionally, it might be initiated by different 
processes, depending on the type of mutation and the target gene, despite resulting in 
similar clinical manifestations. Similarly, the cardiac phenotype might be caused by 
altered Wnt/β-catenin signalling resulting in fibrofatty replacement of cardiac myocytes 
in a wound healing-like process; it might also be caused by loss of cell-cell adhesion or 
both, one process leading to the other. As the desmosome is a complex of interacting 
proteins, it is not surprising that defects in different components lead to similar clinical 
phenotypes, as the affected proteins are involved in common pathways and/or in 
overlapping interactions. More interesting is the fact that mutations in the same 
desmosomal component can give rise to different phenotypes, but this might be due to 
different dosages of the mutant protein in question, different composition of skin and 
heart desmosomes, different levels of mechanical stress, different genetic backgrounds 
among other variations. Clinically, it is important to regard PPK in combination with 
woolly hair (or alopecia) as a “warning signal” for the development of cardiomyopathy, 
as suggested by Norgett et al. (2006). 
 
6.6. Conclusions 
Two general conclusions, which are open to discussion, are proposed in this 
thesis. Firstly, although there are common pathways leading to disease of the 
desmosome which results in cardio-cutaneous syndromes, the initial stages differ, 
according to the molecular defect and the protein in question. The understanding of 
these initial variations or different molecular mechanisms leading to a common 
Chapter 6 – Final Discussion  
 
 207
phenotype is crucial to unveil the range of functions preformed by each individual 
protein of the desmosome and how these functions are altered in disease. Further, this 
understanding might be valuable to develop methods to specifically target the initial 
stages (original problems) in attempts to prevent or cure desmosomal associated disease. 
Secondly, because skin and heart desmosomes are slightly different in composition and 
because skin and heart are different tissues themselves and perform different functions, 
the mechanisms leading to disease might also differ between these tissues. Therefore the 
same protein might be subject to different regulation, might perform different functions 
and their associated defects might lead to different outcomes, even though the molecular 
mechanisms of disease may sometimes overlap. 
More specific conclusions can be drawn from the work described in this thesis, 
some of which support and reinforce previous observations. Firstly, two novel 
recessively inherited JUP mutations are described, associated with skin disease without 
heart involvement for the first time. The resulting PG proteins in these cases are 
expressed in the skin at extremely low levels and are barely incorporated into epidermal 
junctions, leading to the development of skin fragility associated with PPK and woolly 
hair. These proteins are, however, proposed to contribute with normal (Wnt/β-catenin) 
signalling functions in the heart thereby allowing normal heart development, but further 
studies are necessary to conform this hypothesis. Secondly, a novel DP splice variant, 
DPIb, is shown to be expressed in a variety of epithelial tissues as well as in the brain, 
cardiac tissue and aorta at the mRNA level and in keratinocyte cell lines at the protein 
level. Although the functions of this novel isoform remain uncertain, the awareness of 
its existence is important as it might play a particular role in other tissues or compensate 
for defects in DPI. Finally, three different DSP mutations which cause skin disease 
associated or not with cardiomyopathy, were studied. siRNA mediated DPI down-
regulation (which mimicked the DSPI-specific nonsense mutation causing skin and 
heart disease) and DPI/DPII down-regulation (which mimicked the DP 
haploinsufficiency mutations leading to SPPK) caused decreased expression levels of 
DSC2, DSC3 and PKP1 in an experimental system using HaCaT keratinocytes. Further, 
statistically significant differences in the expression levels of DSC3 were observed 
between the two siRNA-mediated knock-down situations. These differences, coupled 
with a suggestion of less prominent adhesion defects in the DPI-knock down cells 
suggest that DPI and DPII are not completely redundant isoforms. A 30 bp-insertion 
mutation was genetically engineered in a DSPI-construct and the recombinant protein 
was shown to form large aggregates at the cell membrane of HaCaT cells. Overall, these 
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results suggest that different DSP mutations have different molecular mechanisms 
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Figure A1. Schematic diagram of epitope recognition sites for the two anti-PG antibodies 
used in this study in relation to wild type PG and PGΔN42. The epitope of the mouse 
monoclonal antibody PG 5.1 maps to the C-terminus at the extreme end of repeat 13 (amino 
acids 632-687) of PG. The mouse monoclonal antibody 15F11 was raised against full length 




Figure A2. Mutant protein PGΔN42 is recognized with an N-terminal PG monoclonal 
antibody, 15F11. Western blotting of skin proteins isolated from a normal control (C), maternal 
(M) and patient A (P) samples with the monoclonal N-terminal antibody 15F11 shows reduced 
levels of truncated PGΔN42 in both maternal (M) and patient (P) samples. Wild type PG is 
observed in control (C) and maternal (M) samples. 
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Appendix B: Optimisations of siRNA knock-down experiment for transient down-
regulation of DP isoforms 
 
B1. Transient down-regulation of DPI with synthetic siRNAs in HaCaT 
keratinocytes 
 
B1.1. Optimisation of the siRNA transfection conditions 
Lipid-based transfections using the DharmaFECT transfection reagent (Thermo 
Fisher Scientific) were performed to deliver siRNAs into HaCaT cells. Transfection 
conditions were first optimised in HaCaT cells, prior to DSP siRNA transfections, in 
order to find the highest transfection efficiency. To accomplish this, siGLO Cyclophilin 
B Control siRNA (Thermo Fisher Scientific) was complexed with three different 
volumes of DharmaFECT transfection reagent – 2, 4 and 6 μl – (as suggested by the 
manufacturer) to deliver a final concentration of 100 nM siRNA per well of a 6-well 
plate. siGLO Cyclophilin B Control siRNA is a stable, fluorescent form of Cyclophilin 
B (peptidylprolyl isomerase B or PPIB) which provides positive correlation of 
fluorescent uptake with transfection efficiency and gene silencing activity. The uptake 
of the control siGLO siRNA was visualised using the Cy3 filter on a fluorescence 
microscope after approximately 20 hours. 
As shown in Figure B1, cells appeared healthy and remained viable following a 
20 hour-incubation with up to 6µl of DharmaFECT. Toxicity was observed after 24 
hours of incubation with DharmaFECT (2, 4 and 6µl) and therefore fresh media was 
always added to the cells 20 hours post-transfection in subsequent experiments. The 
amount of siGLO uptake, as judged by the red fluorescence levels, increased 
progressively with increasing volumes of DharmaFECT, and was highest when cells 
were transfected with 6µl of DharmaFECT. No fluorescence was observed when the 
cells were incubated with DharmaFECT only or with siGLO only (negative controls). 
These results indicated that 6µl was the optimum volume of DharmaFECT to deliver 
siRNAs to HaCaT cells plated at a density of 1x105 cells/ml, since the maximum uptake 
of siRNA was achieved with minimum cell toxicity. These transfections conditions 





Figure B1. Optimisation of siRNA transfection conditions in HaCaT cells with siGLO 
Cyclophilin B Control siRNA and different volumes of DharmaFECT transfection 
reagent. Cells were incubated with a final concentration of 100 nM of siGLO Cyclophilin B 
Control siRNA which was first complexed with 0, 2, 4 or 6 μl of DharmaFECT transfection 
reagent. Cells that were incubated with 6 μl of DharmaFECT had the highest uptake of the 
fluorescently labelled siGLO control siRNA whilst cell toxicity was not observed. Scale bar = 
20 µm. 
 
B1.2. siRNA design for down-regulation of DPI (and DPIb) 
To mimic the p.R1267X nonsense mutation, siRNAs had to be specifically 
designed to target the 648 bp coding region, from nucleotides 3582 to 4050, which is 
the only region common to both DSPI and DSPIb and absent from DSPII mRNAs. The 
Thermo Fisher Scientific siDESIGN Center was used for this purpose which offered 50 
top- scoring candidates (Table B1). 
Four siRNAs (si1, si2, si3 and si4, Figure B2) were chosen from the 50 top-
scoring candidates (Table B1) based on two criteria. Firstly, siRNAs with the highest 
“minimum number of mismatches” of the 19-nucleotide sense and anti-sense strands to 
a sequence record other than the required target (as determined by BLAST analysis) 
were chosen. Secondly, within the siRNAs with the highest “minimum number of 
mismatches” for sense and anti-sense strands, the four siRNAs with highest scores were 
selected (84, 82 and 80). Figure B2 depicts the four siRNAs (si1-si4) chosen to knock-







Table B1. Fifty top-scoring candidate DSPI/DSPIb siRNAs provided by the Thermo Fisher 
Scientific siDESIGN Centre. The chosen four siRNAs based on scoring and number of 




















ctgagataatgcagaagaa 204 37 86 No 2 2 No 
gcgaaggcgagctgaagaa 157 58 84 No 3 3 No 
ataaggagatcgagagact 330 42 84 No 3 >3 Yes 
ccaagaccattcaggacaa 309 47 83 No 2 3 No 
ggcctgtggctctgagata 193 58 82 No 3 3 No 
cttagaaaccagcttgata 62 37 81 No 2 2 No 
agataatgcagaagaagca 207 37 81 No 1 3 Yes 
agatagaactgaagcaggt 234 42 80 No 3 3 Yes 
aaggagatatccatgcaaa 23 37 79 No 3 3 Yes 
gaaaccagcttgatagact 66 42 79 No 3 3 Yes 
aaataaggagatcgagaga 328 37 79 Yes 1 3 Yes 
gatgaaattgtcaggctca 110 42 76 No 1 3 Yes 
gcaaaaggcctgtggctct 187 58 76 No 3 2 No 
agtttcaggaggaggccaa 357 53 76 No 2 1 Yes 
aggagatatccatgcaaaa 24 37 75 No 3 3 No 
gggaaaatcgagatctgaa 90 42 75 No 3 3 No 
agaaaacgcccttcagcaa 172 47 75 No 2 3 No 
ggagatcgagagactcaaa 334 47 75 No 3 3 No 
agatctgaaggatgaaatt 100 32 74 No 2 3 No 
aaggagatcgagagactca 332 47 74 No 2 2 Yes 
tcgagagactcaaagctga 339 47 74 No 3 3 Yes 
atcgagatctgaaggatga 96 42 73 No 2 3 Yes 
gagatctgaaggatgaaat 99 37 73 No 3 2 No 
ggatgaaattgtcaggctc 109 47 73 No 2 3 No 
gccaagaccattcaggaca 308 53 73 No 2 3 No 
agaccaccatcaaggagat 12 47 72 No 2 2 No 
cctgtggctctgagataat 195 47 72 No 3 3 No 
gggaatatgaaaatgaact 384 32 72 No 3 3 No 
aggatgaaattgtcaggct 108 42 71 No 2 3 Yes 
gaaggcgagctgaagaaaa 159 47 71 No 1 3 No 
tggagatagaactgaagca 231 42 71 No 2 3 Yes 
tgaagcaggtcatgcagca 243 53 71 No 2 2 Yes 
gcctgtggctctgagataa 194 53 70 No 3 3 No 
gagataatgcagaagaagc 206 42 70 No 2 3 Yes 
cagcagcgctctgaggaca 257 63 70 No 2 2 Yes 
ccgctgggaatatgaaaat 379 42 70 No 3 3 No 
ccatcaaggagatatccat 18 42 69 No 2 2 No 
aaaagaggatgattccaaa 40 32 69 No 1 2 Yes 
atgaaattgtcaggctcaa 111 37 69 No 2 3 Yes 
aaaacgcccttcagcaaaa 174 42 69 No 2 3 Yes 
ccaccatcaaggagatatc 15 47 69 No 3 2 No 
agaagaagcagcatctgga 216 47 69 No 2 2 Yes 
tagaaaccagcttgataga 64 37 69 No 2 3 Yes 
ttacgaagaccaccatcaa 6 42 69 No 3 3 Yes 
gctgggaatatgaaaatga 381 37 69 No 3 3 No 
cgaaggcgagctgaagaaa 158 53 68 No 2 >3 No 
aaaccagcttgatagactt 67 37 68 No 3 3 Yes 
aagaagcagcatctggaga 218 47 68 No 2 2 Yes 
acaagcagtccctggagga 285 58 68 No 1 2 Yes 




An additional parameter to take into account when designing siRNAs is the seed 
complement frequency which ideally should be as low as possible. Given that none of 
the siRNAs offered by the siDESIGN Centre (except for one) had low seed frequency 
(Table B1) additional methodologies had to be used to reduce off-target signatures. 
Firstly, all four chosen siRNAs had chemical modifications (named by Thermo Fisher 
Scientific as ON-TARGETplus modifications) on their sense and antisense strands 
(even though some of them did not require sense modifications according to the 
siDESIGN Centre, see Table B1). Secondly, a pooling strategy was used (see B1.2) to 




Figure B2. Nucleotide sequences of four siRNAs targeting DSPI/DSPIb and their targeting 
sites. (A) Sense strands of four individual siRNAs designed to specifically target DSPI and 
DSPIb mRNAs. (B) Schematic diagram of a portion of the DSPI, DSPIb and DSPII mRNAs 
including exons 22 to 24 and the position of the p.R1267X (c.3799C>T) nonsense mutation. 
Alternative donor splice sites around positions 5380, 4050 and 3582 (coding nucleotides) 
originate three different splice variants (DSPI, DSPIb and DSPII respectively). R1267X occurs 
in a region common to both DSPI and DSPIb mRNAs and therefore four siRNAs (si1 to si4) 
were design in this region to knock-down DSPI and DSPIb and mimic this mutation. The 
targeting regions of each individual siRNA are indicated with red stars. 
 
B1.3. Three out of four designed siRNAs cause significant down-regulation of 
DPI/DPIb 
In order to test the four chosen siRNAs, HaCaT cells were independently 
transfected with 100nM of each individual siRNA (si1, si2, si3 and si4) using the 
transfection conditions described in B1.1. Additionally, the four siRNAs were pooled at 
a final concentration of 100nM (sipool (1-4)), and a mock control consisting of cells 
incubated with DharmaFECT transfection reagent only (no siRNA) was included. Cells 
were assayed four days post-transfection for DP protein expression by western blot, 
using an antibody that recognises the C-terminus of DP (11-5F; see Table 2.6), which is 
common to all three splice variants. Vinculin was used as a control for equal loading 
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(Figure B3). DPI protein levels were determined using densitometry measurements of 
western blots and normalised to the loading control (vinculin) (Figure B3B). siRNAs 
si2, si3 and si4 caused between 87% (si2) and 95% (si3) down-regulation of DPI. 
Virtually 100% down-regulation of DPIb was also achieved with these duplexes. In 
contrast, si1 did not cause down-regulation of either DPI or DPIb. DPII expression 
levels following si1, si2 and si3 transfections were comparable to those of the mock 
control and following si4 transfection, DPII expression levels appeared to be slightly 
up-regulated. These results indicate that siRNAs si2, si3 and si4 as well as the sipool (1-
4) target DSPI (and DSPIb) specifically in HaCaT cells, without causing down-
























Figure B3. Three out of the four selected siRNAs result in over 85% knock-down of 
DPI/DPIb. (A) Western blot analysis of total HaCaT cell lysates from HaCaT cells transfected 
with 100nM of each of the four siRNAs (si1, si2, si3 and si4) designed to target DSPI/DSPIb, 
and with a pool containing 25nM of each siRNA (sipool (1-4), 100nM final concentration). 
siRNAs si2-4 lead to significant down-regulation of both DPI and DPIb, four days following 
transfection. Mock refers to cells that were incubated with DharmaFECT transfection reagent 
only. Positions of DPI (332KDa) and DPII (260KDa) and the loading control vinculin 
(117KDa) are indicated. DPIb is predicted to be 279KDa (B) DPI protein levels normalised to 




One possible way for attenuating off-target effects is by pooling functional and 
specific siRNA duplexes. This control strategy is particularly important in the present 
case where siRNAs with low seed frequency were not available. Each siRNA within the 
pool will be present as a fraction of the total siRNA concentration. Since each siRNA a 
unique off-target signature, reducing its concentration to a minimum reduces its 
likelihood of causing off-target effects by interacting with unintended mRNAs 
(Anderson et al., 2008). 
Another important control is a quantitative control by means of a siRNA 
titration. This is important because the RNAi components may be saturable, particularly 
the RISC complex (Editorial, 2003). 
Since siRNA duplexes si2-4 were demonstrated to be functional, a pool 
containing 33.3nM of each of the three duplexes was first prepared (for a final 
concentration of approximately 100nM). This pool of siRNAs was designated as siI and 
cells transfected with this pool were designated siI cells. Then, the concentration of the 
pool was varied in a gradient from 100nM to 10nM (final concentrations). Western 
blotting of total lysates from HaCaT cells four days after transfection was carried out 
(Figure B4A) to assess DPI and DPIb expression levels. Densitometry measurements 
revealed over 95% down-regulation of DPI with 100nM, 70nM and 40nM of siI (Figure 
B4B). In contrast, only about 60% knock-down of DPI was observed with 10nM of siI. 
DPII expression levels in siI cells remained comparable to those of mock cells and 
normal untransfected cells, regardless of the concentration of siI. These results indicate 
that the knock down efficiency does not increase with siRNA concentrations above 
40nM and suggest that this concentration is the threshold above which the RNAi 



































Figure B4. Quantitative control of the pool of siRNAs (siI) which includes si2, si3 and si4. 
(A) Western blot of proteins from total HaCaT cell lysates four days after transfection with 
different concentrations of the siI pool (from 100nM to 10nM). Normal refers to cells that have 
been incubated neither with transfection reagent nor with siRNA. Mock refers to cells that were 
incubated with DharmaFECT transfection reagent only. Positions of DPI (332KDa) and DPII 
(260KDa) and the loading control vinculin (117KDa) are indicated. DPIb is predicted to be 
279KDa. (B) DPI expression levels normalised to loading control and presented as a fraction of 
the DPI levels of mock cells. 
 
B1.4. Time-course analysis of DPI down-regulation 
DPI and DPIb expression levels were monitored 2, 4, 6 and 8 days following 
transfection with siI by western blot (Figure B5A). Two days after transfection, a 
significant down-regulation of DPI and DPIb was observed. Four days following 
transfection, the overall protein levels are higher because a larger number of cells were 
assayed when compared to day two post-transfection. However, as shown by the 
loading control (vinculin), the amount of protein loaded on the gel was always 
comparable between mock and siI cells for each time point. A significant down-
regulation of DPI and DPIb was also observed 4 and 6 days post-transfection, however, 
after 8 days DP expression starts reappearing. Densitometry analysis (Figure B5B) 
showed that while DPI was down-regulated by approximately 90% (when compared to 
mock cells for which DPI expression was taken as 100%) up to day 6 following 
transfection, only 40% of DPI knock-down was achieved 8 days post-transfection. In 
light of these results, in subsequent knock down experiments cells were always assayed 
4 days following siRNA transfection because this time point allowed for a significant 





            A 
 
            B 

















Figure B5. Time course expression of DPI. (A) Western blot analysis of proteins from total 
HaCaT cell lysates over a period of 8 days (2, 4, 6 and 8 days) following transfection with the 
siRNA pool (siI). Mock refers to cells that were incubated with DharmaFECT transfection 
reagent only. siI refers to cells that have been transfected with the siRNA pool including si2, si3 
and si4. Positions of DPI (332KDa) and DPII (260KDa) and the loading control vinculin 
(117KDa) are indicated. DPIb is predicted to be 279KDa. (B) DPI expression levels normalised 
to loading control and presented as a fraction of the DPI levels of mock cells for each 
corresponding day. DPI expression on day 0 was taken as 1 for both mock and siI cells. 
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Appendix C: Functional studies of DSPI-nonsense and DP haploinsufficiency 
mutants 
 
C1. Influence of DSPI-nonsense and DSP haploinsufficiency mutations on 
desmosomal protein expression: two independent experiments 
Two independent DSPI and DSPI/DSPII knock-down experiments were 
performed and two to four replicate western blots were carried out for each protein of 
interest. For statistical analysis, the paired t-test was used to compare means of two 
samples. A paired t-test is classically used when measurements are taken from the same 
sample before and after some treatment. However, it can also be used to compare 
samples that are subjected to different conditions, provided the samples in each pair are 
identical otherwise. NT control cells are identical to siI and siI/II cells, except for the 
fact that they are transfected with different siRNAs. More importantly, each data point 
(densitometry value) in one set is inseparably linked with a data point in the other set 
because that data point is on the same western blot and therefore subject to the same 
experimental conditions. For these reasons, the paired t-test was found appropriate for 
these experiments. 
In the first knock down experiment, HaCaT cells were transfected with 40nM 
(final concentration) of the siI pool of siRNAs (which mimic the DSPI-nonsense 
mutation) and with 40nM of the siI/II siRNA which targets all isoforms (mimicking the 
haploinsufficiency mutation). Control cells were transfected with the NT pool of 
siRNAs at a final concentration of 40nM. The total DP content was reduced to 
approximately one half when compared to the NT control, in both siI and siI/II cells 
(47% in siI cells and 43% in siI/II cells, on average). However the DPI:II ratios were 
different: approximately 1:4 in siI cells and approximately 5:1 in siI/II cells (Figures 
C1A and C1C). 
No detectable changes were observed in the expression levels of PKP2 or PKP3, 
PG and DSG2 or DSG3 in siI or siI/II cells, when compared to the NT control cells 
(Figure C1A). In contrast, PKP1 and DSC2 were reduced to about one half and DSC3 
was reduced by approximately one third in siI and siI/II cells (Figures C1B and C1D). A 
closer analysis of Figures C1B and C1D reveals that, on average, while PKP1 
expression levels are similar between siI and siI/II cells, DSC2 and DSC3 levels are 
slightly higher in siI/II then in siI cells. These trends suggest that in contrast with PKP1, 
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the expression levels of DSC2 and DSC3 are influenced by the DPI:II ratios, as the 
levels of total DP are similar between siI and siI/II cells. Moreover, the expression 
levels of DSC2 and DSC3 are slightly higher when the DPI:DPII ratio is larger and 
decrease when the DPI:DPII ratio decreases (i.e, when DPI/II ratio is 1:4 (siI cells), the 
protein level of DSC3 is 33%; when DPI/II ratio is 5:1 (siI/II cells), the level of DSC3 is 
40%) (Figures C1C and C1D). 
In order to confirm these results, a second siRNA knock-down experiment was 
performed (Figure C2) in identical conditions, except that 100mM of the siI/II was used 
instead of 40nM. The concentration of the siI pool was 40nM as before and the NT pool 
was used at 100nM. Increasing the concentration of siI/II did not alter the efficiency of 
DP knock down: DPI and DPII expression levels were on average 54% and 12% 
respectively (compared to DPI expression levels of NT control cells) in the first siI/II 
knock-down experiment (Figure C1C) and 56% and 14% respectively in the second 
siI/II experiment (Figure C2C). 
Although the same concentration of siI was used, the first experiment resulted, 
on average, in 85% down-regulation of DPI (Figure C1C) compared to 96% in the 
second experiment (Figure C2C). This difference probably reflects the inherent 
variability among transfections or western blots. Variability among transfections may 
result from slight differences in cell density at the moment of transfection and the 
clumping of cells may reduce transfection efficiency. Independent westerns blots are 
subject to slightly different conditions due to the inherent errors associated with sample 
loading on the SDS-PAGE gel or blot exposure times, which may account for the 
observed variability. 
In the second knock-down experiment, the average total DP levels were 53% of 
NT control cells in siI cells and 38% in siI/II cells, compared to 47% and 43% 
respectively in the first experiment (Figures C1C and C2C). Even though in the first 
experiment the total DP levels in siI and siI/II cells were slightly lower than in the 
second experiment, the difference in total DP levels between the two knock down 
situations was comparable. The DPI:DPII ratios were 1:24 and 4:1, respectively, in the 
second experiment compared to 1:4 and 5:1 respectively in the first (Figures C1C and 
C2C). While the DPI:DPII ratios were comparable between the two experiments in siI/II 
cells, a much larger DPI:DPII ratio was observed in the first experiment in siI cells. This 
is possibly due to two circumstances. Firstly, as mentioned before, the first siI 
transfection was less efficient than the second (85% compared to 96% down-regulation 
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of DPI, Figures C1C and C2C). Secondly, different DPI:DPII ratios were also observed 
in NT control cells between the two knock-down experiments, because the expression 
levels of DPII were lower in the first experiment (55% of DPI expression levels) than in 
the second experiment (87% of DPI expression levels) (Figures C1C and C2C). 
Therefore, the lower expression levels of DPII in NT cells as well as in siI cells 
accounted for the larger DPI:DPII ratio observed upon the first siI transfection. These 
results suggest that the DPI:DPII ratio in wild type HaCaT cells is not always the same. 
 




   





































Figure C1. Western blot and protein quantification of desmosomal proteins following 
DSPI and DSPI/DSPII knock-down suggests that DSC2 and DSC3 expression levels are 





















































Figure C1. Western blot and protein quantification of desmosomal proteins following 
DSPI and DSPI/DSPII knock-down suggests that DSC2 and DSC3 expression levels are 
dependent upon the DPI:DPII ratios in contrast with PKP1 (first knock-down 
experiment). (A and B) Western blot of total proteins from HaCaT cells, four days after 
transfection with the siI pool, the siI/II siRNA and the NT control pool. The predicted molecular 
weight of each protein is indicated on the left (KDa). (A) DPI and DPII expression levels and 
proteins which levels did not change following siRNA transfection are shown. (B) PKP1, DSC2 
and DSC3 show reduced expression levels following both siI and siI/II transfections compared 
to the NT control; however, DSC2 and DSC3 show lower expression levels in siI cells then in 
siI/II cells. Vinculin was used as a loading control. (C) Protein levels (mean±SEM) of DPI and 
DPII (n=3 blots) and total DP (DPI+DPII) normalised to loading control. DPI and DPII 
expression levels are presented as a fraction of the DPI levels of NT cells and total DP 
expression levels are presented as a fraction of the DP levels of NT cells. (D) Protein levels 
(mean±SEM) of PKP1 (n=3 blots), DSC2 (n=3) and DSC3 (n=3) normalized to the loading 
control and presented as a fraction of the respective NT control levels. PKP1 levels do not 
change between siI and siI/II cells; in contrast, DSC2 and DSC3 expression levels are higher in 
siI cells than in siI/II cells. Statistical significance between siI or siI/II and NT following paired 
t-test: * (p<0.05), ** (p<0.01), *** (p<0.001). 
 
In agreement with the first knock-down experiment, no detectable differences 
were observed in the expression levels of PKP2, PKP3 and DSG3 in either siI or siI/II 
cells compared to NT control cells (Figure C2A). The expression levels of K14 and β-
catenin were determined for the first time in this second knock-down experiment, and 
no major differences were observed between siI or siI/II cells and NT cells (Figure 
C2A). Similarly to the fist experiment, PKP1 expression levels were reduced to about 
40% and did not change between siI and siI/II cells. DSC2 levels increased on average 
from 51% to 59%; and DSC3 levels increased from 41% to 71% (Figures C2B and 
C2D). The larger increase of DSC3 levels between siI and siI/II cells observed in this 
second experiment parallels the larger increase of DPI levels (4% to 56%, Figure C2C) 
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compared to the first experiment (15% to 54%, Figure C1C). These results confirmed 
that the levels of PKP1 remain approximately constant independently of the DPI:DPII 
ratios and of subtle changes in the levels of total DP. In contrast, DSC2 and to a larger 
extent DSC3 expression levels are affected by the DPI:DPII ratios and are higher when 
DPI levels are higher, even when the total DP content decreases slightly. 
 
A                                                                        B 
 
 









































Figure C2. Western blot and protein quantification of junctional proteins following DSPI 
and DSPI/DSPII knock-down suggests that DSC2, DSG2 and DSC3 expression levels are 








































































Figure C2. Western blot and protein quantification of junctional proteins following DSPI 
and DSPI/DSPII knock-down suggests that DSC2, DSG2 and DSC3 expression levels are 
dependent upon the DPI:DPII ratios in contrast with PKP1 (second knock-down 
experiment). (A and B) Western blot of total proteins from HaCaT cells, four days after 
transfection with the siI pool, the siI/II siRNA and the NT control pool. The predicted molecular 
weight of each protein is indicated on the left (KDa). (A) DPI and DPII expression levels and 
proteins which levels did not change following siRNA transfection are shown. (B) PKP1, 
DSC2, DSG2 and DSC3 show reduced expression following both siI and siI/II transfections 
compared to the NT control; however, DSC2, DSG2 and DSC3 show lower expression levels in 
siI cells then in siI/II cells. Vinculin was used as a loading control (C) Protein levels 
(mean±SEM) of DPI and DPII (n=3 blots) and of total DP (DPI+DPII) normalised to loading 
control. DPI and DPII expression levels are presented as a fraction of the DPI levels of NT 
transfected cells. Total DP expression levels are presented as a fraction of the DP levels of NT 
cells. (D) Protein levels (mean±SEM) of PKP1 (n=4 blots), DSC2 (n=2), DSG2 (n=2) and 
DSC3 (n=3) normalized to the loading control and presented as a fraction of the respective NT 
control levels. PKP1 levels do not change between siI and siI/II cells, in contrast DSC2 and 
DSC3 expression levels are higher in siI cells than in siI/II cells. Statistical significance between 




A reduction in DSC2 and DSC3 expression levels was also observed in both siI 
and siI/II cells compared to NT cells by immunocytochemistry, confirming the results 
obtained by western blot (data not shown). 
No major changes were observed in the expression levels of DSG2 in siI and 
siI/II cells in the first knock down experiment (two replicate western blots, Figure 
C1A); however, the second knock down experiment showed that the levels of DSG2 
(two replicate western blots) decrease, on average, to 47% in siI cells and 65% in siI/II 
cells compared to NT cells (100%). This trend suggests that DSG2 expression levels, 
like those of DSC2 and DSC3, might also be affected by the DPI:DPII ratios. The 
discrepancy between the first and second knock-down experiments might reflect the 
variability among westerns blots, and a larger number of replicate western blots would 
be necessary to confirm the changes in the levels of expression of DGS2 between siI 
and siI/II cells. Additionally, this discrepancy might be due to the different DPI knock-
down efficiencies in the two independent experiments, which accounted for differences 




Appendix D: Flexcell adhesion assay 
 
D1. Optimisation of the Flexcell adhesion assay 
As described in section 5.1.3, the FX-4000T System was used to investigate 
morphological changes in cells with desmosome defects, in particular with DSP 
mutations, in response to mechanical stress. 
To optimise the stretching conditions, normal HaCaT cells were subject to cyclic 
mechanical stretch with a frequency of 2 Hz (i.e. two cycles of stretch and relaxation per 
second) and an elongation of amplitude ranging from 11-14% (i.e. increase in diameter 
across the silicone membrane from 11 to 14%). Cells were stretched for 0, 1, 2 and 3 
hours and then fixed and prepared for immunocytochemistry with an antibody raised 
against keratin 14 (LL002; see Table 2.6). Before any stretch was applied (0h), these 
cells showed a normal, well-formed network of keratin 14, which extended from the 
nucleus to the cell periphery (0h, Figure D1). Following 1 hour of stretch, thickening of 
the keratin IFs and more compact bundles were observed, particularly in the perinuclear 
region. These denser keratin IFs were more prominent after 2 hours of stretch (arrows, 
Figure D1). In contrast, following a 3-hour-stretch approximately 90% of the cells had 
lifted off the tissue culture dish, suggesting occurrence of cell death due to the 
prolonged mechanical stress. The few cells that remained adherent to the dish presented 
with keratin networks that appeared less dense than in non-stretched cells and more 
fragile, and fragmentation of filaments was observed in some of these cells, 
predominantly at free edges. 
 
 
Figure D1. Mechanical stress induces thickening of keratin 14 IFs in normal HaCaT 
keratinocytes. For optimisation of the Flexcell adhesion assay, normal HaCaT cells were 
subject to 0h, 1h, 2h and 3h of mechanical stretch of 2 Hz frequency and amplitude ranging 
from 11 to 14%. Immunocytochemistry with a keratin 14 antibody shows a normal, well-formed 
network of keratin IFs before stretch (0h), which extended from the nucleus to the cell 
periphery. Thickening of keratin IFs is observed following 1h stretch which is intensified after 
2h. Scale bar = 10µm. 
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Figure D2. Mechanical stress causes reduced cell-cell adhesion in siI and siI/II HaCaT 
cells. HaCaT cells transfected with (1) a pool of four non-targeting siRNAs (NT control cells), 
(2) a pool of three siRNAs with target DSPI (siI) and (3) an siRNA which targets both DSPI and 
DSPII (siI/II) were subject to mechanical stress using the FX-4000T™ Cell Stretcher (Flexcell 
International, USA). Cyclic stretch at a frequency of 2 Hz and amplitude ranging from 11-14% 
was applied for 0h (unstretched) and 2h. Cells were stained with (A and B) monoclonal 
antibody DP-1 against human DPI (green) and monoclonal antibody AE1/AE3 against human 
pan-cytokeratin (red) (B) Different field views of siI/II cells stretched for 2h show loss of cell-




Figure D3. Mechanical stress causes reduced cell-cell adhesion and slight increase in PG 
cytoplasmic staining in siI/II HaCaT cells. HaCaT cells transfected with a pool of four non-
targeting siRNAs (NT control cells) and a siRNA which targets both DSPI and DSPII (siI/II) 
were subject to cyclic mechanical stress of frequency 2 Hz and amplitude 11-14% using the FX-
4000T™ Cell Stretcher for 0h (unstretched), and 1h. Double immunocytochemistry of NT and 
siI/II cells with antibodies against DPI (green) and PG (red) before and after 2h of stretch. siI/II 
transfected cells show decrease of cell-cell adhesion with widening of intercellular spaces 
between keratinocytes following 2h of mechanical stress. PG staining is only present in the 





Figure D4. Mechanical stress causes reduced cell-cell adhesion but no changes in DSG2/3 
localisation in siI/II HaCaT cells. HaCaT cells transfected with a pool of four non-targeting 
siRNAs (NT control cells) and a siRNA which targets both DSPI and DSPII (siI/II) were subject 
to cyclic mechanical stress of frequency 2 Hz and amplitude 11-14% using the FX-4000T™ 
Cell Stretcher for zero hours (unstretched), 30 min, 1h and 2h. Double immunocytochemistry of 
NT and siI/II cells with antibodies against DPI (green) and DSG1/2 (red) before and after 
stretch. siI/II transfected cells show decrease of cell-cell adhesion with widening of intercellular 
spaces between keratinocytes following 1h and 2h of mechanical stress. DSG1/2 staining is 
comparable between NT and siI/II cells before and after mechanical stretch. Scale bar = 5μm. 
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Appendix E: Materials 
 
 





1µg/ml EGF  
10-8 (0.84 µg/ml) Cholera toxin 
500µg/ml Transferrin 
1.3µg/ml Lyothyronine (L4)  
 
 
E2. Molecular biology materials 
 
10x TBE 
9M Tris base 
9M Boric acid  
0.2M EDTA, pH 8.0 
 
DNA loading buffer 
50% (v/v) Glycerol 
0.2% (w/v) Orange G 
 
STE buffer 





20mg/ml Ponceau S 
0.3g trichloroacetic acid 
 
2x Laemmli buffer 
0.1M Tris-HCl pH 6.8 
0.2M DTT 
4% (w/v) SDS 
0.2% (w/v) bromophenol blue 
20% (v/v) glycerol 
 
SDS sample buffer  
0.125M Tris-HCl (pH6.8) 
4% (w/v) SDS 
20% (v/v) glycerol 
0.001% (w/v) bromophenol blue 
1.44M β-mercaptoethano. 
 
10x Running Buffer 





10x Transfer Buffer 
0.48M Tris base 
0.30M Glycine 
0.37% (w/v) SDS 
Add 20% (v/v) Methanol to 1x Transfer Buffer before use 
 
10x TBS 
0.5M Tris-HCl pH 7.5 
1.5M NaCl 
 
1x TTBS (Tween 20-TBS) 
0.05M Tris-HCl pH 7.5 
0.15M NaCl 
0.1% (v/v) Tween-20 
 
10% separating gel (in 5 ml) 
1.7 ml of Acrylamide mix [Protogel 30% (w/v) acrylamide:0.8% (w/v) Bis-acrylamide 
stock solution (37.5:1)], National diagnostics 
1.9 ml of ddH2O 
1.3 ml of 1.5 M Tris, pH 8.8 
0.05 ml of 10% SDS 
0.05 ml of APS 
0.002 ml of TEMED 
 
5% stacking gel (in 1 ml) 
0.17 ml of Acrylamide mix [Protogel 30% (w/v) acrylamide:0.8% (w/v) Bis-acrylamide 
stock solution (37.5:1)], National diagnostics 
0.68 ml of ddH2O 
0.13 ml of 1.0 M Tris, pH 6.8 
0.01 ml of 10% SDS 
0.01 ml of APS 
0.001 ml of TEMED 
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Appendix F: Homozygous mutations in the 5’ region of the JUP gene result in 
cutaneous disease but normal heart development in children (Cabral et al. 2010) 
 
